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Abstract
Quaternary carbon centres are ubiquitous in nature, typically in natural products. The
task of creating an all carbon quaternary centre, bearing an alkyl moiety with
differentiated functionalities and substituents is a desired key step in organic synthesis.
A variety of endeavours by research groups have lead to the construction of stereogenic
quaternary centres, albeit with narrow scope of substrate. Despite the repertoire of
transition metals/ligands, chiral auxiliaries and reagents available at hand, efficient
enantioselective and organocatalytic methodologies for the construction of all carbon
quaternary centres still remains a daunting challenge for synthetic chemists. One of the
most popular methods to install a quaternary centre is via a conjugate addition, the
addition of a chiral tertiary enolate to an electron deficient alkene or carbonyl compound
has led to high levels of synthetic accomplishment over generations. Our strategy to
assemble such quaternary centres focused on an organocatalytic tandem Michael-aldol
reaction, as an efficient one-pot strategy to install vicinal quaternary centres with good
levels of enantioselective induction. Initial 1,4-conjugate addition of the nucleophile
with ^-acrolein type Michael acceptors generates the enolate, which is now set up to
undergo an intramolecular aldol reaction providing the desired molecules. Molecular
complexes of this class are also amenable to further catalytic transformations and
synthetic elaborations.
This thesis presents our investigations towards organocatalytic enantioselective
strategies for the assembly of fully substituted quaternary centres.
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1.1 Origin and classification of asymmetric organocatalysis
Organocatalysis is the acceleration of a chemical reaction using a catalytic amount of a
small chiral molecule. The term was coined by Macmillan in 2000, who wished to
distinguish the new concept of metal free catalysis. However, as the German chemist
Wolfgang Langenbeck pointed out, organocatalysis is not an entirely new topic; it comes
from the well-known concept of organic catalysis. The first example of asymmetric
organocatalysis was reported by Bredig and Friske in 1912,1(a) both scientists
demonstrated that the addition of HCN to benzaldehyde can be significantly increased in
the presence of cinchona alkaloids quinine and quinidine, albeit in optical yield of
<10%. Bredig et al. underlined the importance of this fundamental concept. However,
the majority of work evolved around the Hajos-Parrish-Eder-Sauer-Wiechert reaction,
which was discovered several years later, and is now used extensively as a tool in steroid
synthesis. Their efforts involved employing (5)-proline in the Robinson annulation
which enabled them to generate a bicyclic ketol 1 with two quaternary centres, one fully
substituted and the other a tertiary alcohol. This annulation step is considered to be an
enol-d-endo cyclisation, with respect to the enamine C-C bond which is integrated in the
bicyclic framework (Scheme 1.1).
O 1) (S)-proline (3 mol%) . jj> 1) p-TsOH
Hzr
O 100%, 94%ee OH 75%, 94%ee
1 2 3
Scheme 1.1 The Hajos-Parrish-Eder-Sauer-Wiechert reaction
Despite the successful preliminary demonstration of using optically active amino acids
in C-C bond forming reactions in the 197(Ps, proline catalysis remained mostly
unexplored for a long time. However, the last decade has seen an explosive growth in
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this field. Methodologies, new catalysts, mechanistic studies and the scope of
organocatalytic reactions have been unravelled only recently. There is a plethora of C-C
bond forming reactions wherein organocatalysis plays a prominent role, for instance
Michael,3 aldol reactions 4 and alkylations.5 A prominent gap that exists in the literature
is the enantioselective organocatalytic construction of quaternary centres, presumably
due to the intricate synthesis involved.
In the past, metal and biocatalysis has dominated the field of asymmetric catalysis.
However, the issues often associated with metal catalysis, for example, toxic metals, air
sensitivity and expensive chiral ligands which are required for asymmetric induction,
prompted the renaissance of organocatalysis. Therefore, over the last decade, the
application of small organic molecules as catalytically active species (usually consisting
of carbon, hydrogen, nitrogen, oxygen, sulfur and phosphorus), has grown rapidly, given
their synthetic versatility, operational simplicity and industrial applications.
Organocatalysts can be generally classified as Lewis Bases, Lewis acids, Bronsted bases
















Scheme 1.2 Different modes of organocatalysis
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Lewis Base (B) catalysts activate the catalytic cycle initially by nucleophilic addition to
the substrate (S). The adduct will then undergo a reaction, which will release the desired
product and catalyst for further turnover. Lewis Acid catalysts activate the cycle by
activating nucleophilic substrates. Bronsted acids and Bronsted bases initiate the
catalytic cycle by partial deprotonation or protonation of the substrate. A powerful
subset of Bronsted acid catalysis is Hydrogen bond catalysis, 7 which has been
introduced as a powerful methodology in asymmetric catalysis. Several groups have
explored the broad diversity of this concept.7
Over the years, Lewis base organocatalysis has demonstrated remarkable advances in
synthetic chemistry. The most commonly used Lewis base organocatalysts are chiral
secondary amines, 8 with aldehydes and ketones being the common substrates.
Activation of the carbonyl substrate can take place in one of two ways, either by
enamine formation (raising the HOMO), or by iminium ion formation (lowering the
LUMO). The double activation mode of these organocatalysts is what labels them as
suitable candidates for organocascade reactions. The scope of these secondary amine
organocatalysts is limited to carbonyl systems; within this class, the use of a-acroleins
as suitable substrates represents a highly demanding task. One of the striking features of
utilising a-acroleins as starting materials is that products of such reactions are ideal for
further elaboration towards complex bioactive molecules.
The enantioselective formation of stereogenic quaternary carbon centres still remains a
daunting challenge in organic synthesis. In organic synthesis, there is a growing need to
provide efficient methodologies for the construction of these quaternary carbon centres.
Quaternary carbon stereogenic centres with four different non hydrogen substituents are
found in a wide range of important natural products and pharmaceutical drugs. 9 Fig 1.1













Tazettine 5 Physostigmine 6
Ph Me
(-)-FR901483 7
Fig 1.1 Selected examples of natural products and drugs bearing a quaternary
centre
Generally, quaternary centres are constructed by employing chiral auxiliaries, ligands,
catalysts or by the functional group transformation of meso compounds. 10 Despite the
requirement of stoichiometric amounts of chiral auxiliaries, they still serve as a valuable
source of asymmetric induction. To date, the existing methods to install a fully
substituted quaternary centre involve using expensive chiral metal complexes, chiral
ligands and chiral auxiliaries. The discovery of environmentally friendly methodologies
for the production of fully susbstituted quaternary centres remains a demanding task.
1.2 Existing methodologies for quaternary centre construction
The installation of a quaternary centre remains one of the most constrained methods in
organic synthesis. This is possibly due to the restricted access to commercially or




Scheme 1.3 Existing strategies for quaternary centre construction
Although vast arrays of synthetic reactions exist for the construction of C-C bonds, there
are only four main classes 10a of C-C bond formation, which lead to the creation of a
fully substituted carbon, each of which possess their own limitations and advantages.
These comprise of (1) the ionic formations, which involve the addition of a tertiary
carboanion 9 to a carbocation 10; rearrangements (2), oxidative and reductive couplings
(3) and cycloaddition reactions (4) (Scheme 1.3). Ionic constructions, wherein one new
C-C bond is formed offer a considerable degree of flexibility, as a vast range of diverse
electrophilic reagents can be employed. Rearrangements, are becoming of importance in
organic synthesis, for example, the [1,3] rearrangement of /3-cyclopropylenones 13
provide spirobicyclic systems 14 in moderate yield. I0b However, one of the drawbacks
with rearrangements is the tendency for deleterious side reactions to take place.
Oxidative and reductive couplings, are rarely synthetically useful, due to numerous side
reactions, for example, polymerisation and the steps are often fraught with regio control
issues. In contrast, cycloaddition reactions have great importance in synthetic chemistry.
Moreover, two new C-C bonds are constructed with high levels of predictable
stereocontrol.
Here the primary focus will be on the enantioselective construction of quaternary
centres, by means ofwhich the addition of tertiary nucleophiles to electrophiles results
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in the construction of quaternary centres. In recent years, 1,4-conjugate additions have
been extensively reviewed 11 and, therefore this section will highlight some of the most
relevant examples of asymmetric 1,4-conjugate addition methodologies
(organocatalytic/metal mediated) to create fully substituted quaternary centres, with a
view to demonstrate their general application in tandem Michael-aldol reactions. 12
1.3. Asymmetric conjugate additions to afford all carbon quaternary centres
Over the last decade, there have been considerable efforts from a number of research
groups in designing new enantioselective conjugate addition methodologies.3 Conjugate
additions (1,4-additions) of carbon nucleophiles to acceptor activated C-C multiple
bonds are considered to be one of the most versatile and vital reactions for the
installation of an all carbon quaternary centre.14 Until recently, the most efficient
strategy for quaternary centre generation, involved employing catalytic amounts of
transition metal catalysts. In 1992, Ito 14 and co-workers demonstrated the prominent
role of chiral phosphine ligands which are promoted by transition metal complexes
(Scheme 1.4). This rhodium/ligand complex served as an effective catalyst for the first
asymmetric enantioselective Michael reaction of chiral transition metals with a-cyano
carboxylates 21 and vinyl ketones 20 to give the desired product 22 in good yield and
enantioselectivity.












Scheme 1.4 Rhodium catalysed asymmetric Michael addition
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The breakthrough in catalytic enantioselective conjugate addition reactions for installing
quaternary centres was established by Shibisaki and co-workers. 15 He demonstrated that
heterobimetallic catalysts are applicable in Michael reactions with methyl vinyl ketone
20 and cyclic 6-membered nags containing /2-ketoesters 23 to give rise :o products with
fully substituted quaternary centres (Scheme 1.5). The reaction was found to proceed in
high yield and enantioselectivity in non polar solvent CH2CI2; it is thought that the Na
enolate will remain coordinated to one of the oxygens of LSB 25,15 thus allowing slow











Scheme 1.5. Catalytic Asymmetric Michael reaction promoted by LSB
The asymmetric 1,4-conjugate addition reaction is most certainly a versatile tool for the
preparation of chiral building blocks, a more recent example of such a reaction is the
copper catalysed 1,4-addition to trisubstituted cyclohexenones (Scheme 1.6). 13
Et,AI
1) catalyst 28 (4 mol%)







Scheme 1.6 Addition ofAlEt3to various 3-substituted cyclohexenones
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Alexakis 16 et al. have demonstrated that trialkylaluminium reagents undergo a copper
catalysed conjugate addition with trisubstituted enones in the presence of coordinating
solvents. Following extensive optimisation; copper thiophene carboxylate in Et20 with
the biphenol-phosphoramidite ligand 28 was found to provide best results, affording the
desired product 27 in excellent yield and enantioselectivity. With successful
demonstration of this methodology, the group were now in the position to explore
further applications of these chiral building blocks.
Alexakis et al,16 reported an additional route for the construction of fully substituted
quaternary centres broadly similar in scope to their previous studies. In this instance, a
more reactive primary organometallic was employed. Their initial efforts focused on
locating chiral ligands which were complementary to copper. A series ofN-heterocyclic
carbenes were screened, employing trisubstituted enone 26 and ethyl magnesium
bromide as a model study. In all cases, the conversion was high; however low
enantioselectivities were observed in some cases. In an attempt to tackle this problem, a
different class of NHCs were synthesised and, to their delight, NHC 30 exerted high
levels of reactivity and enantioselectivity. It is thought that the success of this catalyst is
due to the fact that the chiral substituents around the C-N axis are locked in a rigid




Scheme 1.7 Construction Quaternary centres via a copper-NHC organocataiyst
A plethora of variables were explored, primary and secondary Grignard reagents both
displayed high levels of enantioselectivity in the presence of 30. Also, in this
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unprecedented asymmetric conjugate addition reaction, various tri-substituted
cyclohexenones were suitable candidates.
The above discoveries are all very relevant. However, the limitations of such reactions
include the sensitivity of transition metals to air and moisture, the high cost of ligands
and their fiddly synthesis, the toxicity of the metals, where there tends to be an
expensive recovery procedure for waste treatment. The operational simplicity of
organocatalytic reactions makes it an attractive method for the construction of complex
molecules; inexpensive bench stable catalysts can be employed in organocatalytic
reactions under an aerobic atmosphere in wet solvents. In this regard, there have been
considerable efforts to find organocatalytic alternatives to metal catalysis for the
construction of fully substituted quaternary centres. Some of the notable examples are
reported herein.
1.3.1 Miscellaneous metal mediated tandem Michael additions to create quaternary
centres
Frontier 17 et al. have demonstrated the feasibility of a domino-Nazarov-Michael
cyclisation using cationic Ir(III) complex 34 which proves to be a highly efficient
catalyst in this cyclisation. A broad range of cyclopentenone systems are constructed
bearing three contiguous stereocentres, one ofwhich is a quaternary centre in high yield
with excellent diastereoselectivities. In order to achieve the best results, a reagent
combination ofN-ethylpiperidine (EPP) and complex 34 is mandatory. It is thought that
Lewis acid activation of nitrostyrene 32 via an enolate facilitates a facile intermolecular
Michael addition. In an attempt to rationalise the stereochemical outcome of this
reaction, Frontier et al. have reasoned that the Michael addition takes place on both
faces of the nitroalkene from one face of the enolate; simple model studies are the main
supporting element of this notion. Its possible application in asymmetric synthesis is an
appealing feature of this methodology. By employing chiral organocatalysts,







1) catalyst 34 (4 mol%)








Scheme 1.8 Domino Nazarov cyclisation Michael addition catalysed by Ir(III)
complex
Krische et al. reported the enantioselective 18 tandem conjugate addition-aldol
cyclisation of enone-diones, in which two covalent C-C bonds are created with control
of absolute and relative stereocontrol. This transformation in particular affords five and
six membered rings with two fully substituted quaternary centres, albeit one of the
quaternary centres is present in the prochiral starting material (Scheme 1.9). Employing
[Rh(COD)(OCH3)]2 as the precatalyst and phenyl boronic acid derivatives as the
nucleophile, results in the production of highly diverse products.
1) [Rh(COD)(OCH3)]2 (2.5 mol%)




3) ArB(OH)2 (200 mol%)
Dioxane (0.1 M), 95 °C





Scheme 1.9 Rhodium catalysed tandem-conjugate addition-aldol cyclisation
In an analogous fashion to Krische et al. the intramolecular tandem Michael-aldol
reaction has been explored by Greaney et al. 19 However, tetrabutylammonium iodide is
employed as the nucleophile and a-substituted enoate aldehydes and ketones were
11
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elected as suitable prochiral starting materials in an attempt to construct fully substituted
quaternary centres, which are the most difficult to synthesise. This powerful variant of
the tandem Michael-aldol reaction has only been reported by one other group.20 One of
the attractive features of thi; reaction is the nucleophile is integrated mto the product,
thus enabling an intramolecular aldol reaction providing single diastereomers of cyclic
products with both a fully substituted quaternary centre and vicinal tertiary centre.
Treatment of enoate-aldehyde 37 in DCM with a stoichiometric quantity of the Lewis
acid TiCl4 and B114NI, gratifyingly gave rise to cyclopentanol 38 with high levels of
diastereoselectivity. Naturally, the scope of the reaction was explored and it was found
that the reaction was amenable to heterocyclic synthesis.
O 1) TiCI4 (1 equiv) O
II 2) Bu4NI X
» MeoXrA
II g DCM, 0 "C 'X-V
37 81 % H° 38
9 examples
yield: 47-81%
Scheme 1.10 Lewis acid promoted tandem iodo-aldol cyclisation
The stereochemical outcome of the cyclisation was arrived at by utilising one of the six





Scheme 1.11 Stereochemical rationalisation for tandem-Michael-aldol cyclisation
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The CH2I group prefers to exist in the least hindered equatorial position, as opposed to
occupying the more hindered axial position, thus explaining preferential construction of
the trans product 41.
1.4 Chiral auxiliary mediated 1,4 conjugate additions
The application of chiral auxiliaries, in organic synthesis is an attractive strategy to
introduce chirality into a compound, by virtue of the fact that simple organic molecules
can be employed to generate a temporary stereocentre, usually created by steric
hindrance from the auxiliary. Besides their importance in asymmetric synthesis, they
often tolerate a wide range of substrates and functional groups, whilst preceding under
mild reaction conditions. In addition to this the auxiliary is easily and quantitatively
recycled. One of the main applications of chiral auxiliaries is their fundamental
contribution in enamine catalysis. The success of enamine catalysis is owed to the fact
that they are synthetic equivalents of the parent carbonyl compound and, with enhanced
nucleophilicity; enamines can then undergo a conjugate (Michael-type) addition with a
broad range of electrophilic acceptors.
D~Angelo 21 et al. reported the intermolecular Michael addition of various cyclanones
with a vast range of electrophilic acceptors, utilising (£)-(")" i -phenylethylamine as the
chiral auxiliary, which was initially reported by Pfau et al. as a universal chiral auxiliary
(Scheme 1.12).22
Me. Ph Me. Ph /
Ph-. ^ V u
11 /—NHj H N H N' -|) o 201) Me 45 II 1
^ O"" 6"" 2) H30®
44 4g 47 83%, 89%ee




The chiral imine 46 was treated with methyl vinyl ketone 20, which after hydrolysis
leads to diketone 48 with good levels of reactivity and enantioselectivity. Besides
controlling the regioselectivity, at the more substituted a-position, the absolute
configuration of the newly created stereogenic centre is controlled by employing chiral
auxiliary 45. The intermolecular Michael reaction tolerates both electron withdrawing
groups (EWG), positioned in the ^-position to the carbonyl group and nitrogen and
oxygen atoms incorporated within the cyclanones, albeit with decreased levels of
reactivity and enantioselectivity. After exploration of a series of chiral auxiliaries, a
significant decrease in enantioselectivity was observed when chiral auxiliaries, not
bearing an aromatic group a to the amine moiety, were employed.
D'Angelo 23 et al. demonstrated the versatility of this class of auxiliary. In order to
achieve the enantioselective formation of a spiro centre (fully substituted quaternary
centre), they sought to develop an intramolecular variant of the Michael reaction, giving
rise to spiro centres. Keto ester 49 was condensed with (R)-1 -phenylethylamine 50 at
reflux, giving rise to imine 51. Under high temperature conditions, imine 51 underwent a
6-exo-trig cyclisation to afford spiro derivative 52 with high levels of stereocontrol.
Hydrolysis of imine 52 led to the formation of ketoester 53 in good yield (Scheme 1.13).
Ph Me
Pk V







Scheme 1.13. Preparation of spiro [5.5] undecane derivative 53
It is worthy of note that certain crotonates are unreactive to enamines in the
intermolecular Michael addition. Nevertheless, in the intramolecular reaction an increase
in reactivity and yield is observed with the bifunctional starting material 49. It is thought
that the success of this is due to entropic factors.
14
Introduction
In conclusion, D'Angelo 23 et al. have demonstrated efficient routes for the installation
of fully substituted all carbon quaternary centres, by employing readily available chiral
auxiliaries 45 and 50. Both intramolecular and intermolecular Michael additions are
feasible with a-substituted enones, giving rise to complex molecules with high levels of
regio- and stereo control. Important features of such processes include the ability of the
chiral auxiliary to promote such processes under mild and neutral reaction conditions.
Stille et al. have reported 24 that high asymmetric induction can be achieved when
tetrasubstituted enamines undergo a Michael addition with acryloyl chloride in the
presence of (R)-1 -phenylethylamine, giving rise to d-lactam products 55 with high levels
of diastereomeric excess (Scheme 1.14).
Et02C
54
Scheme 1.14 Aza-Annulation ofyS-enamino esters with acryloyl chloride
Best results were obtained with Et20-BF3 (to promote enamine formation) and (R)-1 -
phenylethylamine 50 in refluxing THF, employing acryloyl chloride as the Michael
acceptor. Surprisingly, no Lewis acid catalysts or high pressure 25 was required for the
reaction to proceed with high levels of reactivity and stereoselectivity; generally the
reactions had gone to completion after 4-6 hours. In order to investigate the outcome
different substituents on the chiral framework would have on the stereoselectivity of the
reaction, a series of chiral auxiliaries were employed. Any deviation from the use of




2) Et20-BF3 f^r^l ® examples
m y'eW: 43-92%3) acryloyl chloride 0 N q r; 57:43 92:8
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scope of the reaction, substituted acrylate derivatives were employed to test the
feasibility of the simultaneous formation of two stereogenic centres. To their delight, the
formation of two vicinal stereogenic centres concomitantly is successful. However,
significant loss in yield of the aza-annulation product is observed, which is partially due
to impurities arising from side reactions. The aza-annulation serves as a valuable




1.5 The application of chiral auxiliaries in natural product synthesis
Auxiliary mediated Michael reactions are employed in natural product synthesis 26 to
strategically create fully substituted quaternary centres. D'Angelo et al. have
demonstrated the application of their previously reported methodology, 22 towards the
construction of optically active diterpenes and steroids. l-Methyl-2-tetralone 56 was
treated with (S)-(-)-1 -phenylethylamine 45 in toluene and set to reflux, addition of
methyl vinyl ketone gave rise to ketol 59 in good yield. Ketol 58 was subjected to p-
TsOH in toluene, after 2 h the desired (i?)-phenanthrone 59 was generated in moderate
yield and excellent enantioselectivity via a retro aldol/aldol cyclisation. The quaternary
centre was established via the chiral auxiliary mediated Michael intermolecular step with











2) AcOH (20%), 20 «C I
70% 70%, 92%ee
56 ' " ' 57 HO 58 59
Scheme 1.15 Enantioselective synthesis of ring-C aromatic steroids via an
asymmetric Michael addition
The major alkaloid encountered in periwinkle, Vincamine was synthesised via a
stereocontrolled elaboration of a quaternary centre. The asymmetric Michael conjugate
addition was employed as the key step 27 to install the quaternary centre. This, in turn,
led to the construction of the [ABD]-type subunit. Early on in the synthesis it became
apparent that installation of the quaternary centre was necessary at the beginning of the
synthetic route. Chiral auxiliary (i?)-l-phenylethylamine 50 was treated with 60 to
generate enaminolactam 61 in good yield. Formation of enaminolactam 61 set the
foundations for the intermolecular Michael addition with
17
Introduction
electrophilic partner methyl acrylate. It was suspected that the presence of the keto
group (enamine carbonyl) was responsible for the failure of the B-N cyclisation. In spite
of this a new synthetic route was devised in order to circumvent the B-N cyclisation
issue. Reduction of the keto group with LiAlH(Ot-Bu)3 in THF led to the formation of
the desired secondary alcohol, together with reduction of the ester to the carboxylic acid.
After a series of transformations/deprotections, the intramolecular cyclisation was
feasible. In the presence of NaHMDS in toluene, cyclisation of 63 afforded
enantiomerically pure 64a, employing Oppolzer's protocol, resulted in a mixture of




















(i) NaHMDS, t-BuONO, toluene
Scheme 1.16 Enantioselective synthesis of (+)-Vincamine 65
By utilising (R)-phenylethylamine 50 as the chiral auxiliary, installation of the crucial
quaternary centre was achieved through an asymmetric conjugate Michael addition. The
18
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desired (+)-Vincamine 65 was synthesised, albeit in poor overall yield (1.2 %) in a linear
sequence from commercially available tryptamine. The synthesis demonstrates the
synthetic utility of chiral auxiliary 50 as an efficient asymmetric inducer in the
intermolecular asymmetric Michael reaction, affording new quaternary centres in a
stereocontrolled manner. It is thought that the remarkable stereocontrol can be
rationalised due to synclinal arrangement of the Michael acceptor with the enamine
nucleophile 61.
Scheme 1.17 Rationale for preference of endo product
Mechanistic studies 28 strongly suggest that alkylation takes place anti to the phenyl ring
of the chiral moiety, thus generating the (R) configuration of the quaternary centre. The
alkylation predominantly takes place at the more substituted a-side of the enamine
functionality, the enamine attacks the electrophile from the endo face; this attack
strongly prevails over the exo face. The endo approach is favoured, due to orbital
interaction between the nitrogen of the enamine and the electron withdrawing group of
the Michael acceptor 69. However, the ewdo-preference is disfavoured when the Michael
acceptor possesses a bulky substituent in the a-position. D'Angelo et al. demonstrated 28
that by utilising a variety of a,/^-substituted alkenyl acceptors, an additional stereogenic
centre could be created adjacent to the all carbon quaternary centre, albeit with the
19
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possibility of trace amounts of the regioisomeric product. Chiral imines have
demonstrated impressive synthetic utility in the formation of all carbon quaternary
centres, hence the demand to elaborate on existing enantioselective variants.
1.6 Intermolecular enantioselective organocatalytic conjugate addition
reactions
The organocatalytic direct asymmetric conjugate addition reaction is without a doubt, a
powerful and versatile method for C-C bond formation. Thus, considerable efforts have
been put forward, in order to provide molecules with enantiomerically enriched
quaternary centres.
Wynberg and Helder 29 reported the first catalytic enantioselective conjugate addition
reaction to construct all carbon quaternary centres, utilising the cinchona alkaloid
quinine.
14 examples
ee; not determined in every case
Scheme 1.18 Asymmetric Michael addition utilising quinine
Conducting the reaction in toluene at room temperature in the presence of quinine gave
rise to the desired adduct 74 in 87% yield. Chiral shift reagent Eu(tfc)3 was added to
product 74 in CDC13 in small portions resulting in two separate methyl peaks of the ester
group being observed in the 'H NMR, the peaks were integrated to give a 1.3:5 ratio,
representing 56% e.e. The scope of the reaction was extensively investigated; a series of
Michael donors were compatible with the reaction conditions with methyl vinyl ketones,
whilst maintaining a high level of enantioselectivity and chemical yield.
20
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Despite the synthesis of all carbon quaternary centres being intrinsically difficult,
Barbas et al.30 have demonstrated the success of the direct Michael reaction of
tt,a;-disubstituted aldehyde donors with (£)-/?-nitrostyrene Michael acceptors, giving
rise to Michael products witn all carbon quaternary centres.
0,N. 1) catalyst 78 (30 mol%) O Ph










d.r: up to 89:11
ee; up to 91%
Scheme 1.19 Catalytic Michael reaction using chiral-amine bifunctional catalysts
Barbas 30 et al. found that when (£)-(+)-1-(2-pyrrolidinylmethyl) pyrrolidine/TFA was
employed as a bifunctional catalyst 78 in the Michael addition between
nitrostyrene 32 and isobutyraldehyde 76, the reaction proceeded in excellent yield with
good levels of enantioselectivity. Further studies confirmed that a series of a,a-
disubstituted aldehydes are tolerated in this class of Michael reaction whilst maintaining
high levels of conversion and enantioselectivity.
Jorgensen 31 and co-workers, shortly after disclosed a highly enantioselective conjugate
addition of /?-dicarbonyl compounds with alkynones 79. Good yields and
enantioselectivities were obtained with various /?-diketones and aromatic alkynones



























Scheme 1.20 Intermolecular enantioselective conjugate addition to alkynones
In order to obtain the configurationally stable (£)-enone 81, addition of a catalytic
amount of BU3P selectively was found to isomerize the E/Z mixture in a one-pot
procedure without having a detrimental effect on yield or enantioselectivity. One of the
attractive features of this methodology is that complex molecules with quaternary
centres and C=C double bonds are generated in one pot, which provide a functional
handle for further transformations.
In 2005, Deng 32 and co-workers further explored this field of organocatalysis. The
asymmetric conjugate addition of cyclic keto esters with nitroalkanes was efficiently
mediated by the modified bifunctional cinchona alkaloid quinine 85. The 1,4 adducts
were generated in a 4.5:1 ratio when the reaction was carried out at rt; nevertheless when
the reaction was cooled to -60 °C, an impressive increase in diastereoselectivity was
observed 18:1. The enantioselectivity is consistent in most cases, regardless of the
temperature of the reaction. Based on the kinetic results which are consistent with a
bifunctional catalysis mode and the increase in stereoselectivity in aprotic solvents, they
are able to propose that the catalyst adopts a gauche-open conformer transition state,




Scheme 1.21 Stereoselective creation of quaternary centres utilising cinchona
alkaloid derivatives
Not only does this reaction represent a highly enantioselective and diastereoselective
organocatalytic conjugate addition for the stereocontrolled formation of all carbon
quaternary centres and tertiary centres, it sets the foundations for the synthesis of highly
complex chiral building blocks for future manipulation.
Encouraged by the success of this C-C bond formation, Deng 32 and co-workers further
explored conjugate additions. However, in this instance, «,/?-unsaturated ketones were
employed as the Michael acceptor.33 When 1 mol% of modified organocatalyst quinine
90a was employed; the reaction between cyclic tert-butyl ketoester 86 and methyl vinyl
ketone 20 proceeded smoothly in excellent yield and enantioselectivity. The scope of the
reaction was investigated, and, to their delight, they found aromatic cyclic/acyclic ft-
ketoesters are also good candidates for the Michael addition to methyl, ethyl and aryl
vinyl ketones, albeit with an increase in catalyst loading and reaction times. In order to
install a fully substituted quaternary centre adjacent to a tertiary centre, /^-substituted
enones were employed (Scheme 1.12). High enantioselectivities and
diastereoselectivities were attained when both five- and six-membered cyclic enones
were employed utilising organocatalyst 90b. The conjugate addition of a tri-substituted
carbon to sterically hindered Michael acceptors is a formidable challenge. Here, they
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have demonstrated the feasibility of this highly efficient conjugate addition using
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Scheme 1.22 Enantioselective conjugate addition of ketoesters to a,/?-unsaturated
enones
Chiral phase transfer catalysts are an additional class of organocatalysts which have
demonstrated excellent asymmetric induction in the construction of all carbon
quaternary centres. Maruoka 34 et al. discovered that in the presence of chiral quaternary
ammonium salt 92, /?-ketoester 86 underwent a highly enantioselective phase-transfer
alkylation with benzyl bromide. The addition of solid inorganic bases, for example
CsOH.H20 in addition with conducting the reaction at -40 °C increased the reaction rate
and the enantioselectivity to 95% e.e. for product 91. Having successfully demonstrated
the feasibility of this conjugate addition and with optimised conditions in hand, the
scope of the reaction was explored.
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Scheme 1.23 Phase-transfer catalytic asymmetric Michael reaction
Functionalised benzylic side chains and 2-alkoxycarbonylcyclohexanones have also
demonstrated high levels of reactivity and enantioselectivity in this particular alkylation.
The reaction of /?-ketoester 86 with methyl vinyl ketone 20 proceeded smoothly under
similar conditions to afford products which comprise of three different functionalities of
carbonyl origin.
Bifunctional thiourea organocatalysts have proved to be a powerful class of catalysts due
to their strong hydrogen bonding ability to a series of functional groups. Previously, urea
derivatives have been employed in a wide range of reactions, for example, the Pictet-
Spengler, Mannich and Strecker reactions, whilst attaining high levels of enantiomeric
excess. Takemoto 7 et al. designed a new chiral bifunctional organocatalyst which
possesses an amino group and a thiourea moiety embedded in a chiral framework.
Thiourea organocatalysts have been generally realised to play a specific role in
organocatalysis to achieve high levels of enantioselectivity. The double hydrogen-
bonding interaction of the N-H with the nitroolefm and the activation of the nucleophile
with the tertiary amine results in high levels of enantioselectivity. Generally, thioureas
tend to be only partially soluble in non polar solvents; this is presumably due to strong
intermolecular hydrogen bonding interactions. However, the presence of the tertiary
amine aids the solubility.
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Scheme 1.24 Bifunctional thiourea catalysed intermolecular Michael reaction
The Michael reaction between /?-nitrostyrene 32 and a-substituted malonate 93 in the
presence of thiourea catalyst 95, proceeds efficiently to afford product 94 in 89 % yield.
In order to optimise this reaction, first of all a series of thiourea derivatives were
screened in an attempt to examine the effect the diamine moiety and the substituents on
the aromatic ring have on the reaction stereoselectivity. Thiourea organocatalyst 96 was
found to exert the best levels of asymmetric induction. It is thought that catalysts bearing
two trifluoromethyl groups display better activity due to the increase in acidity of
thiourea N-H groups. The second variable that was investigated was the size of the ester
group on the nucleophile. In the case of tert-butyl ester the reactivity of the malonate
had decreased, leading to trace amounts of the desired product. When malonate 93 was
employed the reaction had gone to completion in 24 hours affording the desired product
with high levels of enantioselectivity. It appears that in order to achieve high levels of
reactivity the acidity of the malonate is crucial.
Thiourea organocatalyst 95 was found to be a suitable organocatalyst with not only
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Scheme 1.25 Addition of prochiral 1,3-dicarbonyl substrates with nitroleflns
In the above Michael reaction, 7 coupling of /?-nitrostyrene 32 and 1,3-dicarbonyl 96
gave rise to desired adduct 97 in excellent yield and enantioselectivity. Further
investigations into substrate tolerance revealed that when bicyclic /?-ketoesters are
engaged as the reacting partners; it is possible to obtain 97 in high yield and
enantioselectivity. A series of nitroolefins were tolerated in the reaction, albeit with
longer reaction times; yields and enantioselectivities were not affected. In order to
elucidate the reaction mechanism, the reaction of /Tnitrostyrene 32 and diethyl malonate
was carried out utilising thiourea 95. Conducting the reaction in methanol, for instance,
resulted in diminished levels of enantioselectivity, a plausible explanation for this is that
MeOH interacts with 95 via hydrogen bonding, disturbing the interaction between
thiourea 95 and /?-nitrostyrene 32 through a network of hydrogen bonding. Solvents such
as THF reduced the activity of thiourea organocatalyst 95, resulting in decreased levels
of reactivity. In order to elucidate a reasonable explanation for the stereochemical
outcome, the following mechanism was proposed (Scheme 1.26). It is believed that the
tertiary amine of thiourea catalyst 95 deprotonates one of the acidic protons of 98, which
leads to complex (A). The thiourea moiety then interacts with the nitroolefin 32. Due to
the presence of the cyclohexyl group, approach of the nucleophile by transition state (C)
is disfavoured. It seems likely that the reaction will proceed via complex (B), which in
turn will lead to the (D). Transition state (D) then undergoes hydrolysis to afford the
desired product bearing a fully substituted quaternary centre.
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Scheme 1.26 Elucidation of stereochemical outcome
Takemoto 7 et al. have synthesised a new class of bifunctional organocatalysts and, in
addition, they have demonstrated their use in asymmetric Michael reactions, affording
adducts in both high levels of enantioselectivity and diastereoselectivity.
Due to the abundance of highly reactive nitroalkenes, it is understandable that they are
elected as suitable Michael acceptors, in the journey to design new organocatalysts.
Connon and co-workers 35 have reported that by modifying cinchona alkaloid templates,
1,2-diamine catalysts can be synthesised, which have demonstrated high catalytic
activity in the diastereo/enantioselective nitro-Michael addition reaction with a,a-
disubstituted aldehydes (Scheme 1.27). Based on developments made by other groups 36'
37 who have demonstrated the advantages associated with fine tuning of the chiral
environment of cinchona alkaloids, a series of amine analogue organocatalysts were
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prepared. In their findings the 9-amino derivative of dihyroquinine catalyst 101 proved
to be the best catalyst in conjunction with benzoic acid under solvent free conditions at
rt. This particular class of organocatalysts have the capacity to catalyse the nitro-Michael
addition reaction, whilst tolerating a broad range of substrates.
MO, 1) catalyst 101 (10-15 mol%) 0 ph








Scheme 1.27 9-epi-amino cinchona alkaloid derivatives as efficient organocatalysts
In 2005, Deng and co-workers 38 reported the first highly enantioselective catalytic
Michael addition of «,a-disubstituted carbonyl Michael donors with vinyl sulfones. The
reaction was successfully carried out in a non air or moisture sensitive environment
which was catalysed by cinchona alkaloid derivative 90a to afford the fully substituted
all carbon quaternary centre product 104 (Scheme 1.28). Both Quinine and Quinidine
forms of organocatalyst 90a displayed excellent levels of enantioselective induction.
During the organocatalyst screening, it was evident that the presence of an hydroxyl
group in the C-6 position and an alkyl or aryl group on the C-9 position displayed the
better levels of enantioselective induction, contrary to the use of the natural cinchona
alkaloids, which generated the 1,4-adduct as a virtually racemic mixture. In an attempt
to explore other parameters, a range of a-cyanoacetates with diverse electronic and
steric properties were employed. The nature of the a—cyanoacetate was not detrimental
to the enantioselectivity. To their delight, the Michael addition proceeds smoothly with
or-alkyl a-cyanoacetate 102 when 3,5-bis (trifluoromethyl) phenyl vinyl sulfones are
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employed as the electrophiles. A prominent feature of this asymmetric conjugate
addition reaction is its application to the formation of a,a-disubstituted amino acids.
CO,Et
CN










Scheme 1.28 Enantioselective conjugate additions with vinyl sulfones
Following the success of Deng, Chen 39 et al. demonstrated that bifunctional thiourea-
tertiary amine derivatives of type 105 serve as excellent organocatalysts in the
enantioselective asymmetric Michael addition of a-substituted cyanoacetates with vinyl
sulfones, which in turn lead to all carbon quaternary centres, one of the attractive
2 2 •
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Scheme 1.29 Enantioselective Michael addition of a-cyanoacetates with vinyl
sulfones
In order to test the feasibility of the Michael addition utilising a-substituted
cyanoacetates with vinyl sulfones, the reaction was conducted in toluene in the presence
of a bifunctional thiourea derivative 105. In all cases, the addition product was isolated
in good yield. The catalyst which exhibited highest levels of enantioselectivity was the
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acyclic thiourea 105 which was derived from (i?,i?)-l,2-diphenyl ethylenediamine. A
series of a-aryl substituted ethyl cyanoacetates were also suitable Michael donor
candidates, excellent enantioselectivities were achieved in all cases; or-alkyl
cyanoacetates were also applicable in this reaction. Vinyl sulfone 103, however, was
replaced with the highly electrophilic l,l-bis(benzenesulfonyl)ethylene as the Michael
acceptor. This reaction serves as an accessible route for the enantioselective formation of
products with quaternary centres; moreover these products can then smoothly be
2 2converted into y3 ' -amino acids which have significant biological importance.
Dixon and co-workers have recently represented 40 a judicious diastereo- and
enantioselective Michael addition reaction utilising 5-aryl-l,3-dioxolan-4-ones 106 as
pro-nucleophiles, whereby thiourea derivative 108 catalyses the reaction. Given the
general stability, high conformational rigidity and hydrogen bonding proclivities
associated with these thiourea derivatives, it is not surprising why they promote this
intricate C-C bond formation (Scheme 1.30). 41
Scheme 1.30 Enantioselective Michael addition of 5-Aryl-l,3-dioxolan-4-ones
Their findings suggest that in order to promote smooth intermolecular addition of 5-
phenyl-3-dioxolan-4-ones to /?-nitrostyrene 32, the presence of the two CF3 groups is
necessary. The CF3 groups sufficiently lower the pKa of the acidic protons, allowing
enolisation to take place. With optimised conditions in hand for the reaction between 5-
phenyl-3 -dioxolan-4-ones 106 and yff-nitrostyrene with thiourea 108, naturally the scope
of the Michael addition was surveyed. In the case of ort/zo-substituents on the Michael
acceptor, increased enantioselectivities were observed, albeit with an increase in reaction
R 108
R=3,5-(CF3)2-Ph18 examplesyield: 58-92%




times. Likewise a series of different aryl groups on the Michael acceptor were tolerated.
Simple hydrolysis of this acetal functionality is used to facilitate a wide range of further
transformations. One of the remarkable features of this intermolecular Michael addition
is the utilisation of ^-substituted enones, which successfully installs the fully substituted
quaternary carbinol.
Macmillan and co-workers 42 reported the first organocatalytic Mukaiyama-Michael
addition. Iminium ion catalysis provided ^-butenolide adducts in good yields with
excellent enantioselectivities. Their anticipation of initial iminium-ion formation of
chiral amine 112 with a,/?-unsaturated aldehyde derivatives indeed was feasible because
it is the higher reactivity of the iminium-ion species in comparison to the carbonyl group
which facilitates the addition of the furan 109. A vast range of furan derivatives are
tolerated in the reaction, without having a damaging effect on the enantioselectivity. It
also noteworthy, that the nature of the ^-olefin has very little influence on the
stereochemical outcome of the reaction.
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DBNA = 2,4-dinitrobenzoic acid 12 ®xaJTpJ®®yield: 73-87%
R= Pr d.r: syn/anti 1:6,24:1
ee: 84-99%
Scheme 1.31 Direct method for the synthesis of enantioenriched y-butenolide
architecture
An application of these compounds is further manipulation of these ^butenolides 111
can result in the synthesis of spiculisporic acid, which has significant importance in
metal decontamination processes and fine polymer production.
The thiol addition is a well known 1,4-addition reaction which is important in both
biochemical processes and in synthesis. It is, therefore, of interest to develop an
organocatalytic enantioselective variant of the reaction. Oriyama 43 et al. recently
reported a solvent free procedure to afford chiral sulfides with fully substituted
quaternary centres; this was achieved by employing organocatalyst 117. This particular
reaction (Scheme 1.32), works well with /^-substituted a,^-unsaturated aldehydes of
type 113, high enantioselectivities and yields are obtained. Attractive features of this
methodology are the significant substrate flexibility, the reaction tolerates both /?,/£■
disubstituted and a,//-unsaturated aldehydes, thus leading to frilly substituted carbon
centres in the presence of their highly hydrophobic organocatalyst 117. Reduction of






Scheme 1.32 Intermolecular asymmetric conjugate addition of thiols to
a,/^-unsaturated aldehydes
1.7 Enantioselective organocatalytic intramolecular conjugate additions
As previously demonstrated by various groups, there are a number of elegant
enantioselective intermolecular Michael additions for the construction of quaternary
centres, but there is a lack of enantioselective intramolecular Michael reaction variants.
Remarkable progress was reported 44 by List et al. whereby cyclic ketoaldehydes were
furnished in excellent yields and enantioselectivities. In the presence of Macmillan's
first imidazolidinone catalyst 120, a wide range of formyl enones underwent smooth
cyclisation to afford ketoaldehydes 119. The ketoaldehydes are also applicable in
tandem sequences. It is thought that this class of reaction can be further investigated: for
instance by introducing an a-substituent on the aldehyde, an entire new field of
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first reported organocatalytic enantioselective intramolecular
A notable case of an intramolecular Michael addition to create three contiguous
stereocentres, whereby one of which is a quaternary centre has been carried out by
Hayashi and co-workers. Prochiral substrate 121 was synthesised from 3-
ethoxycyclohex-2-en-l-one in a coherent six step sequence. After extensive screening,
the trifluoroacetic acid salt of cysteine derived amine 123 was found to provide excellent
levels of enantioselectivity and diastereoselectivity of bicycle [4.3.0] nonene products
122 (Scheme 1.34).
1) catalyst 123 (10 mol%)
CH3CN. 0 "C





Scheme 1.34 Cysteine-derived organocatalyst promotes intramolecular Michael
reaction
One of the attractive features of this methodology is bicycle [4.3.0] nonene carbon
skeletons are synthesised in one step via an enamine intermediate, which selectively
attacks one of the enantiotopic tz—bonds. Carbon skeletons of this type are found in a
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wide range of natural products, thus explaining the synthetic utility of this Michael
reaction.
Based on the discovery by Hayashi, 45 an organocatalytic oxidative dearomatisation
strategy was developed by Gaunt46 and co-workers (Scheme 1.35).
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Scheme 1.35 Enantioselective dearomatisation strategy utilising pyrolidine
derivatives
Prochiral phenol starting materials 124 are readily oxidised with PhI(OAc)2 to afford
meso-cyclohexadienones 125 in the presence of protic nucleophiles. Catalyst 127
promotes the intramolecular Michael addition reaction to afford a range of highly
functionalised polycyclic molecules 126. In order to develop optimum conditions for the
dearomatisation and intramolecular Michael reaction, wiaso-cyclohexadienone 125 was
isolated and used as a model substrate. In the presence of Jorgenserfs organocatalyst, the
reaction proceeded in both moderate yield and enantioselectivity. In contrast, replacing
the phenyl groups on the chiral framework with two naphthyl groups significantly
improved the diastereo/enantioselectivity due to better facial selectivity in the
desymmeterisation step. The reaction tolerates a broad range of variables. Biaryl phenols
are good candidates for the cyclisation, and non oxygen nucleophiles can also participate
in the cyclisation. The incorporation of heteroatoms in the tether also proves to be
effective in this reaction, allowing for the construction of highly diverse enantiopure
products in high yield. However, substitution on the phenol ring resulted in poor
diastereo/enantioselectivity. The stereochemistry is rationalised via a transition state,
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which strongly suggests the naphthyl groups shield one face of the enamine, the n-n
interaction between the meso-cyclohexadienone and the enamine favours an endo attack
leading to high levels of stereocontrol. This methodology demonstrates the viability of
this class of reaction; highly diverse structural architectures possessing quaternary
centres are synthesised in a simplistic manner.
1.8 Asymmetric conjugate additions in natural product synthesis
Aforementioned, conjugate additions are very important C-C bond forming strategies,
especially in the installation of quaternary centres for natural product synthesis. The
existing methodologies to install quaternary centres via a conjugate addition are reliable
and robust, and several groups have demonstrated the utility of these organocatalytic
enantioselective methodologies in key steps of natural product synthesis.47(a) Macmillan
and co-workers have reported the use of their secondary amine 47(b) organocatalyst 112
in a novel addition cyclisation for the total synthesis of (-)-Flustramine B 131; the
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Scheme 1.36 Total synthesis of (-)-Flustramine B
Pyrroloindolines 128 are a subclass of alkaloid motifs which have been isolated from a
diverse range of natural sources. They have shown to demonstrate remarkable biological
activity, hence the desire to develop new enantioselective methods for the construction
of these complex molecules.
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This conjugate addition of indoles to a,/^-unsaturated aldehydes is achieved with high
levels of of enantiocontrol when the tosic acid salt of chiral catalyst 112 is employed.
Addition of the indole 128 to iminium ion 132, gives rise to the desired fully substituted
quaternary centre. The pending amine group then undergoes a 5-exo-heterocyclisation to
the indolium ion 134, giving rise to tricyclic structure 135, whilst regenerating
imidazolidinone catalyst 112. This class of conjugate addition tolerates both diverse




Given the success of the intermolecular conjugate addition of indoles to a,/funsaturated
aldehydes reported by Macmillan et al. 47'48 Banwell and co-workers 49 employed this
strategy to install the fully substituted quaternary centre. The central issue involved in
the synthesis of these novel anti-cancer agents, is the installation of the quaternary
centre. With a view to install the quaternary centre via an intramolecular Michael
reaction in an enantioselective manner, Macmillan's imidazolidinone 120 was employed
as the organocatalyst to ensure smooth cyclisation affording enantioenriched
tetrahydroindolizine 138. Due to the instability of 138, reduction to the primary alcohol
was carried out to determine the enantiomeric purity. With the stable alcohol in hand the
complete synthesis of 139 was accomplished.
O









1) KOH.EtOH, 18 "C „
pi. , / : MeOjC.









Scheme 1.38 Total synthesis of (-)-leuconolam and (+)-ep/-leuconolam
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Treatment of 140-141 with PCC in the presence of 4 A molecular sieves, generated a
separate mixture of (-)-leuconolam 142 and (+)-e/?/-leuconolam 143. Here, the success
of the intramolecular Michael reaction provides an efficient enantioselective assembly of
fully substituted quaternary centres.
1.9 Enantioselective tandem Michael-aldol reactions
Tandem reactions are those which involve a combination of two or more reactions,
which take place in a consecutive manner.50 Asymmetric tandem transformations are an
attractive strategy for the construction of complex molecules with one or more
contiguous stereocentres. The advantages of this class of reaction are the reaction takes
place in one pot using a single catalyst, while producing less waste and minimising
excessive handling. Tandem organic reactions are often initiated by conjugate additions.
The secondary reaction can then occur in an intermolecular or intramolecular manner
leading to the desired adduct, without isolation of the intermediates (Scheme 1.39).
Scheme 1.39 Typical tandem-Michael aldol cyclisation
Due to the high demand for efficient methods to access these complex molecules by
both academia and industry, considerable efforts have been put forward, in order to find
new methodologies for catalytic asymmetric enantioselective tandem transformations, as
to date there is a lack of tandem Michael-aldol reactions, which result in the formation
of quaternary centres.
One of the first notable examples of a tandem Michael-aldol reaction was reported by
Murphy 51 et al. this reaction was mediated by secondary amines, thiols and phosphines.
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Treatment of ketone 148 in chloroform with an excess ofpiperidine afforded 150 in 60%
yield. In each and every case, one single diastereomer was produced. This observation
led them to believe that the reaction takes place through initial conjugate addition of the
amine, subsequently generating the enol which can then undergo an intramolecular aldol
cyclisation.
yield: 20-93%
Scheme 1.40 Tandem Michael aldol reaction mediated by secondary amines
Cyclic adduct 150 was found to be stable for <6 days, without any sign of the
elimination Baylis-Hillman product. Murphy et al. rely on the union of prochiral starting
material 148 and nucleophile piperidine, for the installation of quaternary centres.
It is worth emphasising that the above tandem Michael-aldol reaction proceeds in the
presence of an achiral secondary amine (Scheme 1.40). Therefore, it appears that by
introducing a secondary chiral amine into this reaction may indeed result in some
enantioselective induction in Michael additions. Chiral amines can serve either to attack
the Michael acceptor in the /^-position, or activate the Michael acceptor by forming an
iminium species or an enamine intermediate. In regard to enantioselective tandem
reactions triggered by conjugate additions, there have been considerable efforts put forth
by many research groups. 12'52 However, the installation of an all carbon quaternary
centre via an organocatalytic enantioselective tandem Michael-aldol reaction still is in its
infancy.
With a view to create C-C bonds in a consecutive manner, and given the lack of
enantioselective organocatalytic strategies in the literature Jorgensen53 et al disclosed
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the first highly enantioselective and diastereoselective organocatalytic tandem Michael-
aldol reaction. Inspired by Macmillan's imidazolidinone organocatalyst, they developed
an imidazoline which was synthesised from readily available phenylalanine.
Catalyst 155 exhibited high levels of enantioselective induction in previous studies for
the enantioselective conjugate addition of nitroalkanes, 54 /Tketoesters 55 and 1,3-
dicarbonyl substrates 56 to a,/^unsaturated enones. To their delight the reaction preceded
in various solvents but, on closer inspection, the use of protic solvents increased yields
significantly. Ethanol was elected as the solvent for further reactions. In the presence of
catalyst 155 in ethanol, cyclohexanone 153 is generated via a tandem Michael-aldol
transformation.
154
Scheme 1.41 Tandem Michael-aldol reaction of acyclic ^-ketoesters with a,fi-
unsaturated ketones
It is thought that chiral catalyst 155 catalyses the intermolecular Michael reaction by
initial iminium ion formation with Michael acceptor 151, which then lowers the LUMO
of the acceptor, rendering it more electrophilic. In addition to forming the iminium ion,
organocatalyst 155 acts as a base by deprotonating the /2-ketoester 152, which readily




isomers. Nevertheless, the intramolecular aldol reaction takes place via in a six
membered chair transition state which sets the large groups in an equatorial position
leading to high levels of diastereoselctivity. In order to determine the scope of the
tandem Michael-aldol reaction, various aromatic and heteroaromahc /^-substituted
unsaturated ketones were treated with /Tketoester 152 to afford cyclohexanones with
high levels of reactivity and enantioselectivity.
Further developments of this class of reaction were explored. 57 The reaction scope can
be extended to /?-diketones and /Mcetosulfones as Michael donors with a,(3 -unsaturated
enones in the presence of catalyst 155 (Scheme 1.42).
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Scheme 1.42 Enantioselective Tandem Michael-aldol reaction of y5-diketones with
a,y3-unsaturated ketones
One of the advantages of this approach is optically active cyclohexanones are
synthesised in a one pot procedure, bearing ketone and sulfone functionalities. The
reactions proceeded well using various electron donating and electron withdrawing
group's substituted on the a,/?-unsaturated ketones. Various a,/?-unsaturated ketones
reacted with 2-phenylsulfonylacetophenone 156 to form cyclohexanones in a
diastereoselective and enantioselective fashion. Cyclohexanones possessing these
functional groups are then attractive substrates for facile transformations.
Given the success of the tandem Michael-aldol reaction previously reported by
Jorgensen, 53 curiosities prompted the research group to further investigate other
possibilities of this class of reaction.58 Given the biological activity associated with
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sulfur containing compounds, 59 employing thiols as the nucleophilic source was an
attractive route to explore. One of the notable observations in this account is that acidic
conditions promote the formation of the quaternary centre tetrahydrothiophene
carbaldehyde 164. However, in the presence of base, a different pathway is taken which
results in the formation of tetrahydrothiophene 163. The outcome of the reaction


































In both cases, acidic or basic, the reaction proceeded well in toluene yielding the
tetrahydrothiophene derivatives. When thiol 159 was treated with ^^unsaturated
aldehyde 158 in the presence of benzoic acid and organocatalyst 165, the asymmetric
tandem reaction favoured the formation of 164. Based on the product generated in the
presence of the acid, it is thought that following the Michael reaction, the catalyst
accelerates the intramolecular aldol reaction, whereas in the presence of the base, simple
enolisation of 160 followed by a diastereospecific aldol reaction lead to the formation of
163. The higher levels of enantioselectivity observed with tetrahydrothiophene 164
reflect this argument. This mechanistic study provides strong evidence that the
enantiodiscriminating step is in the Michael addition and no further enantioselective
induction takes place in the second catalytic step. Tetrahydrothiophene carbaldehydes
164 undergo smooth reduction to afford the corresponding alcohols. This functional
group transformation can be used to mediate a wide range of reactions to form stable
aromatic thiophenes.
Cyclopentenes are found in a vast range of bioactive molecules, thus there has been
considerable interest by organic chemists to develop efficient asymmetric methods for
their construction. However, in the past the general methods are transition metal
mediated. Wang and co-workers 61 have efficiently assembled functionalised chiral
cyclopentenes, by means of an organocatalysed cascade Michael-aldol reaction. Besides
the installation of a quaternary centre, two new C-C bonds are generated in one pot with
high yields and enantioselectivities.
CHO
°
O CS-~0Me 1) catalyst 169 (10 mol%) R (
H +
2) NaOAc (0.5 equiv)
R o C!(CHACI Me°=CC°2Ma
166 167 rt 168
d a mo o u 88%, 92%eek-4-nu2o6H4 11 examples
yield: 63-89%
ee: 91-97%
Scheme 1.44 Enantioselective assembly of functionalised chiral cyclopentenes
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They decided to use dimethyl 2-oxoethylmalonate 167, as a suitable substrate, not only
is it a stable electron rich nucleophile, but also has an electrophilic aldehyde, which
serves as an efficient electrophile for the subsequent intramolecular aldol step. It is also
thought that malonate 167, as a nucleophile will prevent undesirable side reactions, this
is presumably due to the ease in which it is enolised together with the steric hindrance. It
has been demonstrated that a,^-unsaturated aldehyde 166 with dimethyl 2-
oxoethylmalonate 167 in the presence of 10 mol% of catalyst 169 is most efficient in
terms of yield and enantioselectivity.
1.10 Wang's thiol mediated tandem Michael-aldol reactions
In 2006, Wang et al. disclosed 58 a new enantioselective organocatalysed tandem
Michael-aldol reaction which furnished thiochromenes in high yields and
enantioselectivities (Scheme 1.45). Simple activation of aldehyde 171 with chiral
pyrolidine 165 and benzoic acid as an additive, led to formation of the iminium ion;
nucleophilic conjugate addition of thiol 170 to the iminium ion then triggers the cascade
Michael-aldol process, which subsequently undergoes dehydration to afford the desired
thiochromene 172. Following extensive screening, the reaction was found to be
applicable with a variety of unsaturated aldehydes and 2-mercaptobenzaldehyde
derivatives. At first glance, it may seem straightforward to install a quaternary centre
within this class of molecule; one may simply employ <z-substituted aldehydes, which
subsequently would inhibit the dehydration step. However, iminium ion activation with
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Scheme 1.45 Cascade Michael-aldol reaction using 2-mercaptobenzaldehydes
Given the broad utility of the thiol promoted Michael-aldol reaction (vide supra), Wang
fO
and co-workers embarked upon an oxygen variant of this class of reaction. This
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Scheme 1.46 One-pot approach to chiral chromenes
However, to their surprise no reaction occurred when the same reaction conditions for
the thio-Michael aldol reaction were employed. In an attempt to ascertain the reason
behind this, a series of different organocatalysts were surveyed, which closely resembled
169. To their delight, the reaction between rraws-cinnamaldehyde 154 and
salicylaldehyde 173 with 30 mol% (S)-diphenylpyrrolinol triethylsilyl ether 169
proceeded smoothly affording chromene 174 in high yield and enantioselectivity, albeit
with considerably longer reaction times. The oxa-Michael-aldol reaction was tolerant to
a diverse range of substrates, but reaction efficiency and enantioselectivity varied
depending on the electronic and steric nature of the a,/^-unsaturated aldehyde.
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Given that tandem reactions serve as a powerful tool for the construction of complex
structures in both academic and industrial laboratories, Wang 63 et al. further
investigated this class of reaction. In this instance, benzothiopyrans were generated in a
concise fashion, again using the tandem Michael-aidol process (Scheme 1.47). Three
contiguous centres are generated with high enantio and diastereoselectivity. Wang and
co-workers envisioned that by changing the aldehyde to a carboxylic acid derivative the
undesirable dehydration process may be avoided, therefore creating two further
stereocentres.
Scheme 1.47 Thiourea promoted Michael-aldol reaction of 2-mercapto-
benzaldehydes with a,/^unsaturated oxazolidinones
They anticipated that the conjugate addition step may be accelerated by changing the
nature of the Michael acceptor from an aldehyde to an oxazolidinone. This hypothesis
was based upon the capacity ofbifunctional thiourea catalysts to form multiple hydrogen
bonding interactions with the Michael acceptor. In the presence of thiourea 177, the
tandem thio-Michael aldol reaction proceeds smoothly in just 1 hour, affording
benzothiopyrans 176 in high chemical yield (Scheme 1.47). The overall reaction
efficiency is not influenced by the electronic and steric nature of the Michael acceptor,










organocatalyst. From these results they concluded that in order to achieve high levels of
enantiocontrol, the basic and acidic functional group on the catalyst's framework must
be correctly orientated towards the Michael acceptor, together with a network of
hydrogen bonds.
1.11 Conclusions
An extensive survey of existing methodologies, which lead to the construction of all
carbon quaternary centres, has been reported. The construction of complex organic
molecules bearing quaternary centres represents one of the most important synthetic
challenges. This, in some measure, is due to the abundance of quaternary carbon centres
found in a wide range of naturally occurring compounds, and the high level of stereo-
and regiocontrol which can be achieved by employing an organocatalyst. In this respect,
both the enantioselective inter- and intramolecular variants of the conjugate addition
have proven to be a prominent strategic theme in natural product synthesis.
The stereoselective synthesis of natural products relies on asymmetric conjugate
additions to install quaternary centres. These complex molecules can then undergo
further manipulations. Quaternary centres are found in a vast array of natural products.
There are endless examples, Napalilactone, 64 Vincamine, (+)-Quebrachamine, 65 (-)-
Aspidospermidine, (-)-Eburnamomine, physostigmine and podocarpic acid, all ofwhich
depend on an asymmetric conjugate addition to install the all carbon quaternary centre.
The enormous versatility associated with the asymmetric conjugate addition makes it a
highly desirable method to construct complex building blocks, which would be difficult
to obtain by other means.
Several groups have elegantly utilised both inter- and intramolecular asymmetric
conjugate additions, as an efficient way to install quaternary centres. All modes of
organocatalysis are applicable in this class of reaction, Lewis acid, Lewis base, Bronsted
acid and Bronsted Base. Without a doubt, Lewis Base organocatalysis is the most
abundant in organocatalysis, hence the extensive review herein. However, the use of
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chiral H-bond donors (Bronsted acids) is becoming an attractive emerging field in
organocatalysis. It is worthy to note that the majority of asymmetric conjugate additions
are intermolecular and involve acyclic starting materials. This may be due to several
factors, first of all the abundance of readily available acyclic starting materials, and
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Given the importance of oxygenated five membered rings in medicinal and natural-
12
product chemistry, ' our principal aim was to devise a novel organocatalytic
enantioselective methodology, for the assembly of five membered carbocycles. Fig 2.1
shows representative examples of cyclopentanoids embedded within natural products.
Laurene 183 Helenalin 184
Fig 2.1 Representative cyclopentanoid natural products
The construction of six-membered rings plays a dominant role in synthetic organic
chemistry. However, with regard to the assembly of five-membered rings; there is no
particular cyclopentannulation strategy. The isolation of various terpene natural
products, instigated investigations by several research groups for the construction ofnew
cyclopentannulation strategies (Fig 2.1). Prominent methodologies are the Pauson
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Khand reaction, [3+2] cycloaddition of olefins, ring closing metathesis and the Nazarov
cyclisation (Fig 2.2).
Fig 2.2 Existing cyclopentannulation strategies
However, given that the existing routes are confined to a narrow substrate class, we
embarked upon developing a new organocatalytic enantioselective cyclopentannulation
methodology for the synthesis of highly functionalised enantiopure cyclopentanoids. We
reasoned that iminium ion catalysis in the Nazarov cyclisation could be employed as an
elegant asymmetric catalytic route for their synthesis.
2.2 Nazarov Cyclisation
The Nazarov electrocylclisation was discovered in 1949, by Ivan Nikolaevich Nazarov.
This class of reaction 3 generally involves the use of cross-conjugated enones, which
upon treatment with a Lewis acid or Bronsted acid induces the formation of a
pentadienyl cation 199. The cation then undergoes a thermally allowed
4tt—electrocyclisation; resulting in migration of the proton, followed by tautomerisation
of the enol to afford the cyclopentenone 200. The double bond will usually reside in the




Scheme 2.1 Nazarov electrocyclisation mechanism
Over the years, there has been considerable interest in the Nazarov cyclisation. 4-6
Besides, the simplicity in generating the dienone precursors, the reaction proceeds under
mild reaction conditions with fast reaction times.
Work carried out within the Greaney group, illustrates the success of the Nazarov
cyclisation under mild reagent free conditions, 7 i.e. in the absence of a strong Lewis
acid promoter. Divinyl ketones of type 203 in the absence of any harsh acid promoter
undergo cyclopentannulation in the presence of heat, producing a reagent-free
transformation. The success of this transformation was compatible with both
a,a1—dialkyl and oxyallyl dienone substrates, which indicates that the reaction is
tolerant to a broad range of functional groups. The most prominent feature of this
methodology is the development of these neutral conditions may be applicable with acid
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Scheme 2.2 Reagent free Nazarov cyclisations
The Nazarov reaction is one of the few electrocyclisations which are subject to catalysis.
However, despite the synthetic utility of this cyclisation, it was not until 2003 that
asymmetric variants began to surface in the literature.
Aggarwal 5 and Trauner, 6 reported the first asymmetric Nazarov cyclisation, utilising
chiral Lewis acids in 2003. They envisioned that asymmetric induction can be achieved
if the direction of conrotation can be controlled. Divinyl ketones bearing an ester moiety
in the a-position, together with copper box complexes were employed as suitable
substrates in order to test the effect these substrates would have on the conformation of
the Lewis Acid substrate complex. The levels of reactivity and stereoselectivity were
capricious; nevertheless substituting the ester moiety with an amine resulted in higher
levels of reactivity and stereoselectivity. This is most probably due to the decrease in
electron withdrawing ability of the amine. In the presence of a stoichiometric amount of
copper bisoxazoline 207, CuBr4 and AgSbFg, divinyl ketone 205 undergoes smooth
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Scheme 2.3 Asymmetric Nazarov cyclisations using chiral bisoxazoline Lewis acids
In an effort to address the issues often associated with Nazarov cyclisations, for
truly catalytic enantioselective Nazarov reaction, involving an asymmetric protonation
as the key step which is promoted by chiral Lewis acid 210 (Scheme 2.4). Employing 2-
alkoxy-l,4-pentadien-3-ones as substrates together with scandium pybox complex 210,
gave rise to cyclopentenone 209 in good yield. It is thought that substrates of type 208
(not bearing a substituent at the /^-position), are responsible for the higher levels of
enantioselectivity. This is most probably due to strong coordination of the chiral ligand
to the Lewis acid and not the termini of the divinyl ketone 208. A catalytic amount of
scandium pybox complex 210 provides cyclopentenones in relatively high e.e., whilst
addressing the regio-and stereoselectivity issues often associated with this class of
electrocyclisation.
Scheme 2.4 Enantioselective Nazarov cyclisation via an asymmetric proton transfer






Frontier, 4 Trauner 6 and co-workers have demonstrated that the Nazarov cylclisation can
proceed in the presence of a catalytic amount of Lewis acid.
However, the outstanding development with regard to the Nazarov cyclisation, is the
invention of an organocatalytic asymmetric variant. Rueping 8 et al. in 2007 reported the
first enantioselective organocatalytic Nazarov reaction, by means of employing chiral
Bronsted acids (Scheme 2.5).
Scheme 2.5 Brensted acid catalysed Nazarov cyclisation







Over the years, the application of Bronsted acid catalysis has been introduced as a
powerful methodology 8 in asymmetric catalysis. However, despite the demonstrated
success of catalysis through hydrogen bonding; 9 its application in electrocyclisations
has not been extensively researched.
Based on the central function performed by Bronsted acids, Rueping et al. envisioned
that catalytic protonation of a divinyl ketone would be feasible by employing chiral
binol phosphates (BH*). Activation of the electrophile by catalytic protonation would
result in the formation of the intermediary chiral ion pair (pentadienyl cation and the
phosphate anion) B adduct, subsequent anticlockwise conrotatory 4 71 electrocyclisation
gives rise to oxyallyl cation C, which following regioselective elimination of a proton
gives rise to D. The enol is then reprotonated by the phosphonate, which results in the
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Scheme 2.6 Bronsted acid catalysed Nazarov cyclisation
Excellent levels of enantioselectivity were achieved utilising chiral binol phosphates.
However, by employing catalyst of type 214, not only was there an increase in reactivity
but additionally there was a significant increase in diastereoselectivity and
enantioselectivity. This may be due to the increase in acidity of the Bronsted acid in
comparison to the binol phosphate, as the presence of the N-trifyl group 10 increases the
stability of the counteranion and lowers the pKa of the acidic proton, thus increasing the
reactivity. With the optimised conditions in hand, a variety of diverse divinyl ketones




2.3 Results and Discussion I
At the beginning of our study, no organocatalytic enantioselective variant of the Nazarov
cyclisation had surfaced in the literature. It still remains a daunting challenge in
organocatalysis. The challenges often associated with the Nazarov reaction involve
controlling the regio and stereoselectivity in the proto/deprotonation steps, in addition to
possible racemisation of the cyclopentenone if cyclisation takes place slowly.
Due to the scarcity of asymmetric variants in the literature, we embarked on a novel
asymmetric Lewis base organocatalysed cyclopentannulation strategy, which could in
principle generate any cyclopentanoid structure as a single enantiomer.
We envisaged that if a simple chiral amine was added to a divinyl ketone 215, a chiral
divinyl iminium ion 216 could be generated, subsequently this increase in
electrophilicity of the carbonyl functionality will promote torqueselective cyclisation,
giving rise to aminallyl cation 217, followed by hydrolysis in situ to regenerate the chiral
amine catalyst together with the desired cyclopentenone 219.
Scheme 2.7 Organocatalytic iminium ion mediated cyclisation
However, on close inspection, there are a number of factors which have to be considered
in order to achieve our goal. One of the most prominent being initial iminium ion
formation between the divinyl ketone and the amine. Divinyl ketones tend to be
deactivated towards nucleophilic attack at the carbonyl group, in addition with the steric
hindrance accompanied with a number of Nazarov substrates. In this instance, it is
therefore essential that the catalyst has the ability to undergo initial iminium ion
formation with the divinyl ketones.
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Our aim was to develop a catalyst which had the capacity to mediate a wide range of
enantioselective organocatalytic reactions; above all focussing on organocatalysts for
application in the Nazarov reaction.
We sought to develop a novel catalyst which would undergo facile iminium ion
formation; would be hydrolytically labile to permit catalyst turnover and last of all must
exert excellent asymmetric induction. The pioneering work demonstrated by Macmillan
11
et al. whereby chiral imidazolidinones exhibit high levels of asymmetric induction in
the enantioselective Diels-Alder reaction, prompted us to consider chiral hydrazines and
hydroxylamines as a potential class of organocatalysts which would be fit for application
in the Nazarov electrocyclisation. These two classes of compound are excellent
nucleophiles, due to the neighbouring heteroatom (the a-effect). 12'13
19
Tomkinson et al. have extensively explored the ar-effect concept in iminium ion
catalysis. A series of experiments were carried out in order to establish whether the
incorporation of a heteroatom adjacent to the nucleophile increased the rate of iminium
ion formation, which is believed to be the rate determining step in this class of reaction.
By utilising the Diels-Alder reaction as a model study, their endeavours did suggest that
the incorporation of an adjacent heteroatom does indeed accelerate the rate of reaction
significantly.
An additional feature when considering nucleophilicity is the nitrogen cone angle. As
demonstrated by Tomkinson 12 et al. acyclic nucleophiles bearing a heteroatom adjacent
to the nitrogen atom are reactive catalysts in the Diels-Alder reaction. However, cyclic
derivatives lead to an increase in reaction rate and yield of isolated products. It is
thought that the underlying explanation 13 for this is due to the conformational restriction
produced by the cyclic ring, as the ease ofwhich hybridisation can take place in cyclic
derivatives is considerably more difficult than acyclic. For this reason, together with an
increase in equilibrium constant (due to stabilisation of the iminium ion), explains why
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secondary amines embedded within a five membered ring are far more efficient as
organocatalysts than primary amines.
In an attempt to develop novel catalysts which have the capacity to provide an effective
platform for iminium ion catalysis with deactivated divinyl ketones, we focussed on
synthesising chiral secondary amines embedded within a chiral framework which would
have the ability to impart facial selectivity (Fig 2.3).
Blocking group to impart facial selectivity
Fig 2.3 Pyrazolidinones and oxadiazolidinones as potential organocatalysts
Enhance nucleophilicity




2.3.1 Enantioselective synthesis of 1,2,4-Oxadiazolidinone 230
Taking into consideration all of the above features, we embarked upon the synthesis of a
novel enantiomerically pure secondary amine organocatalyst. Initial studies involved the
racemic synthesis of pyrrazolidinones, but since kinetic resolution was required in order
to obtain one enantiomer of the desired product, we decided to abandon this approach,
due to poor isolated yield of the racemic pyrrazolidinone. Synthesis of pyrrazolidinone
223 is depicted in (Scheme 2.8).
EtOH
222 0 °C 223
47%
Scheme 2.8 Pyrrazolidinone racemic synthesis
We envisaged a more direct approach, which did not involve resolution. Captivated by
the work carried out by Carreira et al. which involved the synthesis of 1,2,4-
Oxadiazolidinones 14 as configurationally stable chiral building blocks, we decided to
adopt this route as an efficient way to gain access to five-membered rings which possess
the desired features necessary in order to ascertain their potential as versatile
organocatalysts. At first glance, this route seems to be an elegant way to incorporate
highly diverse functional groups within the catalysts framework. In addition to the
carbonyl group present on the a-heteroatom which will facilitate the iminium-ion
hydrolysis.
The origin of enantioselectivity is created by employing a mannosyl derived chiral
auxiliary 15 (Scheme 2.9). D-Mannose 224 is converted to acetonide 225, upon treatment
of 225 with N-hydroxylamine hydrochloride in ethanol, giving rise to high levels of




this is evidenced by exposure of 226/227 to anisaldehyde in toluene at high temperature
resulting in the formation ofnitrone 228.
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Scheme 2.9 Chiral auxiliary mediated synthesis of oxadiazolidinone 230
Nitrone 228 is treated with benzyl isocyanate. This concerted 1,3-dipolar 16
cycloaddition leads to the construction of 1,2,4-oxadiazolidinone 229 with extremely
high levels of diastereoselectivity. After filtration, the cycloadduct 229 is triturated with
methanol, leaving behind a white solid. The next step is removal of the sugar derived
auxiliary. Exposure of cycloadduct 229 to acidic media in MeOH/fEO, eliminates the
isopropylidene groups to give the tetrol, this is demonstrated by tic, the reaction is left
standing until complete hydrolysis, whereby the 1,2,4-oxadiazolidinone 230 is released
together with the water soluble carbohydrate remnant.
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In conjunction with the synthesis of cycloadduct 230, other derivatives were synthesised
in order to have an array of 1,2,4-oxadiazolidinones at hand. It is necessary to
incorporate blocking groups which have the ability to impart facial selectivity.
Pivaldehyde was selected as a suitable candidate, given its steric hindrance implications.
Treatment of nitrone 234 with ethylisocyanate, proved to be disappointing, tic analysis
displayed unreacted starting material, which after prolonged reaction times lead to
decomposition.
Cycloadduct 232 was synthesised in an analogous manner to 230, though hydrolysis of
the auxiliary proved to be troublesome. Employing the stated conditions resulted in




































Scheme 2.10 Modification of 1,2,4-oxadiazolidinone 230
233
In an effort to overcome the limitations associated with auxiliary hydrolysis, we carried
out a series of experiments. First of all, several variations in reaction conditions were
attempted, for example, different acids, reduction in reaction temperature, and a
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decreased number of acid equivalents were employed in order to circumvent the
hydrolysis issues. However, all attempts failed to yield the desired hydrolysed
oxadiazolidinone 233 (Scheme 2.10).
It is thought that the oxadia :olidinone 232 degrades in the presence of acid, due to the
presence of the labile N-0 bond.
2.3.2 Lewis base Nazarov cyclisation
Table (2-1) Attempts to hydrolyse the sugar derived auxiliary
Entry Acid Conditions Product 233
1 p-TsOH(lOeq) Me0H/H20(6:l) 50 °C decomposition
2 (-)CSA(lOeq) Me0H/H20(6:l) 50 °C decomposition
3 p-TsOH(lOeq) Me0H/H20(6:l) 0 °C decomposition
4 p-TsOH(5eq) Me0H/H20(6:l) 0 °C decomposition
5 p-TsOH(5eq) DCM, rt decomposition
To examine the feasibility of a novel Lewis Base Nazarov cyclisation, we envisaged
employing oxadiazolidinone 230 as the free amine in the Nazarov cyclisation directly,
together with an acid co-catalyst. Simple divinyl ketone substrates (Scheme 2.11) were
synthesised as suitable models, to explore this concept. Following literature 17
precedents, divinyl ketones of type 236 were synthesised in a simple manner.
Straightforward Grignard addition to the appropriate aldehyde gave rise to the desired




Table (2-2) Optimisation of Lewis base organocatalysed Nazarov cyclisation
Entry Substrate Acid/Catalyst Conditions Yield
(mol %) (%)
1 236 TFA(IO) DMF, rt, 18h 66
2 236 TFA/230(10) Me0H/H20(19 1), rt, 24h 73
3 236 TFA/230(10) MeOH/H20(19 1),70 °C, 16h 58
4 236 TFA/230(20) MeOH/H20(19 1),70 °C, 16h 61
5 236 TFA/230(100) Me0H/H20(19 1), rt,10-12h 76
6 236 TFA/230(10) Me0H/H20(19 1),-78°C, 32h 59
Initial investigations involved exploring the feasibility of this cyclopentannulation
strategy utilising substrate 236. First of all, a catalytic amount of TFA was added to 236
in DMF, this served as the control experiment. To our delight, after 18h at rt,
cyclopentenone 237 was isolated in good yield. Following this result, we repeated the
reaction, in this instance oxadiazolidinone organocatalyst 230 was introduced with a
view to imply asymmetric induction. Due to the insolubility of oxadiazolidinone 230 in
DMF, we opted to replace DMF with a MeOH/FLO mixture. After 24 h at rt, 237 was
isolated in slightly higher yield (Table 2-2, entry 1 vs 2), albeit with prolonged reaction
times. This was an encouraging result, as it suggested the background reaction was not
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performing a prominent role, therefore iminium ion catalysis indeed could be taking
place. In an attempt to reduce the reaction time, the reaction was repeated and left to
reflux at 70 °C, we were pleased to isolate the clean product after 16 h, albeit in slightly
attenuated yield. In an attempt to keep reaction time to a minimum, together with good
yield of the cyclopentenone, the catalyst loading was increased to 20 mol%. However,
the reaction rate was consistent, regardless of a slight increase in catalyst loading (entry
3 vs 4). In the presence of a stoichiometric amount of organocatalyst 230, both yield and
reaction rate increased. However, in order to avoid employing one equivalent of
oxadiazolidinone 230, we envisaged that with optimisation, similar results could be
obtained with a catalytic quantity of 230. When the mixture was kept at lower
temperatures (< -78 °C), cyclisation was slower, however, in spite of this the chemical
yield of divinyl ketone 237 was reasonable. (Table 2-2)
With an assay in hand of cyclopentenone 237, we were enthusiastic to determine if
iminium ion catalysis/Bronsted acid catalysis was taking place when oxadiazolidinone
230 was introduced in the reaction, moreover, if 230 provided an asymmetric
environment for the cyclisation. Analysis by chiral HPLC was used as a suitable method
to determine the enantiomeric excess. Initially, separation by means of a chiralpak OD-
H column proved to be problematic. However, after optimisation, a clean trace of
racemic cyclopentenone 237 was obtained. With optimised conditions in hand, sample
237 (Table 2-2, entry 2) was analysed. However, despite cyclopentenone 237 having
being exposed to an asymmetric environment, we did not observe any enantioselectivity
by chiral HPLC. In an attempt to determine whether epimerisation had taken place upon
storage (0 °C), the reaction was repeated. As before, identical results were obtained. All
samples (Table 2-2) which were analysed by chiral HPLC displayed no
enantioselectivity. The rationale behind this may lie with the fact that oxadiazolidinone
230 does not display the correct blocking group which is essential for enantiofacial
discrimination. Further efforts were carried out in order to establish the fundamental
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obstruction responsible for lack of enantioselectivity. Given that, both position and
nature of substituents on the divinyl ketone are important factors which influence the









Scheme 2.12 Nazarov cyclisation using derivatised divinyl ketones
Table (2-3) Limitations and scope of the Lewis base organocatalysed Nazarov
cyclisation.
Entry Substrate Acid/ Catalyst Conditions Yield
(mol %) (%)
1 238a TFA(IO) Me0H/H20(19:l),rt, 18h 58
2 238a TFA/230(10) MeOH/H20( 19:1), rt, 8h 73
3 238b TFA(IO) Me0H/H20(19:l), rt, 16h 67
4 238b TFA/230(10) Me0H/H20(19:l), rt, 6h 55
5 238b TFA/230(20) MeOFl/H20(19:1), rt, 5h 49
We next turned our attention to exploring the scope of this methodology, by employing
alternative substrates. Divinyl ketones 238a-238b were synthesised 17 in a similar
manner as before. When symmetrical substrates of type 238a were added to a
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MeOH/tkO mixture in the presence of TFA, smooth cyclisation took place affording
cyclopentenone 239a in good yield. The next step involved subjecting 238a to the
optimised conditions (Table 2-3 entry 2). To our delight 239a was generated in higher
yield, together with a decrease in reaction time. However, despite smooih cyclisation of
238a, analysis by chiral HPLC again displayed no enantioselectivity. In a similar
manner to 238a, divinylketone 238b underwent smooth cyclisation in the presence of
TFA (10 mol%) affording 239b in moderate yield. When 230 is introduced together with
TFA, the cyclisation of 238b takes place at a considerably faster rate (Table 2-3, entry 3
vs 4), however, cyclopentenone 239b is obtained in a slightly attenuated 55% yield. In
all cases, regardless of the nature of the divinyl ketone, no enantioselectivity was
observed. (Table 2-3, entries 3, 4 and 5). Table 2-3 outlines the different conditions
which were employed in order to optimise the reaction.
Given these results, this led us to judge that oxadiazolidinone 230 serves as an
organocatalyst. However, it does not provide any asymmetric induction in this system.
This is evidenced by the fact that the reaction proceeds at a faster rate when 230 is
present. (Table 2-3, entry 1 vs 2).
We next turned our attention to employing different strengths of co-acid, in an effort to
achieve superior levels of reactivity and enantioselectivity. It is thought that acids
facilitate the formation of activated iminium ion species, consequently promoting the
reaction. Activation of the carbonyl moiety originates by virtue of acid protonation,
subsequently this encourages nucleophilic addition of oxadiazolidinone 230 to the
highly electrophilic carbonyl functional group. As a result of this the iminium ion is
generated. It is therefore necessary to delve into the nature of the additive, as the
strength of the acid may affect the level of enantioselectivity. (Table 2-4)
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Table (2-4) Screening of co-acids






1 238b CF3S03H/230(10) Me0H/H20(19:l),rt, 8h 57
p-TsOH/230(10) Me0H/H20(19:l), rt, 12h 63
C6H5C02H/230(10) Me0H/H20(19:l), rt, 30h 55
When 238b was treated with oxadiazolidinone 230 and triflic acid as the co-acid, as
expected the reaction was significantly faster, albeit with diminished yield. Given that
triflic acid is considered as a very strong acid, we opted to employ an acid which was
weaker than triflic acid, but stronger than TFA. In this respect p-TsOH seemed fit for
this purpose, given that it exists in solid form and can therefore be conveniently weighed
out. Yet again, the reaction was significantly faster. However, in both cases chiral HPLC
displayed no enantioselectivity. Concerned by this observation we considered that the
strength of the acid may lead to erosion in enantioselectivity upon workup. We next
turned our attention to employing a considerably weaker acid, benzoic acid was chosen.
In this instance, the cyclisation was slower together with a decrease in yield. It is with
these observations, which led us to conclude that formation of the iminium ion is rate
determining, due to the rate enhancement in the presence of a stronger acid. (Table 2.4
entry 1 vs 3). Disappointingly no enantioselective discrimination took place.
In conclusion oxadiazolidinone 230 serves as an organocatalyst; but it does not possess
the correct chiral architecture necessary for enantioselective induction. As a result of this
we decided to employ our oxadiazolidinone 230 in a different class of organocatalytic
reaction, in an attempt to decipher the fundamental cause of this observation and to test
the true power and elegant application of oxadiazolidinone 230 in asymmetric synthesis.
76
Results andDiscussion I
2.3.3 Enantioselective Diels-Alder cyclisation
The Diels-Alder cycloaddition which involves a conjugated diene engaging with a
dienophile was first documented 18 by Otto Diels and Kurt Alder in 1928. Since then,
considerable interest has arisen in developing an asymmetric variant of this
cycloaddition.
Macmillan et al. reported 11 the first enantioselective organocatalytic Diels-Alder
cyclisation. Their efforts to explore this strategy involved using (A)-cinnamaldehyde 171
with a broad range of chiral secondary amine salts, this results in formation of the
iminium ion (Scheme 2.13). It is this LUMO-lowering activation which is responsible
for engaging the diene partner in the reaction. Following extensive screening of a broad
range of secondary amines, Macmillan et al. discovered that imidazolidinone 120 was

















Scheme 2.13 Macmillan's organocatalysed Diels-Alder reaction
Borrowing from Macmillan's 11 methodology, wherein chiral secondary amines of type
120 have the capacity to catalyse the asymmetric Diels-Alder 18 reaction. We decided to
employ oxadiazolidinone 230 in this class of reaction.
When considering iminium ion catalysis, there are three main issues which have to be
addressed, first of all iminium ion formation is crucial, secondly efficient cycloaddition
and last of all simple hydrolysis to release the desired product with regeneration of the
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catalyst is necessary. We envisaged that by employing oxadiazolidinone 230 in this
reaction as a novel molecular scaffold, it could serve as an effective enantioselective
organocatalyst. We rationalised that the rate of the reaction could be accelerated by
exploiting the a-effect.
Initial studies involved using (iT)-cinnamaldehyde 171 and cyclopentadiene 240 as a
benchmark reaction in order to establish the optimal conditions for this cyclisation.
Scheme 2.14 Model reaction for Diels-Alder cyclisation
Given the simplicity of Macmillan's strategy, we adopted these conditions as a standard
platform for optimal screening. Our initial efforts, focussed on the strength of the co-
acid, as previously mentioned the nature of the co-acid influences both the overall
reaction rate and level of enantioselectivity.






1 CF3S03H/230(10) Me0H/H20(19 1), rt, lOh 62 1:1.5
2 HC104/230(10) Me0H/H20(19 l),rt - -
3 HC1/230(10) Me0H/H20(19 1), rt, 12h 59 1:1.6
4 CF3C02H/230(10) Me0H/H20(19 1), rt, 12h 88 1:1.8
5 p-TsOH/230(10) Me0H/H20(19 1), rt, 14-16h 73 1.4:1
78
Results andDiscussion I
Oxadiazolidinone 230 in MeOH/H20 (1 M solution) was added to freshly distilled (£)-
cinnamaldehyde, shortly after the co-acid was added via syringe or directly added by a
spatula; this solution was left to stir for 1-2 minutes before addition of cyclopentadiene.
When stronger acids are employed in this reaction (Table 2-5, entries 1-3), the
cycloaddition takes place at a faster rate compared to when weaker acids
are used (Table 2-5, entry 1 vs 5), albeit in moderate yield. In all cases, the cycloaddition
is facile in the presence of 230, favouring formation of the exo isomer, it is thought that
in polar solvents the endo selectivity is enhanced, together with acceleration in reaction
rate. 19 This is presumably due to enforced hydrophobic interactions between the diene
and dienophile, allowing the reagents to be in close proximity, which results in rate
acceleration. Upon addition of perchloric acid to the catalyst-aldehyde mixture, the
reaction turns a black/green colour, when cyclopentadiene is added. It is thought this is
due to polymerisation of the cyclopentadiene or degradation of other reagents caused by
the strength of the acid. Attempts to circumvent this issue involved decreasing the
MeOH/H20 ratio; we envisaged that if the amount of H20 in the reaction media is
increased, then the possibility of degradation or polymerisation would be diminished.
However, with regard to perchloric acid, a greenish black slurry was obtained in all
cases.
In parallel with our studies, Ogilvie 20 et al. in 2005 developed an asymmetric variant of
the Diels-Alder cyclisation by means of exploiting the a-effect. In this instance, the
chirality is derived from a hydrazide, which is embedded within a dense camphor
scaffold. Initial screening involved using hydrazide catalyst 242 possessing a phenyl
side chain, to their delight this strategy promoted the cycloaddition, albeit in modest







Scheme 2.15 Aqueous enantioselective Diels-Alder reactions
Further studies, revealed that when the sidechain is modified from a phenyl to a benzyl
then there is a significant increase in yield and enantioselectivity. Upon closer
inspection, a prominent correlation was apparent between the strength of the co-acid and
reaction efficiency. Their findings demonstrated that as the acid strength increases both
enantioselectivity, yield and rate of the reaction increase with prevalence of the exo
isomer in each case. Preliminary mechanistic studies disclose that iminium formation is
far more facile with hydrazide 242 and (fs)-cinnamaldehyde compared with Macmillan's
imidazolidinone organocatalyst 120. This reaction tolerates a broad range of both
dienophiles and dienes, whilst maintaining high levels of enantioselectivity.
Ogilvie et al. have inspired other groups to investigate this class of organocatalytic
Diels-Alder cycloaddition. Lee and co-workers 21 have recently demonstrated that the
asymmetric Diels-Alder cyclisation can be catalysed by cyclic sulfonyl hydrazines. A
series of chiral cyclic sulfonyl hydrazines have been synthesised from camphor sulfonic
acid. In their findings, best results were achieved using sulfonyl hydrazine 242 alongside
trichloroacetic acid as the co-acid. In terms of catalyst structure, alkylating at the
Na position led to superior levels of enantiomeric excess, in comparison to alkylation at
the N'0 position. Virtually all Na alkylated catalysts performed well. However, benzyl
and ethyl groups in the Na position proved to provide the best chemical yields and
enantioselectivities. Naturally, in order to further explore the scope and limitations of
this methodology, a series of varied dienophiles were introduced. Equally, both aliphatic
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and aromatic aldehydes were tolerated in the reaction; but aromatic aldehydes gave
better enantioselectivities, whilst aliphatic dienophiles had faster reaction rates.
1} catalyst 243 (20 mol%)
2) CCI3C02H (10 mol%)
Brine. O'C or rt
92%, 1:1.1 exoiendo




Scheme 2.16 Camphor sulfonyl hydrazines as organocatalysts in the Diels-Alder
reaction
Conducting the reaction in brine, not only affords the products in better chemical yield
and e.e., but is considerably faster. It is thought that in the presence of some salts; the
cyclisation can be promoted; this can be owed to the hydrophobic effect.23 It is thought,
that certain salts enhance hydrophobic packing of the diene and the dienophile in the
transition state.
At this stage, our efforts focused on determining the enantioselectivity of our
organocatalysed Diels-Alder reaction. Access to a chiral GLC was not possible; so we
decided to expose our substrates to chiral HPLC. Numerous attempts to obtain a clean
trace of both exo and endo isomers were carried out, although all attempts met with
failure. Separation by means of chiral HPLC was intrinsically difficult, despite the
strong chromophore inherent within the product. In an attempt to resolve this problem,
further efforts focussed on establishing a simplistic, yet accurate method to determine
the enantioselectivity. In our findings, it became apparent that Fujioka 22 et al. had
established an efficient route to combat this issue. As a result of employing (+)-(R,R)-
hydrobenzoin, an acetalisation takes place giving rise to a diastereomeric mixture,
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furthermore by using !H NMR, the ratio of diastereomers would indicate the
enantiomeric excess (Scheme 2.17).
241 -endo Ph Ph
244a-endo 244b-endo
244c-exo 244d-exo
Scheme 2.17 (+)-(J?,/^-auxiliary to determine enantiomeric excess
Optical resolution 21 of Diels-Alder norbornene aldehyde derivatives (Table 2.6 entry 1
and 4), was carried out using (+)-(i?,i?)-hydrobenzoin as a chiral auxiliary in the
presence of a catalytic amount of p-TsOH. The acetilisation of 241 proceeded in good
yield furnishing a diastereomeric mixture 244 which was isolated by column
chromatography.
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Fig 2.4(a) Enantiomeric excess in the presence of MacmillanN (5J)-5-Benzyl-2,2,3-
trimethylimidazolidin-4-one monohydrochloride and (b) (>{)-4-benzyl-3-(4-methoxy
phenyl)- [1,2,4]-oxadiazolidin-5-one
Amplification of the acetal proton signal of cycloadducts 244 by 'H NMR, illustrated a
10% enantiomeric excess of the exo isomer (Fig 2.4(b)). In order to determine if this was
an accurate method to measure enantioselectivity, a control experiment was carried out
(Fig 2.4(a)). In the presence of Macmillan's organocatalyst 120, as expected 'H NMR
analysis illustrated a 93% enantiomeric excess of the exo isomer. Despite
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observing low levels of enantiocontrol with 230 in some respect it was a gratifying
result, as it suggested iminium ion catalysis was taking place. However, further
exploration was required in order to promote high levels of enantiocontrol whilst
maintaining reaction efficiency.
2.3.4 NMR studies of iminium ion formation
To better understand the overall process, we decided to study the catalytic cycle by
means of 'H NMR, given that our catalyst performed well in a Me0H/H20 combination
we opted for this solvent mixture for our NMR studies.
It is thought that the presence of the H2O enhances the rate of iminium ion formation
due to the increased proton transfer between the carbonyl compound and the
organocatalyst. Iminium ion formation was studied by employing equimolar quantities
of freshly distilled (£)-cinnamaldehyde (0.04 g, 0.303 mmol), (i?)-4-benzyl-3-(4-
methoxyphenyl)-[l,2,4]-oxadiazolidin-5-one 230 (0.086 g , 0.303 mmol) in a 19:1
CD30D:D20 (1 ml), and triflic acid (27 pL, 0.045 g, 0.303 mmol). The reaction was
maintained at rt by 'H NMR, which involved acquiring spectra at five minute intervals.
First of all, a 'H NMR was taken of catalyst 230 in CD30D:D20, (£)-cinnamaldehyde
was added to the mixture, upon addition of triflic acid, the (£)-cinnamaldehyde proton
peak in the NMR declines instantaneously (Fig 2.5(c)). After fifteen minutes no change
was apparent in the spectrum. In an attempt to elucidate in detail the mechanistics
involved, the reaction was repeated in the absence of the catalyst, one equivalent of
triflic acid was added to (£)-cinnamaldehyde. In this instance the aldehyde peak in the
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Fig 2.5(a) 'I! NMR of (>t)^l-benzyl-3-(4-methoxyphenyl)-[l,2,4]-oxadiazolidin-5-one
in CD3OD. (b) 'H NMR of (vP)^-benzyl-3-(4-methoxyphenyl)-[l,2,4]-oxadiazolidin-




In order to gain insight into the effect the counteranion has on the process, we repeated
the reaction using different strengths of co-acid. In most cases, similar results were
obtained in the presence of p-TsOH, suggesting that the strength of the acid did not
correlate with the catalyst efficiency. However, when weaker acids bromoacetic acid and
chloroacetic acid were used in the reaction, the aldehyde peak did not decline,
suggesting no proton transfer was taking place, inhibiting iminium ion formation.
Our mechanistic studies provided us with strong evidence that iminium formation was
taking place rapidly. Despite depleted levels of enantiomeric excess, this was an
encouraging result as it suggested oxadiazolidinone 230 was promoting iminium form
ation. However, it was the nature of the sidechain at the chiral centre which was
deleterious to the enantiomeric excess. We envisaged that changes to the indicated
sidechain were essential in order to observe appropriate levels of enantiocontrol. Given
that our route for organocatalyst construction is highly adaptable, 13 we choose this
strategy as a suitable method to incorporate highly diverse sidechains within the
catalysts framework.
First of all, we wished to rationalise the success of Macmillan's imidazolidinone
organocatalyst with regard to the Diels-Alder cycloaddition, in an attempt to decipher
the fundamental obstacle involved with our strategy. Upon closer inspection, the puzzle
was unravelled. The success with regard to stereocontrol in Macmillan's approach is
based on two elements. First of all, complete control of iminium ion geometry is
achieved, the (£)-iminium isomer is favoured in order to avoid nonbonding interactions
between the aldehyde olefin and the geminal methyl substituent, hence locking the
structure in a fixed geometry, secondly the presence of the benzyl group successfully
blocks the dienophile from approaching the re face, which therefore promotes attack of
the dienophile from the si face, thus achieving high levels of enantiocontrol of both
endo-exo products (Fig 2.6). In most cases, the exo product predominates with extended
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reaction times; it is believed this is because the exo product is thermodynamically
favoured.
Fig 2.6 Control of iminium ion geometry
With respect to oxadiazolidinone 230, all attempts to deliver significant levels of
enantiocontrol failed. We believe this is due to lack of control of the iminium ion
geometry, it is thought that in the absence of geminal dimethyl groups both geometries
are likely to exist, and as a result of this both the Re and Si face are exposed to
cycloaddition which explain the lack of enantiocontrol. To further investigate this
rationale, we decided to synthesise a novel oxadiazolidinone organocatalyst, which
would have the capacity to block one face regardless of the iminium ion geometry
adopted by the substrate. We focussed on inserting a sidechain which was large enough
to hinder attack from both faces. In terms of catalyst modification, we adopted the





































In a similar manner to oxadiazolidinone 230, nitrone 249 was synthesised in good yield,
nitrone 249 was then exposed to benzoylisocyanate which after one hour gave rise to
cycloadduct 250 in excellent yield, and simple trituration provided us with a white
precipitate. The presence of the benzoyl group within the catalysts framework is not
essential in order to achieve good enantiocontrol, although it is necessary to remove the
benzoyl portion prior to auxiliary cleavage in order to avoid complex mixtures soon
after. Aforementioned, auxiliary hydrolysis tends to be capricious, following smooth
deprotection of the benzoyl group cycloadduct 251 successfully underwent auxiliary
hydrolysis, albeit in low yield to afford cycloadduct 252. A misfortune which
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accompanied cycloadduct 252 was its insolubility in a wide range of solvents.
Cycloadduct 252 failed to dissolve in a MeOH/H20 mixture, H20 and a range of organic
solvents. Failure of 252 to dissolve inhibited our exploration of the potential of 252 as an
organocatalyst. In conjunction with the synthesis of 252, we developed nitrone 253
which is derived form oxime 227 and anthracenealdehyde. In order to address the
solubility issue associated with cycloadduct 252, we treated nitrone 253 with 4-
nitrophenylisocyanate, we believed that the presence of the nitrophenyl group would aid
solubility, whilst displaying blocking group potential. To our delight cycloadduct 254
proved to be a stable complex molecule, subsequently this prompted us to expose 254 to
acidic media. In spite of this 255 was not isolated as a free base, yet again numerous
spots appeared on tic which signified destruction in the presence of acid.
2.4 Conclusions
Initially, our first objective was to develop a novel enantioselective methodology for the
construction of highly functionalised cyclopentanoids. Our initial strategy for this
invention was to develop a unique organocatalyst which would embrace chiral iminium
ion catalysis, predominantly focusing on the Nazarov cyclisation. The scarcity of reports
in the literature of this type of reaction was the driving force behind this innovative
application. However the most prominent and single model of an enantioselective
organocatalytic Nazarov reaction is the Bronsted acid catalysed reaction reported by
Rueping 8 et al. In this instance chiral binol phosphates were used to activate the
carbonyl moiety, this was a sufficient method to promote the electrocyclisation.
Based on our results we concluded that our oxadiazolidinone 230 was an efficient
organocatalyst however it was not a viable source of chirality in the Nazarov reaction,
despite exploring numerous reaction conditions. This unfortunate but relevant result led
us to devise an alternative application of 230 which was based on the Diels-Alder
reaction as a model system. Whilst 230 was an efficient organocatalyst in the Diels-
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Alder cycloaddition, due to lack of control of iminium ion geometry, poor levels of
enantiocontrol were observed as a consequence of this.
Having successfully identified a suitable scaffold which can serve as an organocatalyst,
we next turned our attention to tackle the iminium ion geometry matter; we envisioned
that this issue would be addressed if alterations to the catalysts framework were carried
out. However, despite successfully synthesising diverse oxadiazolidinones, hydrolysis of
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3.1 Introduction The Morita-Baylis-Hillman reaction
The development of an efficient method to access intricate molecular architectures
remains one of the most significant challenges in organic synthesis. Asymmetric tandem
transformations are an attractive approach. An increase in molecular complexity is
attained, i.e., products with two or more contiguous stereocentres, simply by employing
1 2
readily available starting materials and a catalyst. '
An important and useful carbon-carbon bond forming reaction is the Morita-Baylis-
Hillman (MBH) reaction, 3 which belongs to the family of tandem conjugate addition
aldol processes. The (MBH) is an attractive reaction, it is atom economic, simple
prochiral starting materials can be employed to afford complex molecules without
generating waste or byproducts, 4 and last of all it can be selective. The (MBH) reaction
was reported by Morita in 1968, where tertiary phosphines were employed to catalyze
the reaction of acrylic compounds with aldehydes. 5 Shortly after, a German patent was
then filed by Baylis and Hillman in 1972. 6 The three component reaction involves the
coupling of the a-position of the activated alkene with a carbon electrophile containing
an electron deficient sp2 carbon which is catalyzed by a tertiary amine, to generate
multifunctional molecules 3 (Scheme 3.1).
R= aryl, alkyl, heteroaryl
R1= H, COOR, alkyl
X= O, NCPPR, NTs, NS02Ph
Scheme 3.1 Classic Morita-Baylis-Hillman reaction
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3.1.1 Asymmetric Morita Baylis Hillman reactions
The Morita-Baylis-Hillman reaction results in the formation of a chiral centre, which
opens up the possibility of asymmetric induction. The chiral induction can be delivered
from any one of the four components, i.e., the activated alkene, tertiary amine, and
electrophile or solvent. Discovering new catalytic systems for the (MBH) reaction has
attracted considerable attention; however, few successful chiral catalysts have been
demonstrated. In 1995, Hirama et al. reported the asymmetric Baylis-Hillman reaction
using C2-Symmetric 2,3-disubstituted DABCOs 7 (Scheme 3.2).









Scheme 3.2 Asymmetric Morita Baylis Hillman using chiral DABCO
Hirama7 and co-workers found that when catalyst 258a was employed in the above
reaction under atmospheric pressure the reaction proceeded very slowly. However, when
the reaction was subjected to high pressure conditions (5 kbar), a dramatic increase in
reaction rate and enantioselectivitywas observed.
In 2005, Wang 8 et al. reported the use of a new type of bifunctional organocatalyst
which has been developed to promote the enantioselective (MBH) reaction. The reaction
rate proceeded smoothly with cyclohexanone and various aldehydes, whilst attaining
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high levels of chemical yield. The thiourea group has hydrogen bond acidity which
activates the carbonyl group of a,/?-unsaturated substrates, this activation facilitates the
Michael addition of the tertiary amine to the Michael acceptor (Scheme 3.4).
yic»u. uj-ut /o
ee: 60-94%
Scheme 3.3 Morita Baylis Hillman promoted by bifunctional thiourea
organocatalysts
The reaction of 2-cyclohexen-l-one with 3-phenylpropionaldehyde to afford allylic
alcohols was used as a model reaction, 7 in order to test the catalytic ability of the
bifunctional organocatalysts. After extensive screening of reaction conditions, it was
found that the best levels of enantioselectivity (94% e.e.) were achieved when the
reaction was conducted in acetonitrile at 0 °C with 10 mol% of bifunctional amine-
thiourea catalyst 261. Thiourea catalyst 261 proved to be superior in this transformation
(Scheme 3.3), this is due to the stronger H-bonding interaction with the carbonyl group,
which was brought about by the 3,5-bis(trifluoromethyl)phenyl group. A plausible
mechanism for the asymmetric (MBH) reaction is outlined below (Scheme 3.4).
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Scheme 3.4 Mechanism of bifunctional thiourea organocatalyst
The vast majority of tandem aldol reactions reported in the literature are intermolecular
and use mono or 1,2-substituted Michael acceptors. However, in order to successfully
install a quaternary centre, a-substituted Michael acceptors are required. The
development of stereoselective methodologies for the formation of quaternary centres
remains a huge challenge for synthetic chemists. Given the importance of quaternary
stereogenic centres in biologically active molecules, this provided us with the incentive
to develop new selective methodologies for the construction of quaternary centres.9
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3.2 Results and Discussion II
Given the value of the iodo-aldol cyclisation, 10 we were curious to examine the scope of
this process, with a view to introduce chirality into the system. Initial efforts to develop
an asymmetric variant of this process involved employing enone-aldehyde prochiral
substrates of nature 265, (S)-proline as the organocatalyst and BU4NI as the nucleophile.
However, disappointingly all attempts of an enol-5-exo ring closure met with failure. It
is thought that the reagent combination TiCU/Ba^NI is exceptionally effective at
generating the [5-iodo carbonyl compounds. However, when BU4NI is paired with a
catalytic amount of the Lewis base organocatalyst (S)-proline, no 1,4-addition or
cyclisation takes place. Similarly, when (S)-proline is replaced by Macmillan's
organocatalyst 120 and oxadiazolidinone 230, yet again no reaction takes place which
results in recovered starting material. These observations suggest that in the absence of a
strong Lewis acid resembling TiCL, BU4NI proves to be an ineffective nucleophile.
O




Scheme 3.5 Iodo-aldol reaction of enone-aldehyde 265
In order to synthesise hindered ^-thioalcohols, allowing for the formation of lull carbon
quaternary stereogenic centres. We decided to explore the scope of the enantioselective
thio-aldol reaction. To the best of our knowledge, the utilisation of a-acroleins in
enantioselective synthesis is still in its infancy,11 this is presumably due to the difficulty
involved in activating a-acroleins with organocatalysts. In order to introduce chirality








2) Thiol (1.1 equiv)
R= 265= Ph, 267= H, 268= iPr
R1= aryl
solvent
R= 269= Ph, R1= Ph
Scheme 3.6 Proposed thio-aldol cyclisation
Our initial idea was to employ enal-aldehyde substrate 267 as a model substrate for the
thio-aldol cyclisation. Simple ozonolysis of cyclohexene gave rise to hexanal in high
yield, which upon methenylation afforded the aldehyde acetal substrate 270. 6,6-
dimethoxy-2-methylenehexanal 271 underwent straightforward hydrolysis using acidic
conditions to afford the desired 2-methylenehexanal 267. Due to the unstability of 267
with silica and high volatility, determination of the yield was not feasible. When 2-
methylenehexanal 267 was treated with thiophenol in toluene, the reaction had gone to
completion in less than one hour. However, the reaction was repeated and monitored by
'H NMR and taking aliquots. After fifteen minutes, 'H NMR analysis displayed no
starting material or side products. Due to the rate at which this cyclisation takes place, it
seemed that the background reaction would dominate, thus inhibiting organocatalysis to
take place. The reaction was repeated and carried out at lower temperatures; however,
the reaction took place at a similar rate.
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Scheme 3.7 Synthesis of enal-aldehyde substrate 267
We next turned our attention to developing an alternative dialdehyde substrate. Greaney
et al.10 reported the use of (^-substituted enoate aldehydes in the iodo-aldol cyclisation.
Based on this work, we envisioned that if reduction of the ester functional group to the
enal was feasible, then this class of substrate may be an interesting starting material in
the thio-aldol cyclisation. Ester-acetal substrate 273 was subjected to DIBAL-H in
toluene at -78 °C, after 3 hours there was traces of the alcohol, together with the desired
aldehyde. Purification by column chromatography gave rise to enal-acetal 274. In order
to gain access to more starting material, the alcohol-acetal was oxidised with PCC in
dichloromethane, which afforded enal-acetal 274. The initial strategy to hydrolyse the
acetal functionality of 274, was to treat enal-acetal 274 with acetic acid in HCI (1 M).
Unfortunately, the deprotection of the acetal functionality under these conditions met
with failure. Further endeavours to hydrolyse the acetal, involved employing DDQ,
however, yet again all attempts to smoothly hydrolyse 274, were unsuccessful.
Finally enal-acetal 274 underwent deprotection using PPTS in aqueous acetonitrile,
albeit in 52% yield (Scheme 3.8). Nevertheless, an optimum yield of 74% was achieved,
by replacing PPTS with lithium tetrafluoroborate (1.2 equiv), a surprising result, when
considering that unsubstituted 1,3-dioxolanes as protecting groups, usually proceed at a
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slow rate with low to moderate yields in the presence of this mild Lewis acid. 12
However, enal-aldehyde 275 proved to be unstable to silica. Crude 'H NMR analysis
revealed 275 to be of suitable purity, without the need for purification by column
chromatography.
Enal-aldehyde 275 was treated with thiophenol (1.1 equiv) in toluene, rendering 277 as a
(5:3) mixture of diastereomers, in 69% yield; both of which were stable to silica;
allowing for successful purification, by means of column chromatography.
After successful introduction of thiophenol to enal-aldehyde 275, by means of a
Michael-aldol tandem process, we turned our attention to generate more starting material
275, in an attempt to further explore this reaction. However, on close inspection the
hydrolysis of enal-acetal 274 is troublesome when repeated on large scale. Significant
depletion in the chemical yield was observed, together with formation of an unexpected
carbocycle 276. It is thought that this serendipitous discovery occurs during hydrolysis
of the acetal, the ethoxy groups attack the highly reactive enal, subsequently giving rise
to carbocycle 276 as a 4:3 mixture of diastereomers.
Despite enal substrate 275 undergoing smooth ring closure to afford 277, given the lack
of material, the uncertainty of the purity and the intricate synthesis involved in the
preparation of the prochiral starting material, we decided not to embark on an




Scheme 3.8 Synthesis of enal-aldehyde substrate 275
In our search for electing suitable substrates, enone-aldehydes were chosen as
appropriate carbocyclization substrates. We envisioned that by employing less reactive
substrates in this reaction, the background reaction would be minimised, allowing for
organocatalysis to play a role. These can be synthesised as shown in 13 (Scheme 3.9).
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Scheme 3.9 Synthesis of enone-aldehyde substrate 265
1-Phenylcycloxexene 278 underwent ozonolysis 13 in the presence of MeOH/DCM to
produce a chain with an acetal group at the termini. The presence of the acetal group is
essential, in order to allow insertion of the exo-methylene group adjacent to the ketone.
LiHMDS was used as the base to generate the enolate, which then reacted with Bohme s
or Eschenmosef s salt, allowing installation of the enal functionality in one single step.
The enal-acetal substrate was then deprotected in acetone with a catalytic amount of 1M
HCI to afford the desired enone-aldehyde substrate. To explore the possibility of the
tandem thio-aldol reaction, a model reaction between 265 and thiophenol (1.1 equiv)
was performed in DCM under an atmosphere of N2 at rt, in the absence of any
organocatalyst. To our delight, after 4 h at rt, tic monitoring showed total consumption
of the starting material, and after purification by column chromatography, the desired
cyclopentenol was isolated in 56% yield, together with the 1,4-addition product 282 in
18% yield (Scheme 3.10). 'H NMR analysis of the crude mixture indicated a 3:2 mixture




Scheme 3.10 Thio Michael-aldol cyclisation
The above reaction was repeated and heated to 50 °C and left to stir for 2 h. In this
instance we did observe the cyclopentenol as the sole product in 69% yield (5:4
trans:cis), without any of the 1,4-addition product 281. In order to investigate the effect
a polar solvent would have on the yield and rate of the reaction, we replaced DCM with
MeOH as a solvent. The desired cyclopentenol 269 was isolated in 34% yield, but the
major product was the dimethyl acetal product 280 in 47% yield (Table 3-1). Screening
of different solvents was carried out; which demonstrated toluene to be the most
effective solvent, providing the desired product in the best yield.
With the model reaction proceeding smoothly in the absence of any organocatalyst, our
next goal was to introduce chirality into this system. In order to achieve high levels of
asymmetric induction in the 1,4 addition reaction of thiols to a,/?-unsaturated
compounds, several factors have to be considered, i.e., structure of catalyst, donors,
acceptors, solvent, concentration and temperature of reaction media.
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Table (3-1) Solvent screening of racemic tandem thio-aldol reaction
Entry Solvent Thiophenol Temperature Time Yield d.r
(eq) (°C) (h) (%) trans:cis
1 DCM 1.1 rt 4 56 3:2
2 MeOH 1.1 rt 6 34 3:2
3 DCM 1.1 50 2 69 5:4
4 Toluene 1.1 rt 4 89 3:2
Since the 1960's, cinchona alkaloids have been considered to be useful tools for highly
enantioselective reactions. 14 In an attempt to carry out the above reaction in an
asymmetric manner, we employed 5 mol% (-) cinchonine as the organocatalyst. A
solution of the enone-aldehyde substrate 265 in toluene was added to a stirred solution
of 5 mol% (-) cinchonidine in dry toluene under an atmosphere of N2. The mixture was
left to stir for 20 min at rt and then cooled to -20 °C. A solution of thiophenol in dry
toluene was then added dropwise to the solution. When the reaction had reached
completion, the reaction was washed with H20, and extracted with diethyl ether. 'H
NMR analysis of the crude reaction mixture indicated a 3:2 mixture of diastereomers
(determined from the integration of the two tertiary proton peaks at 8min= 4.62 ppm (t,
1H, J = 6.4 Hz) vs trans 5maj = 4.56 ppm (m, 1H) in the 'H NMR), which could be
separated by chromatography. Chiral HPLC analysis was employed to determine the
enantiomeric excess, the best separation was found with chiralpak AD-H column (Table
3-2, entry 1, 24:0 e.e.). In an effort to improve the enantioselectivity and
diastereoselectivity, we increased the catalyst loading to 10 mol% and cooled the
reaction to -78 °C, before addition of the thiophenol in toluene. The reaction was
complete after 6 h compared with (Table 3-2, entry 1); at -20 °C for 4 h. However, there
was no significant change in yield; it was observed that the enantiomeric excess had
decreased when the catalyst loading was increased. The decrease in enantioselectivity is
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presumably due to the lower reaction temperature, suggesting that racemisation takes
place at lower temperatures.
3.2.2 Organocatalyst screening of the thio-aldol cyclisation
i u 1) organocatalyst




Scheme 3.11 Bronsted acid catalysed thio-aldol cyclisation
269-trans
Table (3-2) Optimisation studies of the Bronsted acid catalysed thio-aldol
cyclisation
Entry Catalyst Temp Time Yield d.r. e.e. (%)
(mol %) (°C) (h) (%) trans\cis cis'.trans
1 Cinchonidine 5 -20 4 85 3:2 24:0
2 Cinchonidine 10 -78 6 87 2:1 2:15
3 Quinine 10 -20 2 81 3:2 49:23
4 Cinchonine 10 -20 4 89 2:3 35:33
5 Cinchonine -20 10 64 4:5 2:6
10(5equiv H2O)
6 Quinidine 10 -20 4 88 2:3 40:37
7 Quinine 10 -40 5 75 3:2 51:32
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When (-) cinchonidine was replaced with (-) quinine, the reaction rate and e.e. had
increased significantly. Quinine appears to be a superior catalyst in comparison to (-)
cinchonidine in the addition of thiophenol to enone-aldehyde 265. There have been
breakthrough contributions put forth by several groups, reporting the success of the
thio-aldol reaction was carried out, in the presence of H2O (5 equiv). The reaction
proceeded at a slower rate than the others (Table 3-2, entry 5); however, there was
significant erosion in the enantioselectivity. It is thought that the hydrogen bond
accepting solvents like H2O are responsible for weakening the ionic interaction between
the anion and the cation in the transition state (vide Fig 3.0). It is the hydroxyl group of
the catalyst which forms the hydrogen bond with the carbonyl group leading to a
structured transition state, therefore a possible explanation for the decrease in e.e. could
be that the coordinating solvents block the hydroxyl group, therefore activation of the
electrophiles is inhibited, which consequently leads to a destabilisation of the transition
state, resulting in low levels of enantioselectivity.
R
282
Fig 3.0 Cinchona alkaloid catalyst transition state
When (+)-cinchonine was used in the reaction, an increase in yield was observed,
together with increased levels of enantiocontrol. (Table 3-2, entry 1 vs 4). By employing




(+)-quininidine to the reaction mixture, moderate levels of enantiocontrol were achieved.
At lower reaction temperatures (Table 3-2, entry 3 to 7), increased levels of
enantiocontrol are observed for both diastereomers when (-)-quinine is employed.
Wynberg et al. reported 17 that cinchona alkaloids and /?-amino alcohols catalyze the
reaction of thiols to a,/^-unsaturated compounds. However, desirable enantioselectivities
were not attained. They proposed that the chinchona alkaloids catalyse the reaction via a
tight transition state complex. There are three stabilizing interactions responsible for
catalysing the reaction, first of all there must be an electrostatic interaction between the
thiolate anion and the ammonium cation of the cinchona alkaloid, secondly there must
be a hydrogen bond interaction between the hydroxyl group on the catalyst and the
enone of the carbonyl group, and last of all there must be a dispersion interaction
between the aromatic ring system of the catalyst and the thiol anion. These findings
coincide with ours, in the way that when we employ (-) quinine as the organocatalyst we
observe increased levels of enantioselectivity of both diastereomers. The above
experiments indicate that the presence of the free hydroxyl group is essential in order to
achieve high conversion and enantioselectivity. The presence of the methoxy group
illustrates an increase in e.e, this suggests that the dispersion reaction between the
aromatic ring system and the thiol anion plays an important role in the transition state of
the reaction, as its absence results in lower enantioselectivities. Gratifyingly, the natural
cinchona alkaloids can be employed in the tandem thio-aldol reaction, albeit with
modest enantioselectivity.
3.2.3 Derivitisation of cinchona alkaloids
In an attempt to improve the enantioselctivity of these reactions, we were interested in
modifying existing cinchona alkaloids. Deng and co-workers 18 have developed a new
class of chiral bifunctional organic catalysts which are derived from cinchona alkaloids.
These organocatalysts are easily accessible from (-)-quinine and (+)-quinidine, and have
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been shown to be effective in asymmetric conjugate additions. Given their
straightforward assembly and high efficiency in the conjugate addition of malonate to
nitroalkanes,19 this encouraged us to synthesise these derivatives.
90b 283
Fig 3.1 Modification of cinchona alkaloids
Catalyst 90b was prepared in one-step by adding NaH to a solution of (+)-quinidine in
DMF, the reaction was left to stir at rt for 2 h, Benzyl chloride was added dropwise via a
syringe. Purification by flash chromatography gave yellowish oil. Having synthesised
catalyst 283, we turned our efforts to investigate its applicability in the thio-aldol
reaction. Our findings illustrated that when the C-9 hydroxyl group is substituted with an
OR group, a significant drop in enantioselectivity is observed, this observation suggests
that the presence of the hydroxyl group is necessary in order to achieve moderate
enantioselectivity. This strongly indicates that the hydroxyl group stabilises the anion
intermediate through hydrogen bonding, which accelerates the aldol addition reaction.
1) organocatalyst








Table (3-3) Further optimisation of the thio-aldol cyclisation
Entry Catalyst Temp Time Yield d.r. e.e. (%)
(10mol%) (°C) (h) (%) trans'.cls cis:trans
1 283 -20 6 78 1:2 12:27
2 90b -20 5 83 1:1 28:28
3 Hydroquinine -20 3 85 5:4 22:29
4 Hydroquinidine -20 3 79 4:5 47:43
5 101 -20 2 91 3:2 40:61
6 284 -20 4 79 5:4 14:5
7 Ephedrine 286 -20 1 86 3:2 0:19
8 Ephedrine 287 -20 1 89 2:1 0:15
9 230 -20 24 74 3:2 0:46
10 230 -40 36 68 3:2 0:42
11 323* -20 6 59 5:4 32:37
* See experimental for catalyst structure
1 o
In order to rationalise the key role played by the hydroxyl group, we synthesised
catalyst 90b. Catalyst 283 is suspended in DMF with NaSEt; this gave rise to the desired
demethylated catalyst 90b. Deng and co-workers reported that cinchona alkaloids
bearing a hydroxyl group in the 6" position instead of a methoxy group improve the
enantioselectivity of the 1,4-addition reaction with malonates to nitroalkanes. In spite of
this report, catalyst 90b is less efficient in the thio-aldol reaction (Table 3-2 entry 6 vs
Table 3-3 entry 2), in terms of enantioselectivity when C-9= OBn. The position of the
hydroxyl group is highly influential in our reaction, these results are consistent with the
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notion that the hydroxyl group at C-9 is conformationally mobile and utilises both the C-
9 hydroxyl and quinuclidine functionalities to stabilise the transition state, allowing
enantioselective 1,4 addition.
When hydroquinine and hydroquinidine were employed as bifunctional organocatalysts
the reaction rates were faster, and the enantioselectivity in the case of hydroquinidine
was moderate. When the C-9 hydroxyl is replaced by NH2, the conversion is greater in
favour of the minor diastereomer (Table 3-3, entry 5). Catalyst 101 afforded promising
catalytic capacity in terms of enantioselectivity, this is presumably due to stronger
hydrogen bonding interaction between the a,/?-carbonyl substrate 265 and the NH2 of
catalyst 101. Encouraged by these results, we began to investigate the use of thiourea
organocatalysts, these bifunctional thiourea derivatives 7 of cinchona alkaloids have a
dual hydrogen bonding 19 Lewis acid activation interaction with the carbonyl substrates.
The amine function activates the nucleophile and the thiourea moiety hydrogen bonds
with the carbonyl substrate, allowing facile addition of the nucleophile.
Fig 3.2 Thiourea Organocatalysts
The N-H groups of the thiourea provide a binding site for the electrophile; they are also
responsible for stabilising the catalyst-enolate ion pair by hydrogen bonds. The ion pairs









Fig 3.3 Thiourea Transition State Models
285b
In the case of thioureas, two reaction pathways can be envisioned (vide Fig 3.3), it is
reasonable to assume that ion pair 285b exists before addition of the thiophenol. In order
to organise and gain access to the available asymmetric binding pockets for the reacting
substrates, ion pair 285a is adopted, allowing addition of the nucleophile. We employed
thiourea 284 in our model reaction with enone-aldehyde 265. To our surprise the
enantioselectivity of the reaction was significantly lower when thiourea 284 (Table 3-3,
entry 6), was employed in our reaction.
Ephedra and erythro alkaloids are frequently used in asymmetric synthesis as the source
of chirality. Not only have these /^-hydroxy amines been reported to considerably
accelerate the rate of reactions and levels of enantioselectivity; they can be easily
modified, allowing straightforward investigations of the scope and utility of this class of
catalyst. Given that this type of bifunctional catalyst is commercially available and
performs well in a wide range of reactions, we decided to employ them in our thio-aldol
cyclisation (Table 3-3, entries 7 and 8). However, to our surprise, we observed a
significant depletion in enantioselectivity, despite having an increase in rate
acceleration. Both, (-)-N-methylephedrine 286 and (+)-N-methylephedrine 287 were






Fig 3.4 (-)-N-methylephedrine and (+)-N-methylephedrine
There is a scarcity in the literature of chiral secondary amines reacting with a-alkyl-
substituted enals. This is attributed to unsuccessful iminium ion formation due to steric
hindrance around the catalyst framework. The organocatalysts which are successful in
the Diels-Alder reaction, prove not to be effective with or-acrolein type Michael
acceptors. Oxadiazolidinone 230 did not perform well in the Diels-Alder reaction;
however, we decided to employ it in reactions utilising a-acroleins, to find out if
iminium ion formation was feasible. Using the same conditions to the other thio-aldol
reactions, 10 mol% of 230 was added (Table 3-3, entry 9). The reaction was set up at -20
°C and left overnight, allowing it to warm to rt. Following, workup and purification the
sample was analysed by chiral HPLC. To our delight, we did observe some stereofacial
control. The cis diastereomer was obtained with an impressive 46% e.e., albeit with the
trans diastereomer being racemic.
In order to gain insight into this reaction, utilising 230 in the absence of any co-acid, the
reaction was repeated at -40 °C. Yet again, the trans diastereomer was racemic, and the
cis diastereomer was obtained with an enantiomeric excess of 42%. Oxadiazolidinone
230, may catalyse the reaction, in one of two ways. It might undergo iminium ion
formation with enone-aldehyde 265, lowering the LUMO, or by Bronsted acid catalysis,
which would activate the electrophilic enone by catalytic protonation. Commercially
available (S)-proline and Macmillan's organocatalyst 120 were employed in this
reaction, in order to explore different natured chiral secondary amines. After 6 hours the
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reaction had gone to completion. Purification by column chromatography, followed by
chiral HPLC analysis proved the sample to be racemic in both cases.
However, when oxadiazolidinone 230 was employed as the chiral source with enone-
aldehyde 268, no reaction took place. This could be due to steric hindrance imparted by
the isopropyl group, discouraging iminium ion formation of substrate 268 with
oxadiazolidinone 230.
In an attempt to increase the diastereoselectivity and enantioselectivity of the thio-aldol
reaction, we next turned our attention to altering the nature of the R group on the enone-
aldehyde substrate Substrate enone-aldehyde 268 was synthesised in an analogous route
to the synthesis of enone-aldehyde 265. (Scheme 3.13)
1) 03, MeOH/DCM













Scheme 3.13 Synthesis of thio-aldol isopropyl substrate
A solution of substrate 268 in toluene was added to a solution of quinine in toluene and
left to stir for 20 minutes. The reaction was cooled to -20 °C and the thiophenol/toluene






When quinine was employed as the catalyst (Table 3-4, entry 1), the reaction was slower
compared with enone-aldehyde 265 with quinine (Table 3-2, entry 3). The 1,4 addition
of the thiophenol to 268 was facile. However, the 1,4-addition product was visible by
tic, and after 20 minutes an aliquot was taken. The crude lH NMR indicated the sole
product as the 1,4-addition products. Nevertheless, the aldolisation proceeded, and after
8 h the reaction had gone to completion. The thio-aldol product 291 was isolated in an
impressive 89% yield as a 3:1 mixture of inseparable diastereomers. The
enantioselectivity was moderate in this instance (Table 3-4, entry l).We were pleased to
observe smooth cyclisation in 8 h to afford the hindered y-thioalcohol 291.
However, there is substantial room for improvement in terms of enantioselectivity.
Quinidine the quasienantiomer of quinine was utilised in the reaction, and as expected
quinidine gave the opposite enantiomer with higher enantioselectivity of the major
diastereomer. Cinchonidine which differs from quinine only by the absence of a
methoxy group at C-6" provided the desired ^thioalcohol 291 smoothly in good yield,
albeit with an erosion in enantioselectivity. Cinchonidine illustrated the most promising
catalytic capacity in terms of diastereoselectivity and enantioselectivity (Table 3-4, entry
4). The major cis diastereomer exhibited higher levels of enantioselectivity. In all cases
the diastereoselectivity was consistent, in favour of the major cis diastereomer 291.
When enone-aldehyde 268 was added to toluene in the absence of an organocatalyst,
hindered ^thioalcohol 291 was not formed; instead a complex mixture was isolated.
This indicates that the aldolisation is mediated by the presence of a cinchona alkaloid
1) organocatalyst
2) Thiophenol (1.1 equiv)
Toluene
291 -trans




with respect to 268; therefore a non-enantioselective variant was not easily recognised.
The enantioselectivity was determined by chiral HPLC, by elucidating the ratio of
diastereomers and calculating the enantioselectivity respectively.
Table (3-4) Investigations of substrate scope for the thio-aldol cyclisation
Entry Catalyst Temp Time Yield d.r e.e.
(10 mol %) (°C) (h) (%) trans:cis (%)
1 Quinine -20 8 89 1:3 32:17
2 Quinidine -20 6 85 1:4 3:34
3 Cinchonine -20 7 90 1:2 11:11
4 Cinchonidine -20 7 93 1:7 32:70
3.2.4 Stereochemical rationale for thio-aldol product 291
The diastereoselectivity remains, however, low in most cases for carbocycle 269.
Nevertheless, when substrate 268 is employed, there is an increase in the
diastereoselectivity. A possible explanation for this increase is illustrated (vide infra
3.15), using the model shown for substrate 268.
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294 295 291 -trans
Scheme 3.15 Stereochemical model for thio-aldol cyclisation for substrate 268
The increase in diastereoselectivity is thought to arise from the steric hindrance imparted
by the isopropyl group. The initial conjugate addition of the thiophenol generates the cis
enolate which undergoes subsequent intramolecular aldol cyclisation via a five-
membered transition state. The presence of the isopropyl group promotes the hydroxyl
group and the thiomethyl group to exist in a cis relationship. Discrimination between the
two conformations maybe attributed to the orientation of the hydroxyl group, which is
placed in the less hindered position, i.e., cis to the thiomethyl protons, with the tertiary
proton occupying the axial position. The trans structure which has the hydroxyl group
occupying the more hindered axial position, illustrates why the cis product is favoured in
this instance.
With respect to 269, the phenyl group imparts less steric hindrance, therefore both cis
and trans transition states are of equal energy, accounting for the lower levels of
stereocontrol in the aldol cyclisation step.
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O
269-trans
Fig 3.5 Stereochemical conformation of 269
Two dimensional NMR studies revealed that the major diastereomer of 2-hydroxy-l-
(phenylthiomethyl) cyclopentyl (phenyl) methanone 269 had a trans relationship. This
assumption was based upon NOESY experimentation, which showed medium
enhancements between the proton at the tertiary centre and the thiomethyl protons (2),
this indicated that the hydroxyl groups and the thiomethyl groups were on opposite faces
of the carbocycle. The diastereomer which is the minor in most cases has a cis
relationship, a triplet peak for the tertiary proton (1) appeared at 5 min= 4.62 ppm (t, 1H,




Fig 3.6 NOESY spectra illustrating trans assignment of 269
In order to investigate the substrate scope of the thio-aldol reaction, enone-aldehyde 301
13 *
was synthesised. Enal-acetal 271 was synthesised from cyclohexene. Ethyl magnesium
bromide was added dropwise to 271, to afford the secondary alcohol 296 (71%), which
was then oxidised with PCC to afford the desired enone-acetal 297 (77%). HC1 (1 M)
































Scheme 3.16 Derivitisation of enone-aldehyde substrate 265
Ethylenone-aldehyde 298 was treated with thiophenol in toluene in the absence of an
organocatalyst. The reaction was complete after 10 hours, which gave rise to an
inseparable diastereomeric mixture (4:3) of /-thioalcohol 299. Ethylenone-aldehyde
298 was then treated with quinine, which gave rise to 299 as a 5:3 mixture of
diastereomers. Due to the inseparable mixture of diastereomers, HPLC analysis proved
to be complex in terms of e.e. determination. Four peaks were observed, two of which
are diastereomers, and the enantiomer of each diastereomer. (Appendix 2)
With quinine and cinchonidine as promising catalyst systems at hand, we decided to
explore the scope and limitations of this methodology. It was of interest to prepare
substrates with different functionalities, for example enoate-aldehydes, aldehyde-
aldehyde substrates and enal-enone substrates. (Scheme 3.17)
1) organocatalyst (10 mol%)










Scheme 3.17 1,4-conjugate addition reaction with enal-enone substrates
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In the presence of a catalytic amount of cinchona alkaloid, substrates 300, 301 and 302
failed to afford the desired cyclopentenols. Successsful 1,4 addition took place in fast
reaction times both in the presence and absence of an organocatalyst, however, the
intramolecular aldol reaction did not occur. It is thought that this result may be due to
the lower levels of reactivity associated with the enone acceptor, together with the steric
hindrance imparted by the nature of the R group are plausible factors responsible for the
unsuccessful cyclisation.
The iodo-aldol cyclisation reported by the Greaney group, 10 demonstrated the smooth
cyclisation of enoate-aldehyde 308 with TiCl4 to give rise to the y-iodoalcohol product
with high levels of diastereoselectivity. With the synthetic sequence of substrate 273
established, we synthesised enoate-aldehyde 308 to utilise in our thio-aldol reaction.
Scheme 3.18 Synthesis of ester-aldehyde substrate 308
In this instance the enantioselective variant was not so easily recognised, due to the
lower reactivity of enoates, thus the addition of thiophenol would proceed at a slow rate,





the moderate enantioselectivity levels displayed by enone-aldehyde 269, as the
background reaction maybe too facile, causing a decrease in enantioselectivity. When
thiophenol is added to enoate-aldehyde 308 (Table 3-5, entry 1), in the absence of any
catalyst at -20 °C, no reaction took place despite the reaction warming to rt. This
observation had promising potential in terms of inducing high levels of asymmetric
induction. The non enantioselective variant (Scheme 3.19) of this reaction was found to
proceed in the presence of a catalytic amount of triphenylphosphine, it is thought that the
triphenylphosphine performs as a nucleophilic catalyst; first of all it undergoes 1,4-
addition to the enoate-aldehyde, this in turn will generate the enolate 309, the enolate
will deprotonate the thiol, promoting addition of the thiol anion to the Michael acceptor.
Scheme 3.19 Role of triphenylphosphine
308 310-trans 310-c/s
Scheme 3.20 Reaction screening of enoate-aldehyde 308
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Table (3-5) Investigations of substrate scope for the thio-aldol cyclisation
Entry Catalyst Temp Time Yield d.r e.e.




- - - -
2 PPh3 -20 12 59 2:1
3 Cinchonine -20 8 73 1:2 5:19
4 Quinine -20 6 68 3:2 25:14
When catalytic amounts of cinchonine and quinine were employed in the reaction (Table
3-5, entries 3 and 4), the reaction proceeded smoothly to afford the desired functionally
diverse hetero ^thioalcohol 310 as a mixture of diastereomers, albeit with low levels of
enantioselctivity. This result suggests that the background reaction is not deleterious to
the enantioselectivity in the enone-aldehyde carbocyclisation.
In an attempt to improve the enantioselectivity, we turned our attention of altering the
structure of the thiol. We anticipated that the rate of the conjugate addition step may be
influenced by changing the nature of the thiol. We found that when we employed 4-
methoxytoluenethiol the reaction rate had decreased significantly, this effect maybe due
to the presence of the CH2 which increases the pKa of the thiol, thiophenol is more
acidic SH pKa~6.5 than 4-methoxytoluenethiol SH pKa~ 9.43, therefore the rate of
reaction with thiophenol is significantly faster.
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311 312 313 314
67%, <±r * transxis 3:2 78%,d.r * tr$n$:ci$ 4:3 73%,d.r = trans:cis 3:2 70% d.r » trans.cis 3:1
48h 30h ee = 32:30 28h 32h
Scheme 3.21 Scope ofBronsted acid catalysed thio-aldol cyclisation
We were pleased to find that when 4-methoxytoluenethiol was utilised in the reaction,
after 48 hours the reaction had gone to completion, giving rise to product 311 as an
inseparable 3:2 diastereomeric mixture. We found that when benzylic thiols are
employed the reaction rate was slower; this again can be attributed to the higher pKa of
the SH. When 4-methoxybenzenethiol was used, the reaction was faster (32h). However,
when compared to the reaction when thiophenol is used (2h) this is a considerably
slower reaction.
In all cases the diastereoselectivity is moderate and in some cases the diastereomers
were inseparable by column chromatography or recrystallisation. Therefore, determining
the enantiomeric excess was somewhat difficult. The minor and major diastereomers of
the ^thioalcohol 313 were isolated, with modest enantioselectivity. We were optimistic
by the compatibility of the thio-aldol reaction with a range of diverse thiols. These
results illustrate that the moderate enantioselectivities are not caused by the facile
addition of thiophenol in our earlier studies. When 4-methylbenzylmercaptan is
employed the enantioselectivities are comparable with thiophenol (Table 3-2, entry 4).
In the absence of a catalyst, the non-enantioselective variant was not feasible when
benzylic thiols were utilised. Due to lack ofmaterial, PPI13 was not employed to test the




Finally, a suitable asymmetric methodology for the construction of five-
membered carbocycles has been developed. The tandem intramolecular Michael-aldol
cyclisation tolerates a broad range of enone-aldehyde substrates. Furthermore, a series of
carbocycles are constructed which possess vicinal quaternary and secondary/tertiary
stereocentres in high yield with moderate enantioselectivities. The sequence is
efficiently catalysed by cinchona alkaloids and occurs in impressive high yields, whilst
creating two new sterically congested stereocentres.
Further efforts should focus on enhancing levels of enantiomeric excess in addition with
exploring the use of different nucleophiles and substrates. Future work should
concentrate on demonstrating the versatility of this methodology, allowing for an
efficient asymmetric synthesis of spirocyclic compounds of type 316, which were
previously accessible by alkylations 20 using transition metals (Scheme 3.22).
bo
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4.0 Conclusions and FutureWork
The overall aim of the PhD was to develop innovative and robust asymmetric
cyclopentannulation methodologies for the synthesis of highly functionalised
cyclopentanoids given that five-membered rings are a ubiquitous feature in a plethora of
bio-active compounds.
Our initial studies focussed on developing new reactions and novel organocatalysts,
whereby both concepts could be applied resulting in the construction of biologically
important motifs. Primitive studies focussed on developing enantioselective
organocatalysts for application in the Nazarov electrocyclisation. Successful synthesis of
the oxadiaxolidinone 230, allowed us to test the feasibility of an iminium ion catalysed
Nazarov cyclisation. After extensive studies of different reaction conditions,
disappointingly considerable levels of enantiocontrol were not observed. At this stage
we decided to employ oxadiazolidinone 230 in an existing enantioselective reaction, the
Diels-Alder reaction was an attractive cyclisation to explore despite its distant
association with the construction of five-membered rings. The enantioselective Diels-
Alder reaction is well documented and would allow us to gain insight into the
underlying mechanism of 230, in addition to analysis of the asymmetric material.
Unfortunately only low levels of enantiofacial discrimination were observed in the
Diels-Alder reaction, this is presumably due to lack of iminium ion geometry control. In
spite of these negative results, it allowed us to investigate new methods for the
construction of five-membered rings.
We next turned our attention to developing an alternative asymmetric route towards the
synthesis of five- membered rings bearing vicinal quaternary centres. Given the lack of
reports in the literature, we decided to embark upon an efficient strategy for the
synthesis of these complex molecules. This challenge was accomplished via a novel
Bronsted acid catalysed promoted thio-Michael aldol cyclisation of enone-aldehyde
prochiral starting materials. Our findings indicated that the steric hindrance imparted by
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the isopropyl group enhanced the stereoselectivity and enantioselctivity, chiral HPLC
illustrated that in the addition reaction levels of 70% e.e. were reached, despite the
difficulties often associated with sterically hindered aldol cyclisations. The use of a
variety of thiol nucleophiles proved to be very successful, resulting in the assembly of
diverse five-membered rings with two stereogenic centres.
One of the striking features of this methodology is that this one-pot procedure results in
the assembly of complex five-membered rings which can be further elaborated for the
synthesis of complex bio-active compounds.
Immediate future work should focus on further optimisation to enhance both
diastereoselectivity and enantiomeric excess, in addition with further elaboration of
these five-membered rings to mediate the synthesis of complex natural products, further








'H nuclear magnetic resonance (NMR) spectra were recorded using an internal
deuterium lock for the indicated reference at ambient probe temperatures on either a
Bruker AC250 (250 MHz) or a Bruker DPX360 (360 MHz) Fourier transform
instrument. The data is presented as follows: chemical shift (in ppm on the 8 scale),
integration, multiplicity, coupling constant (J in Hz) and the assignment. I3C NMR
spectra were recorded at ambient probe temperatures on either a Bruker AC250 (63
MHz) or a Bruker DPX360 (91 MHz) instrument and are reported in ppm on the 8 scale.
Distortion Enhancement Polarisation Transfer (DEPT) spectra were recorded to assign
the carbon signals as methyl (CH3), methylene (CH2), methine (CH) or
quaternarycarbons (C). Infra Red spectra were recorded on a JASCO FT/IR-460 plus
instrument using 4mm sodium chloride plates. The wavelengths of the maximum
absorbance (vmax) are quoted in cm"1. Samples were sent to the EPSRC National Mass
Spectrometry Service Centre, Swansea for MS analysis. Accurate mass measurements
were obtained on a Finnigan MAT 900 XLT double focusing mass spectrometer. The
data is recorded as the ionisation method followed by the calculated and measured
masses. Optical rotations were measured on an AA-1000 polarimeter with a pathlength
of 0.5 dm at the sodium D line (589 nm) and reported as follows: [a] d concentration (c
in g/100 mL) and solvent. Melting points were determined on a Gallenkamp
Electrothermal melting point apparatus and are uncorrected. TLC was performed on
Merck 60F254 silica plates and visualised by UV light and/or anisaldehyde1 or
potassium permanganate 11 stains. Compounds were purified by wet flash
chromatography using Merck Kieselgel 60 (particle size 35-70A) silica under a positive
pressureand the eluent compositions are quoted as a percentage. Chiral HPLC was
performed using a Waters instrument with an AD-H column equipped with a UV
detector. A standard flow rate of 1 mL/min of a propan-2-ol/hexanes mixture as the
eluent was used. Anhydrous toluene, dichloromethane, tetrahydrofiiran, diethyl ether,
methanol and acetonitrile were obtained from an innovative technologies solvent
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purification system unless otherwise stated. All other chemicals were used as supplied
except where otherwise stated in the text. All experiments were performed under an inert
atmosphere of nitrogen under anhydrous conditions using oven dried apparatus cooled in
a dessicator prior to use. Standard techniques for handling air-sensitive materials were
employed.
'Anisaldehyde stain was prepared as follows: Concentrated sulfuric acid (10 mL) was
added carefully to a cooled solution of ethanol (200 mL) and p-methoxybenzaldehyde
(10 mL).
"Potassium Permanganate stain was prepared as follows:Potassium Permanganate(6 g)








To a stirred solution of freshly distilled phenylacetaldehyde (2.00 g, 16.66 mmol, 1
equiv) in dry DCM (28 mL), was added carboethoxymethylene triphenylphosphorane
(6.95 g, 19.9 mmol, 1.2 equiv) in one portion at room temperature. The solution was left
to stir for 16 h. After stirring the solution was concentrated in vacuo, redissolved in
(10:1) Petroleum ether: Et20 filtered and concentrated. This procedure was repeated
twice. Purification by column chromatography (Si02> 96 % Petroleum ether, Et20)
afforded the (Z)-isomer (132 mg, 5 %) as a colorless oil, followed by the (E)-isomer
(1.50 g, 47 %) as a colorless oil; (Z)-isomer IR (neat)/ cm"1): o max 3020 (Ar), 1726
(C=0), 1660. !H NMR (250 MHz, CDC13) 8: 7.45-7.19 (m, 5H, ArH), 6.41 (dt, 1H, J=
7.5, and 11.4 Hz, CH=CH), 5.90 (dt, 1H, J= 1.6 and 11.4 Hz, CH=CH), 4.25 (q, 2H, J=
7.1 Hz, OCH2CH3), 4.06 (dd, 2H, J= 1.6 and 7.5 Hz, CH2Ar), 1.37 (t, 3H, J= 7.1 Hz,
OCH2CH3). 13C NMR (63 MHz, CDC13) 5: 169.8 (C=0), 146.5 (CH=CH), 138.1 (ipso),
130.2 (ArH), 128.6 (CH=CH), 127.2 (ArH), 122.3 (ArH), 61.0 (OCH2CH3), 39.2
(CH2Ar), 14.2 (OCH2CH3). (E)-isomer IR (neat)/ cm"1): u max 3022 (Ar), 1724 (C=0),
1659. *H NMR (250 MHz, CDC13) 8: 7.43-7.21 (m, 5H, ArH), 7.16 (dt, 1H, J= 6.8, and
15.6 Hz, CH=CH), 5.86 (dt, 1H, J= 1.5 and 15.5 Hz, CH=CH), 4.23 (q, 2H, J= 7.2 Hz,
OCH2CH3), 3.55 (dd, 2H, J= 1.5 and 6.8 Hz, CH2Ar), 1.35 (t, 3H, J= 7.2 Hz,
OCH2CH3). 13C NMR (63 MHz, CDC13) 8: 166.8 (C=0), 147.8 (CH=CH), 138.2 (ipso),




'H NMR and 13C NMR data was in agreement with the literature 1
5-benzylpyrazolidin-3-one, 223
223
To a solution of ethanol (5 mL), (E)-ethyl-4-phenylbut-2-enoate 222 (200 mg, 1.05
mmol, 1 equiv) was added. The solution was cooled to 0 °C. Hydrazine monohydrate (58
mg, 1.16 mmol, 1.1 equiv) was added to ethanol (5 mL) and added dropwise to the three
necked-flask. After 24 h the reaction was refluxed at 70 °C for a further 48 h. The
reaction mixture was concentrated in vacuo. Purification by column chromatography
(Si02, 98 % DCM, methanol) afforded the title compound (85 mg, 46 %) as a colorless
oil; IR (neat) cm"1): u max 3209 (Ar), 1685 (C=0). *H NMR (360 MHz, CDC13) 5:7.93-
7.16 (m, 5H, ArH), 3.77 (m, 1H, CH), 2.84 (dd, 1H, J= 6.8 and 12.1 Hz, CHC=0), 2.69
(dd, 1H, J= 7.2 AND 13.8 Hz, CHC=0), 2.39 (dd, 1H, J= 7.3 and 16.3 Hz, CHAr), 2.17
(dd, 1H, J= 7.6 and 16.3 Hz, CHAr). 13C NMR (91 MHz, CDC13) 5: 176.7 (C=0), 137.1
(ipso), 128.9 (ArH), 128.1 (ArH), 126.6 (ArH), 59.4 (CH), 37.8 (CH2Ar), 37.1 (CH2).
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White solid; !H NMR (250 MHz, CDC13) 5: 7.45-7.25 (m, 10H, ArH), 7.25-7.15 (m, 2H, 2 x
CH), 2.20 (s, 6H, 2 x CH3).
1 2
H NMR data was in agreement with the literature
2,4-Dimethyl-l-phenylpenta-l,4-dien-3-one, 238b
O
Colorless oil; *H NMR (250 MHz, CDC13) 5: 7.42-7.25 (m, 6H, ArH, 1 x CH), 5.68
(dq, 1H, J= 1.5, 1.5 Hz, 1 x CH), 5.56 (dq, 1H, J= 1.0, 1.5 Hz, 1 x CH), 2.10 (d, 3H, J=
1.4 Hz, CH3), 2.02 (dd, 3H, J= 0.9, 1.5 Hz, CH3).






Colorless oil; JH NMR (250 MHz, CDC13) 5: 7.47 (q, 1H, J= 1.3 Hz, 1 x CH), 7.42-7.38
(m, 4H, ArH), 7.33-7.29 (m, 1H, ArH), 6.59 (dq, 1H, J= 1.7, 11.5 Hz, 1 x CH), 6.25
(dq, 1H, J= 7.0, 11.6 Hz, 1 x CH), 2.10 (d, 3H, J= 1.5 Hz, 1 x CH3), 2.02 (dd, 3H, J=
1.8,7.2 Hz, CH3).
'H NMR data was in agreement with the literature.3b
General Procedure for Amine-Catalysed Nazarov Cyclisation
To a solution of (7?)-4-benzyl-3-(4-methoxyphenyl)-[l,2,4]-oxadiazolidin-5-one in
MeOH/H20 (95/5, v/v, 1.0 M) was added the divinyl ketone. The solution was left to stir
for 1-2 minutes before addition of the co-acid. After completion of the reaction the
mixture was diluted with Et20 and washed successively with H20 and brine. The
organic layer was dried over magnesium sulfate, filtered and concentrated by rotary
evaporation. Purification by column chromatography (Si02; 10 % Et20, hexanes)





Colorless oil;in *H NMR (250 MHz, CDC13) 8: 7.55-7.39 (m, 5H, ArH), 3.15 (ddq, 1H,
J= 18.1, 7.0 and 2.0 Hz, CH2 trans to CH3), 2.55 (m, 1H, CH), 2.32 (m, 1H, CH), 1.92
(m, 3H, CH3CH), 1.26 (d, 3H, J= 7.1 Hz, CH3).
'H NMR data was in agreement with the literature. 4
111 See Appendix for HPLC data of compound 239b.
2,4-dimethyl-3-phenylcyclopent-2-enone, 237
o
Colorless oil; *H NMR (250 MHz, CDCI3) 5: 7.41-7.22 (m, 5H, ArH), 3.39-3.31 (m,
1H, CHCH3), 2.80 (dd, 1H, J= 6.4, 18.8 Hz, CHCO), 2.13 (dd, 1H, J= 2.1, 18.8 Hz,
CHCO), 1.84 (d, 3H, J= 1.6 Hz, CH3), 1.05 (d, 3H, J= 7.1 Hz, CH3).






Colorless oil; JH NMR (250 MHz, CDC13) 8: 7.37-7.06 (m, 10H, ArH), 3.98 (m, 1H,
CHCH3), 2.41 (m, 1H, CH), 2.01 (d, 3H, J= 2.0 Hz, CH3), 1.35 (d, 3H, J= 7.3 Hz,
CH3).
'H NMR data was in agreement with the literature.5
General Procedure for Amine-Catalysed Diels-Alder Cyclisation 6a
To a solution of (i?)-4-benzyl-3-(4-methoxyphenyl)-[l,2,4]-oxadiazolidin-5-one in
Me0H/H20 (95/5, v/v, 1.0 M) was added the «,/7-unsaturated aldehyde, followed by
addition of the co-acid. The solution was left to stir for 1-2 minutes before addition of
the freshly cracked cyclopentadiene. Upon consumption of the limiting reagent, the
reaction mixture was diluted with Et30 and washed successively with H2O and brine (3
x 50 mL). The organic layer was dried over magnesium sulfate, filtered and concentrated
by rotary evaporation. Hydrolysis of the diemthylacetal was achieved by stirring the
crude product mixture in TFA:H20:CHC13 (1:1:2) for 2h at room temperature, followed
by neutralisation with saturated aq. NaHC03 and extraction with Et20. Purification by




(li?,2/?,3i?,45)-3-phenylbicyclo [2.2.1] hept-5-ene-2-carbaldehyde and (IS,IS,3S,
4/?)-3-phenylbicyclo [2.2.1] hept-5-ene-2-carbaldehyde (Table 2.6 entry 1) 241
Prepared according to the general procedure with (E)-cinnamaldehyde (144 pL, 1.14
mmol, 1 equiv), cyclopentadiene (278 pL, 3.41 mmol, 3 equiv) and (R)-4-benzyl-3-(4-
methoxyphenyl)-[l,2,4]-oxadiazolidin-5-one (0.033 g, 0.114 mmol, 0.1 equiv) affording
the title compound as a colourless oil. (140 mg, 62%). exo:endo (1:1.5). 'H NMR (250
MHz, CDC13) 5: 9.89 (d, 1H, J= 2.0 Hz, CHO, endo), 9.57 (d, 1H, J= 2.2 Hz, CHO,
exo), 7.31-7.09 (m, 10H, ArH), 6.39 (dd, 1H, J= 3.2, 5.6 Hz, CH=CH), 6.31 (dd, 1H, J=
3.7, 5.7 Hz, CH=CH), 6.15 (dd, 1H, J= 2.7, 5.7 Hz, CH=CH), 6.05 (dd, 1H, J= 3.3, 5.7
Hz, CH=CH), 3.70 (m, 1H, CH), 3.31 (br, 1H, CH), 3.22-3.17 (m, 2H, CH), 3.12-3.04
(m, 2H, CH), 2.95 (ddd, 1H, J= 2.2, 3.5, 4.9 Hz, CH), 2.57 (dt, 1H, J= 1.8, 3.5 Hz, CH),
1.80 (m, 1H, CH), 1.76 (m, 1H, CH), 1.63-1.53 (m, 2H, 2 x CH).
]H NMR and data was in agreement with the literature. 6a'6b
241 -exo 241 -endo
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General Procedure for Optical Resolution ofNorbornene Aldehyde Derivatives 7
A catalytic amount of p-TsOH (0.1 equiv) was added to a solution of 3-phenylbicyclo
[2.2.1] hept-5-ene-2-carbaldehyde, (+)-(i?,/?]-hydrobenzoin (1 equiv) was added in
toluene under an atmosphere of N2 and the resulting mixture was stirred for 12 h at rt.
After completion of the reaction, the solution was quenched with NaHC03 and extracted
with EtOAc. The organic layer was washed with brine, dried over magnesium sulphate,
filtered and concentrated by rotary evaporation. Purification by column chromatography







Prepared according to the general procedure with p-TsOH (0.0033 g, 0.0192 mmol, 0.1
equiv) 3-phenylbicyclo[2.2.1]hept-5-ene-2-carbaldehyde (0.036 g, 0.192 mmol, 1 equiv)
and (+)-(i?,i?)-hydrobenzoin (0.036 g, 0.192 mmol, 1 equiv) afforded the title compound
(65 mg, 86 %) as a colorless oil. 1H NMR (360 MHz, CDCI3) 5: 5.67 (d, 1H, J- 4.7 Hz,
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CH02, exo), 5.66 (d, 1H, J= 5.9 Hz, CH02, exo), 5.15 (d, 1H, J= 8.1 Hz, CH02, endo),
5.12 (d, 1H, J= 8.1 Hz, CH02, endo).1
2,3:5,6-Di-0-isopropylidene-D-mannose Oxime 227
225 226 227
A three-necked round bottomed flask was charged with acetone (50 mL, HPLC grade)
and D-mannose (5.00 g, 27.75 mmol, 1 equiv) P2O5 (32.69 g, 115.16 mmol, 4.15 equiv)
is added in portions and the mixture is stirred overnight for 25 hours. Ca(OH)2 (3.70 g,
49.95 mmol, 1.8 equiv) and activated carbon (1.42 g) are added and the mixture is
stirred for ca.20 min before it is filtered through celite, rinsing thoroughly with acetone.
This afforded a light yellow filtrate, which was evaporated to dryness in vacuo leaving
225 (6.46 g, 89 %) as a light yellow solid. The crude lactol (6.46 g, 27.75 mmol) is
dissolved in absolute ethanol (100 mL), NH2OH.HCl (2.41 g, 34.69 mmol, 1.25 equiv)
and Na0Ac.3H20 (4.72 g, 34.69 mmol, 1.25 equiv) are added and the mixture is
warmed to 65-70 °C for 1 h. After cooling to room temperature, the bulk of the ethanol
is removed in vacuo and the residue is partitioned between EtOAc and saturated
NaHC03 solution. The organic layer is washed with saturated NaHC03 solution. The
combined aqueous portions are extracted with EtOAc (2 x 250 mL) and the combined
organic extracts are a washed with brine (2 x 150 mL), and dried over magnesium
sulphate to afford the title (6.03 g, 79 %) compound as a yellow solid; 'H NMR (250
MHz, CDCI3) 5: 9.69 (br, 1H, NH), 7.11 (d, 1H, J= 3.5 Hz, CHC=N), 5.25 (dd, 1H, J=
3.5, 7.6 Hz, CH), 4.56 (d, 1H, J= 7.5 Hz, CH), 4.52 (d, 1H, J= 6.8 Hz, CH), 4.16 (m,
1H, CH), 4.11-4.0 (m, 2H, 2 x CH), 3.68 (d, 1H, J= 6.7 Hz, CH), 1.52 (s, 3H, CH3),
1.42 (s, 3H, CH3), 1.40 (s, 3H, CH3), 1.34 (s, 3H, CH3). 13C NMR (91 MHz, CDCI3) 5:
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152.8 (CNH), 110.2 (C(CH3)2), 86.0 (CH), 78.5 (CH), 78.0 (CH) 73.5 (CH), 68.3 (CH2),
65.7 (CH), 26.7 (CH3), 26.6 (CH3), 25.3 (CH3) and 25.2 (CH3).
'H NMR and 13C NMR data was in agreement with the literature.8
[(3aA,4iS',6i?,6a5)-6-(/?)-2,2-Dimethyl-l[l,3]dioxol-4-yl]-[l-4(-methoxy-phenyl)-
meth-(£)-ylidene]-amine N-oxide 228
To 4-methoxybenzaldehyde (1.19 g, 1.06 mL, 8.72 mmol, 1.2 equiv) and 2,3:5,6-0-
isopropylidene-D-Mannose oxime 227 (2 g, 7.264 mmol, 1 equiv) is added toluene (10
mL). Upon heating to reflux, all solids dissolve and the resulting solution is kept at
reflux for 16 h. Water is continuously removed from the reaction mixture using a Dean-
Stark trap. The stirred solution is cooled and the crystals formed are filtered off, washed
with hexane, and dried in vacuo to afford the target compound (2.45 g, 85 %) as a
colorless crystals; lit. 9 m.p. 154 °C (toluene); *H NMR (250 MHz, CDC13) 6: 8.22 (d,
2H, J= 7.0 Hz, ArH), 7.48 (s, 1H, ArH), 6.95 (m, 2H, ArH), 5.44 (s, 1H, CHNO), 5.35
(d, 1H, J= 6.0 Hz, CH), 5.00 (dd, 1H, J= 4.0, 6.0 Hz, CH), 4.69 (dd, 1H, J= 3.9, 7.3 Hz
CH), 4.40 (m, 1H, CH), 4.10 (d, 2H, J= 9.5 Hz, CH2), 3.86 (s, 3H, OCH3), 1.53 (s, 3H,
CH3), 1.46 (s, 3H, CH3), 1.38 (s, 3H, CH3), 1.37 (s, 3H, CH3). 13C NMR (63 MHz,







113.9 (C (CH3)2), 110.0 (C (CH3)2), 103.8 (CH), 86.3 (CH), 85.2 (CH), 81.1 (CH), 73.9
(CH), 67.2 (CH2), 56.1 (OCH3), 27.5 (CH3), 26.7 (CH3), 25.9 (CH3) and 25.1 (CH3).




To nitrone 228 (2.45 g, 6.21 mmol, 1 equiv) in CH2C12 (5 mL) at 23 °C is added benzyl
isocyanate (0.827 g, 6.21 mmol, 1 equiv). The solution is heated to reflux and kept at
this temperature for 40 h. After cooling, the suspension is concentrated in vacuo to
afford an off-white solid. The solid is recrystallised from isopropanol and the crystals
are dried in vacuo to afford the target compound (2.94 g, 90 %) as colourless crystals;
lit. 9 m.p. 190 °C (methanol); XH NMR (250 MHz, CDC13) 5: 7.38-7.32 (m, 3H, ArH),
7.19-7.12 (m, 4H, ArH), 6.96-6.91 (m, 2H, ArH), 5.20 (s, 1H, CHNO), 4.93 (d, 1H, J=
6.0 Hz, CH), 4.84-4.71 (m, 2H, 2 x CH), 4.59 (s, 1H, CH), 4.23 (m,lH, CH), 3.90 (dd,
1H, J= 6.4, 8.7 Hz, CH), 3.83 (s, 3H, OCH3), 3.71-3.64 (m, 2H, 2 x CH), 3.49 (dd, 1H ,
J= 4.8, 8.7 Hz, CH), 1.44 (s, 3H, CH3), 1.30 (s, 3H, CH3), 1.29 (s, 3H, CH3), 1.25 (s,
3H, CH3). 13C NMR (63 MHz, CDC13) 8: 161.0 (OMe ipso), 156.6 (C=0), 135.4 (ipso),
129.8 (ipso), 129.6 (ArH), 129.1 (ArH), 127.9 (ArH), 114.9 (ArH), 113.6 ((C (CH3)2),





73.5 (CH), 67.4 (CH2), 56.3 (OCH3), 46.7 (CH2), 27.6 (CH3), 26.8 (CH3), 26.1 (CH3)
and 25.3 (CH3).
*H NMR and 13C NMR data was in agreement with the literature.9
(l?)-4-benzyl-3-(4-methoxyphenyl)-[l,2,4]-oxadiazolidin-5-one 230
To oxadiazolidinone 229 (10.02 g, 19.0 mmol, 1 equiv) in methanol/water (6:1) (250
ml.) at 23 °C is added 4-toluenesulfonic acid hydrate (36.14 g, 190.0 mmol, 10 equiv).
The solution is heated at reflux and kept at this temperature for 2 h. After cooling,
K3P04 (24.20 g, 114.0 mmol, 6 equiv) is added and the suspension is concentrated in
vacuo to a quarter of the original volume. To this suspension is added EtOAc and water.
The phases are separated and the aqueous phase is extracted with EtOAc. The combined
organic phases are washed with brine (3 x 100 mL), dried MgS04 and concentrated in
vacuo. Purification by column chromatography (Si02, 40 % EtOAc, hexanes) afforded
the title compound (3.85 g, 71 %). as a colorless oil; [(x]d25- +158° (c 0.30, CHC13); lit.9
[a]D35= +170° (c 0.95, CHC13); *H NMR (360 MHz, CDC13) 8: 7.32-7.25 (m, 5H, ArH),
7.12-7.07 (m, 2H, ArH), 6.99-6.94 (m, 2H, ArH), 5.35 (s, 1H, CHNH), 4.77 (d, 1H, J=
14.8 Hz, CH2Ar), 3.85 (s, 3H, OCH3), 3.78 (d, 1H, J= 14.8 Hz CH2Ar). 13C NMR (63
MHz, CDC13) 5: 162.1 (OMe ipso), 160.2 (C=0), 135.1 (ipso), 129.9 (ipso), 129.5










To a-naphthylcarboxaldehyde (6.78 g, 43.4 mmol, 1 equiv) and 2,3:5,6-O-
isopropylidene-D-mannose 227 (11.95 g, 43.4 mmol, 1 equiv) is added toluene (90 mL).
Upon heating to reflux, all solids dissolve and the resulting solution is kept at reflux for
30 h. Water is continuously removed from the reaction using a Dean Stark trap. The
stirred solution is cooled and the crystals formed are filtered off, washed with hexane,
and dried in vacuo to afford the target compound (13.6 g, 76 %) as colourless crystals;
lit. 9 m.p. 153 °C (toluene); *H NMR (250 MHz, CDC13) 5: 9.52 (d, 1H, J= 8.6 Hz,
ArH), 8.44 (s, 1H, CHNO), 8.03 (d, 1H, J= 8.2 Hz, ArH), 7.97-7.89 (m, 2H ArH),
7.63-7.52 (m, 3H, ArH), 5.63 (s, 1H, CH), 5.44 (d, 1H, J= 6.0 Hz, CH), 5.03 (dd, 1H,
J= 3.9, 5.9 Hz, CH),4.75 (dd, 1H, J= 3.9, 7.0 Hz CH), 4.49 (m, 1H, CH), 4.21-4.17 (m,
2H, CH2),1.57 (s, 3H, CH3), 1.49 (s, 3H, CH3), 1.41 (s, 3H, CH3), 1.40 (s, 3H, CH3).
13C NMR (63 MHz, CDC13) 5: 134.1 (CHNO), 132.4 (ArH), 131.4 (ipso), 130.0 (ipso),
129.4 (ArH), 128.1 (ArH), 127.9 (ipso), 126.7 (ArH), 126.2 (ArH), 125.1 (ArH), 122.1
(ArH), 114.0 (C(CH3)2), 110.1 (C(CH3)2), 104.6 (CH), 86.2 (CH), 85.3 (CH), 80.9 (CH),





'H NMR and 13C NMR data was in agreement with the literature. 9
(3R)-4-benzoyl-2-(6-(2,2-dimethyl-l,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuro[3,
4-d][l,3]dioxol-4-yl)-3-(naphthalene-l-yl)-l,2,4-oxadiazolidin-5-one 250
To Nitrone 249 (7.11 g, 17.2 mmol, 1 equiv) in CH2C12 (18 mL) at 23 °C is added
Benzoyl isocyanate (2.53 g, 17.2 mmol, 1 equiv). The solution is left to stir for 18 h, and
then the suspension is concentrated in vacuo to afford an off-white solid. The solid is
recrystallised from isopropanol and the crystals are dried in vacuo to afford the target
compound (8.08 g, 84 %) as colourless crystals; lit.8 m.p. 168 °C (methanol); 'H NMR
(250 MHz, CDC13) 5: 8.25 (d, 1H, J= 8.5 Hz, ArH), 7.92-7.89 (m, 2H, ArH), 7.76-7.71
(m, 3H, ArH), 7.63-7.47 (m, 6H, ArH), 7.29 (s, 1H, CHN), 5.87 (s, 1H, CH),5.03 (bs,
1H, CH), 4.96 (d, 1H, J= 6.0 Hz, CH), 4.76 (dd, 1H, J= 3.8, 5.8 Hz, CH), 4.49-4.37 (m,
2H, CH2), 4.09 (d, 1H, J= 5.8 Hz, CH), 1.51 (s, 3H, CH3), 1.47 (s, 3H, CH3), 1.41 (s,
3H, CH3), 1.32 (s, 3H, CH3).






To oxadiazolidinone 250 (5.5 g, 9.81 mmol, 1 equiv) in methanol (50 mL) at 23 °C is
added K2CO3 (0.136 g, 0.981 mmol, 0.1 equiv). The solution is stirred for 1 h, and then
diluted with aqueous NH4CI, H2O and EtOAc. The phases are separated and the aqueous
phase is extracted with EtOAc. The combined organic phases are washed with brine,
dried MgS04 and concentrated in vacuo. Purification by column chromatography (Si02,
60 % EtOAc, hexanes) afforded the title compound (3.54 g, 79 %) as a colorless solid;
lit. 9 m.p. 197 °C (toluene); *H NMR (250 MHz, CDC13) 5: 8.16 (d, 1H, J= 8.5 Hz,
ArH), 7.9 (d, 2H, J= 8.1 Hz, ArH), 7.73-7.45 (m, 4H, ArH), 6.59 (s, 1H, CHN), 5.92
(s, 1H, CH), 5.06 (s, 1H, CH), 4.97 (d, 1H, J= 6.1 Hz, CH), 4.76 (dd, 1H, J= 3.8, 6.1
Hz, CH), 4.45 (m, 1H, CH), 4.33 (dd, 1H, J= 3.9, 5.1 Hz, CH), 4.08 (d, 1H, J= 6.0 Hz,
CH), 1.51 (s, 3H ,CH3), 1.45 (s, 3H, CH3), 1.41 (s, 3H, CH3), 1.32 (s, 3H, CH3).






To anthracenealdehyde (6.11 g, 29.6 mmol, 1 equiv) and 2,3:5,6-0-isopropylidene-D-
mannose (8.15 g, 29.6 mmol, 1 equiv) is added toluene (60 mL). Upon heating to reflux,
all solids dissolve and the resulting solution is kept at reflux for 22 h. Water is
continuously removed from the reaction using a Dean Stark trap. The stirred solution is
cooled and the crystals formed are filtered off, washed with hexane, and dried in vacuo
to afford the target compound (10.74 g, 76 %) as yellowish crystals; [a]D25= -49° (c
0.38, CHCI3); m.p. 223-225 °C (EtOAc in hexanes); IR (neat)cm1): u max 2941(C-H),
1118(C-0). *H NMR (250 MHz, CDCI3) 5: 8.56 (d, 2H, J= 7.7 Hz, ArH), 8.02 (d, 2H,
J= 8.1 Hz, ArH), 7.82 (d, 2H, J= 8.9 Hz, ArH), 7.56-7.48 (m, 4H ArH), 5.85 (s, 1H,
CHNO), 5.28 (d, 1H, J= 6.0 Hz, CH), 5.07 (dd, 1H, J= 3.8, 6.0 Hz, CH), 4.81 (dd, 1H,
J= 3.9, 7.4 Hz, CH), 4.50-4.45 (m, 2H, CH2), 4.18 (d, 1H, J= 5.3 Hz ,CH), 1.59 (s, 3H,
CH3), 1.47 (s, 3H, CH3), 1.43 (s, 3H, CH3), 1.40 (s, 3H, CH3). ,3C NMR (63 MHz,
CDCI3) 5: 131.8 (ipso), 130.3 (ipso), 129.8 (CHNO), 127.6 (ArH), 126.1 (ArH), 125.5
(ArH), 114.1 (C(CH3)2), 110.2 (C(CH3)2), 104.2 (CH), 86.7 (CH), 85.3 (CH), 81.2 (CH),
73.9 (CH), 67.4 (CH2), 27.5 (CH3), 26.8 (CH3), 25.9 (CH3) and 25.3 (CH3). HRMS






To Nitrone 253 (1.7 g, 3.55 mmol, 1 equiv) in CH2CI2 (10 mL) at 23 °C is added 4-
nitrophenylisocyanate (0.58 g, 3.55 mmol, 1 equiv). The solution is left at rt to stir for 48
h. The suspension is concentrated in vacuo to afford a yellow solid. Purification by
column chromatography (Si02,30% Et20, hexanes) afforded the title compound (1.77 g,
79 %) as yellow crystals; [a]D 25= -88° (c 0.25, CH2C12); m.p. 167-169°C (EtOAc in
hexanes); IR (neat) cm"1): u max2986 (ArCH), 1770 (C=0). 'H NMR (250 MHz, CDCI3)
8: 8.60-8.55 (m, 4H, ArH), 8.05-8.03 (m, 2H, ArH), 7.84-7.78 (m, 2H, ArH), 7.58-7.41
(m, 2H, ArH), 7.27-7.23 (m, 3H, ArH), 5.19 (s, 1H, CHN), 5.09 (d, 1H, J= 6.0 Hz,
CH), 4.64 (dd, 1H, J= 3.7, 6.0 Hz, CH), 3.90-3.86 (m, 1H, CH), 3.49 (s, 1H, CH), 3.07
(dd, 1H, J= 6.1, 8.8 Hz, CH), 2.89 (dd, 1H, J= 3.5, 8.7 Hz, CH), 1.58 (dd, 1H, J= 5.0,
8.9 Hz, CH), 1.46 (s, 3H, CH3), 1.33 (s, 3H, CH3), 1.08 (s, 3H, CH3), 0.72 (s, 3H,
CH3). 13C NMR (63 MHz, CDCI3) 5: 153.3 (C=0), 145.1 (ipso), 141.2 (ipso), 133.1
(ArH), 130.9 (ipso), 125.9 (ArH), 124.9 (ArH), 122.1 (ArH), 121.6 (ipso), 113.7 ((C
(CH3)2), 109.6 ((C (CH3)2), 101.2 (CHN), 84.2 (CH), 83.8 (CH), 80.4 (CH), 79.0 (CH),
72.5 (CH), 66.5 (CH2), 26.8 (CH3), 26.6 (CH3), 25.9 (CH3) and 25.1 (CH3). HRMS








To (£)-c innamaldehyde (0.59 g, 562 pL, 4.45 mmol, 1.24 equiv) and 2,3:5,6-0-
isopropylidene-D-mannose (0.99 g, 3.59 mmol, 1 equiv) is added toluene (10 mL). Upon
heating to reflux, all solids dissolve and the resulting solution is kept at reflux for 14 h.
Water is continuously removed from the reaction using a Dean Stark trap. The stirred
solution is cooled and the crystals formed are filtered off, washed with hexane, and dried
in vacuo to afford the target compound (1.14 g, 82 %) as an off white solid; lit. 9 m.p.
176 °C (toluene); !H NMR (250 MHz, CDC13) 5: 7.54-7.30 (m, 7H, ArH, 2 x CH=CH),
7.04 (d, 1H, J= 14.7 Hz, CH=CH), 5.37 (s, 1H, CH), 5.24 (d, 1H, J= 6.0 Hz, CH), 4.97
(dd, 1H, J= 3.9, 5.9 Hz, CH), 4.57 (dd, 1H, J= 3.9, 7.2 Hz, CH), 4.42 (m, 1H, CH),
4.13-4.09 (m, 2H, CH2), 1.52 (s, 3H, CH3), 1.47 (s, 3H, CH3), 1.32 (s, 3H, CH3), 1.30
(s, 3H, CH3). 13C NMR (91 MHz, CDC13) 5: 141.0 (CHNH), 136.5 (CH), 136.2 (ipso),
130.3 (ArH), 129.6 (ArH), 128.2 (ArH), 117.8 (CH), 113.9 (C (CH3)2), 110.1 (C
(CH3)2), 102.7 (CH), 86.0 (CH), 85.1 (CH), 80.9 (CH), 73.9 (CH), 67.2 (CH2), 27.5
(CH3), 26.7 (CH3), 25.9 (CH3) and 25.1 (CH3).







tetrahydro-furo [3,4-d\ [1,3]dioxol-4-yl]-4-phenyl)-3-((£)-styryl)-[l ,2,4]
oxadiazolidin-5-one, 232
To nitrone 231 (0.50 g, 1.29 mmol, 1 equiv) in CH2CI2 (5 mL) at 23 °C is added phenyl
isocyanate (0.154 g, 1.29 mmol, 1 equiv). The solution is left stirring at rt for 16 h. The
suspension is concentrated in vacuo to afford an off-white solid. The solid is
recrystallised from isopropanol and the crystals are dried in vacuo to afford the target
compound (520 mg, 79 %) as colourless crystals; *H NMR (250 MHz, CDCI3) 8: 7.41-
7.09 (m, 10H, ArH), 6.64 (d, 1H, J= 15.8 Hz, CH=CH), 6.16 (dd, 1H, J= 6.8, 15.9 Hz,
1H, CH=CH), 5.75 (d, 1H, J= 6.7 Hz, CHN), 4.91 (d, 1H, J= 6.0 Hz, CH), 4.79 (dd, 1H,
J= 3.6, 6.0 Hz, CH), 4.68 (s, 1H, CH), 4.32 (m, 1H, CH), 4.12-3.91 (m, 3H, 1 x CH, 1 x
CH2), 1.38 (s, 3H, CH3), 1.34 (s, 3H, CH3), 1.28 (s, 3H, CH3), 1.25 (s, 3H, CH3). ,3C
NMR (63 MHz, CDCI3) 5: 154.6 (COO), 136.4 (CHN), 135.5 (ipso), 130.0 (ArH),
129.7 (ArH), 129.6 (ArH), 129.4 (ArH), 127.7 (ArH), 126.2 (ArH), 124.1 (ipso), 121.0
(CH), 113.7 (C (CH3)2), 109.9 (C (CH3)2), 97.4 (CH), 84.3 (CH), 83.9 (CH), 80.6 (CH),
78.2 (CH), 73.7 (CH), 67.3 (CH2), 27.5 (CH3), 26.5 (CH3), 25.8 (CH3) and 25.0 (CH3).






To oxadiazolidinone 251 (3 g, 6.57 mmol, 1 equiv) in methanol/water (6:1) (170 mL) at
23 °C is added 4-toluenesulfonic acid hydrate (12.49 g, 65.7 mmol, 10 equiv). The
solution is heated at reflux and kept at this temperature for 2 h. After cooling, K3PO4
(8.37 g, 39.4 mmol, 6 equiv) is added and the suspension is concentrated in vacuo to a
quarter of the original volume. To this suspension is added EtOAc and water. The
phases are separated and the aqueous phase is extracted with EtOAc. The combined
organic phases are washed with brine (3 x 100 mL), dried MgS04 and concentrated in
vacuo to afford the target compound (490 mg, 35 %) as colourless crystals, lit. 8 m.p.
136 °C (toluene); [a]D25= +11° (c 0.2, CH2C12); lit.8 [a]D356= +180° (c 0.40, CH2C12);
*H NMR (250 MHz, CD3OD) 5: 9.17 (s, 1H, CHN), 8.60 (m, 1H, ArH), 8.10-7.91 (m,
3H, ArH), 7.67-7.52 (m, 3H, ArH). 13C NMR (91 MHz, CDC13) 5: 156.0 (C=0), 136.1
(CHN), 134.1 (ipso), 130.8 (ArH), 130.7 (ipso), 129.6 (ArH), 128.4 (ArH), 127.2 (ipso),
126.1 (ArH) and 125.0 (ArH).
*H NMR and 13C NMR data was in agreement with the literature.9
153
Experimental
5.3 Experimental Procedures For Chapter 3
6,6-dimethoxyhexenal 270
A 500 mL, three-necked, round-bottomed flask is fitted with a glass tube to admit ozone,
a glass stopper and a magnetic stirring bar and is charged with cyclohexene (10.02 g,
122 mmol, 1 equiv), 250 mL dichloromethane, and 50 mL of methanol. The flask is
cooled to -78 °C and ozone is bubbled through the solution when stirring. Reaction
completion is judged by tic, nitrogen is then passed through the solution and then the
cold bath is removed. The ozone inlet is replaced with a glass stopper; p-TsOH is added
(2.025 g, 12.2 mmol, 0.1 equiv). The solution is allowed to warm to room temperature as
it stirs under an atmosphere of nitrogen for 90 min. Anhydrous sodium bicarbonate (3.56
g, 30.5 mmol, 0.4 equiv) is added to the flask and the mixture is stirred for 15 min, and
then 18 mL of dimethylsulfide is added. After being stirred for 12 h, the heterogeneous
mixture is concentrated to approximately 50 mL by rotary evaporation. Dichloromethane
is added and the mixture is washed with water. The aqueous layer is extracted with two
more portions of dichloromethane, and the combined organic layers are washed with
water. After extracting the aqueous layer with dichloromethane, the organic layers are
dried over magnesium sulphate, filtered and concentrated by rotary evaporation.
Purification by column chromatography (Si02, 30% Et20, hexanes) afforded the title
compound (14.1 g, 72 %) as a colorless oil. 1H NMR (250 MHz ,CDCl3) 5: 10.0 (t, 1H,
J= 1.7 Hz, CHO), 4.57 (t, 1H, J= 5.6 Hz , CH(OCH3)2), 3.54 (s, 6H, (OCH3)2), 2.73 (t,
2H, J= 7.3 Hz, CH2CHO), 1.72-1.46 (m, 6H, 3 x CH2). 13C NMR (63 MHz ,CDC13) 5:




!H NMR and 13C NMR data was in agreement with the literature. 10
6,6-dimethoxy-2-methylenehexanal 271
o
To a solution of 6,6-dimethoxyhexenal (1.02 g, 6.37 mmol, 1 equiv) in dichloromethane
(99.5 mL) and triethylamine (3.09 g, 4.26 mL, 30.56 mmol, 4.8 equiv) was added
Eschenmosehs salt (5.65 g, 30.56 mmol, 4.8 equiv). After stirring for 18 h the reaction
was quenched with saturated NaHC03 and extracted three times with dichloromethane.
The combined organic layers were washed with brine (3 x 50 mL), dried MgS04,
filtered and concentrated in vacuo. Purification by column chromatography (Si02, 30%
Et20, hexanes) afforded the title compound (954 mg, 87 %) as a colorless oil; 'H NMR
(250 MHz,CDC13) 5: 9.64 (s, 1H, CHO), 6.37 (d, 1H, J= 0.7 Hz, CH2=), 6.11 (d, 1H, J=
0.7 Hz, CH2=), 4.47 (t, 1H, J= 5.9 Hz , CH(OCH3)2), 3.41 (6H, s, (OCH3)2), 2.37 (t, 2H,
J= 7.3 Hz, CH2CHOCH3), 1.85-1.64 (m, 2H, 1 x CH2), 0.93 (m, 2H, 1 x CH2). ,3C
NMR (63 MHz, CDC13) 5: 195.0 (CHO), 150.3 (quat), 134.6 (CH2=), 104.7









6,6-Dimethoxy-2-methylenehexanal (100 mg, 0.58 mmol, 1 equiv) was dissolved in
acetic acid (0.7 mL) and the solution was cooled to 0-5 °C in an ice bath. As soon as the
solution started to freeze, HC1 solution (1 M, 0.2 mL) was added at once and the solution
was left to stir for 2 h in the same bath. The mixture was diluted with DCM (30 mL) and
the solution washed successively with water (4 mL), saturated NaHC03 solution (until
the aqueous layer was basic), water (4 mL) and dried over anhydrous MgS04 and
concentrated in vacuo. Purification by column chromatography (Si02, 30 % Et20,
hexanes) afforded the title compound (59 mg, yield not determined) as a colorless oil.
*H NMR (250 MHz, CDC13) 5: 9.82 (t, 1H, J= 1.5 Hz, CHOCH2), 9.6 7(s, 1H, CHO),
6.35 (d, 1H, J= 0.5 Hz, CH2=), 6.12 (d, 1H, J= 0.5 Hz, CH2=), 2.53 (t, 2H, J= 7.3 Hz,
CH2CHO), 2.37 (t, 2H, J= 6.8 Hz, CH2CH2=), 1.92-1.79 (m, 2H, 1 x CH2). 13C NMR
(63 MHz, CDC13) 8: 202.2 (CHO), 194.7 (CHO), 149.9 (quat), 134.9 (CH2=), 35.0
(CH2), 31.9 (CH2) and 25.6 (CH2).
*H NMR and 13C NMR data was in agreement with the literature.11
6-oxo-6-phenylhexanal 317
A 500 mL, three-necked, round-bottomed flask is fitted with a glass tube to admit ozone,





(6.06 g, 38.3 mmol, 1 equiv), dichloromethane (250 mL) and methanol (50 mL). The
flask is cooled to -78 °C and ozone is bubbled through the solution when stirring.
Reaction completion is judged by tic, nitrogen is then passed through the solution and
then the cold bath is removed. The solution is allowed to warm to room temperature as it
stirs under an atmosphere of nitrogen then triphenylphosphine (11.95 g, 45.58 mmol,
1.19 equiv) was added. After being stirred for 12 h, the heterogeneous mixture is
concentrated to approximately 50 mL by rotary evaporation. Purification by column
chromatography (Si02,20 % Et20, hexanes) afforded the title compound (6.69 g, 92 %)
as a white solid; *H NMR (360 MHz, CDC13) 5: 9.8 (t, 1H, J= 1.6Hz, CHO), 7.97-7.94
(m, 2H, ArH), 7.57-7.43 (m, 3H, ArH), 3.01 (t, 2H, J= 6.8 Hz, CH2C=0), 2.51 (dt, 2H,
J= 1.6, 7.0 Hz, CH2CHO), 1.83-1.69 (m, 4H, 2 x CH2). 13C NMR (63 MHz, CDC13) 5:
202.2 (C=0), 199.7 (CHO), 136.9 (ipso), 133.0 (ArH), 128.6 (ArH), 128.0 (ArH), 43.8
(CH2), 38.1 (CH2), 23.6 (CH2), and 21.7 (CH2).
'H NMR and 13C NMR data was in agreement with the literature. 12
2-methylene-6-oxo-6-phenylhexanal 300
To a solution of 6-oxo-6-phenylhexanal 317 (0.150 g, 0.789 mmol, 1 equiv) in DCM (20
mL) and NEt3 (0.398 g, 549 pL, 3.94 mmol, 5 equiv) was added Bohme's salt (0.221 g,
2.36 mmol, 3 equiv). The reaction was left to stir for 18 h, and then quenched with
NaHC03 and extracted three times with DCM. After completion the solvent was
evaporated and the crude product was purified by column chromatography (25 % Et20,
hexanes) afforded the title compound (135 mg, 85 %) as a colorless oil. IR (neat)/cm ):





5: 9.56 (s, 1H, CHO), 7.96-7.94 (m, 2H, ArH), 7.57-7.26 (m, 3H, ArH), 6.33 (s, 1H,
CH2=), 6.05 (s, 1H, CH2=), 3.00 (t, 2H, J= 7.4 Hz, CH2C=0), 2.36 (t, 2H, J= 7.2 Hz,
CH2CH2=), 1.97-1.89 (m, 2H, 1 x CH2). 13C NMR (91 MHz, CDC13) 5: 199.7 (C=0),
194.6 (CHO), 149.6 (quat), 136.9 {ipso), 134.5 (CH2=), 133.0 (ArH), 128.6 (ArH), 128.0
(ArH), 37.8 (CH2), 27.2 (CH2) and 22.2 (CH2). HRMS (ES+) m/z calculated for
Ci3H1502 [M+H] + 203.1067, found 203.1070.
6-oxo-6-phenyl-2-(phenylthiomethylhexanal 303
To a solution of 2-methylene-6-oxo-6-phenylhexanal 300 (0.1 g, 0.495 mmol, 1 equiv)
in toluene (1 mL), thiophenol was added (0.082 g, 76 pL, 0.742 mmol, 1.5 equiv) and
the resulting solution was stirred for 3 h at rt. After completion the solvent was
evaporated and the crude product was purified by column chromatography (Si02> 10 %
Et20, hexanes) afforded the title compound (127 mg, 82 %) as a colorless oil; IR
(neat)/cm"1): u max 1724 (C=0), 1684 (C=0). JH NMR (360 MHz, CDC13) 5: 9.60 (d,
1H, J= 2.0 Hz, CHO), 7.86-7.81 (m, 2H, ArH), 7.47-7.11 (m, 8H, ArH), 3.18 (ABX,
1H, Jab= 13.4 Hz, Jax= 5.9Hz, Jbx= 7.5 Hz, CH2SPh), 2.97 (ABX, 1H, JAB= 13.3 Hz,
Jax= 5.9 Hz, JBX= 7.3 Hz, CH2SPh), 2.90 (t, 2H, J= 6.6 Hz, CH2C=0), 2.50 (m, 1H,
CHCH2SPh), 1.78-1.57 (m, 4H, 2 x CH2). 13C NMR (91 MHz, CDC13) 5: 202.7 (C=0),
199.3 (C=0), 136.7 {ipso), 135.2 {ipso), 133.1 (ArH), 130.2 (ArH), 129.1 (ArH), 128.6
(ArH), 127.9 (ArH), 126.7 (ArH), 50.9 (CH), 38.0 (CH2), 32.9 (CH2), 27.8 (CH2) and





To a solution of 2-methylene-6-oxo-6-phenylhexanal 300 (0.1 g, 0.495 mmol, 1 equiv)
in toluene (1 mL), piperidine was added (0.055 g, 64 pL, 0.643 mmol, 1.3 equiv) and the
resulting solution was stirred for 8 h at rt. After completion the solvent was evaporated
and the crude product was purified by column chromatography (Si02j 10% Et20,
hexanes) affording the title compound (121 mg, 85 %) as a colorless oil. IR (neat) cm"1):
u max 3346 (OH), 2933 (CH2), 1676 (C=0), 1125 (C-O). JH NMR (360 MHz, CDCI3) 5:
8.05-8.00 (m, 2H, ArH), 7.53 (m, 1H, ArH), 7.48-7.42 (m, 2H, ArH), 4.07 (t, 1H, J=
8.9 Hz, CHOH), 3.77 (m, 1H, CHCOPh), 2.60 (d, 1H, J=3.7, CH), 2.57 (d, 1H, J= 3.7
Hz, CH), 2.41-1.47 (m, 15H, 7 x CH2, 1 x CH). 13C NMR (91 MHz, CDCI3) 5: 202.3
(C=0), 137.3 (ipso), 132.9 (ArH), 128.7 (ArH), 128.4 (ArH), 82.7 (CHOH), 63.8 (CH2),
55.3 (CH2), 52.5 (CH), 43.2 (CH), 26.5 (CH2), 26.1 (CH2), 26.0 (CH2) and 24.1 (CH2).





To a solution of 2,2-diethoxy-ethylamine (4 g, 30.03 mmol, 1 equiv) in dry DCM (80
mL), triethylamine was added (9.11 g, 90.09 mmol, 3 equiv), the reaction was cooled to
0 °C and p-toluenesulfonylchloride was added to the solution. After 24 h, the reaction
mixture was quenched with water and extracted with DCM (3 x 100 mL). The combined
organic layers were dried MgSCL, filtered and concentrated in vacuo. The residue was
recrystallised from dichloromethane/hexane to give the title compound (7.5 g, 87 %) as a
crystalline solid; *H NMR (250 MHz, CDC13) 5: 7.73 (d, J= 6.6 Hz, 2H, ArH), 7.33 (d,
J= 6.6 Hz, 2H, ArH), 4.46 (t, 1H, J= 5.6Hz, CH(OEt)2), 3.67-3.43 (m, 4H, (CH2CH 3)2),
3.02 (d, 2H, J= 6.5 Hz, CH2CH(OEt)2), 2.42 (s, 3H, CH3A1H), 1.17 (t, 6H, J= 7.0 Hz,
CH3CH2)2).13 C NMR (63 MHz, CDC13); 143.5 (ipso), 136.8 (ipso), 129.7 (ArH), 127.1
(ArH), 100.7 (CH(OCH2CH3), 63.2 (CH2), 45.4 (CH2), 21.5 (CH3) and 15.2 (CH3).




To a solution of N-(2,2-diethoxyethyl)-4-methylbenzenesulfonamide (1.98 g, 6.89
mmol, 1 equiv) in dry DMF (50 mL) at 0 °C, NaH (60 % dispersion, 0.301 g, 8.96
mmol, 1.3 equiv) was added, the suspension was stirred for 30 min at rt before adding
the methyl 2-(bromoethyl) acrylate (2.86 g, 14.81 mmol, 2.15 equiv) dropwise. After 24
h, the reaction mixture was quenched with water and extracted with diethylether (3 x
150 mL).The combined organic layers were dried MgS&t, filtered and concentrated in
vacuo. The residue was purified by flash chromatography on silica gel (Si02, 10 %
Et20/hexanes) to give the title compound (2.35 g, 85 %) as a colourless oil; IR (neat)/
cm"1): u max 2976 (CH2), 1719 (C=0), 1159 (C-O). JH NMR (250 MHz, CDC13) 5: 7.38
(d, 2H, J= 8.2 Hz, ArH), 7.27 (d, 2H, J= 8.2 Hz, ArH), 6.29 (s, 1H, CH2=), 5.74 (s, 1H,
CH2=), 4.57 (t, 1H, J= 5.4 Hz, CH(OEt)2), 4.16 (q, 2H, J= 7.1 Hz, OCH2CH3), 3.68-
3.59 (m, 2H, (OCH2CH3)2), 3.50-3.38 (m, 2H, (OCH2CH3)2), 3.28 (d, 2H, J= 5.5 Hz,
CH2CH(OCH2CH3)2), 2.41 (s, 3H, CH3ArH), 1.58 (s, 2H, (CH2CH2=), 1.26 (t, 3H, J=
7.1 Hz, OCH3CH2), 1.15 (t, 6H, J= 7.0 Hz, OCH3CH2)2). 13C NMR (63 MHz, CDC13) 8:
165.9 (COOEt), 143.3 (quat), 137.2 (ArH), 135.7 (ipso), 129.6 (CH2=), 127.2 (ArH),
126.8 (ArH), 102.1 (CHOCH3), 63.2 (CH2), 60.8 (CH2), 50.9 (CH2), 49.7 (CH2), 21.5
(CH3), 15.2 (CH3) and 14.1 (CH3).




To Ethyl-2-((N-(2,2-diethoxyethyl)-4methylphenylsulfonamide) methylacrylate 273
(1.85 g, 4.63 mmol, 1 equiv) in dry DCM (50 mL) and toluene (10 mL) at -78 °C, was
added DIBAL-H dropwise (1M solution in hexane, 5.09 mL, 5.09 mmol, 1.1 equiv), the
suspension was stirred for 12 h. To the reaction mixture was added potassium sodium
tartrate solution; the mixture was vigorously stirred for 30 min and extracted with DCM
(3 x 100 mL). The combined organic layers were dried MgS04, filtered and concentrated
in vacuo. After completion, the solvent was evaporated and the crude product was
purified by column chromatography (Si02, 40 % Et20, hexanes) to afford the title
compound (1.49 g, 90 %) as a colorless oil; IR (neat)/ cm"1): u max 3452 (OH), 3062
(CHAr), 2970 (CH2), 1148 (C-O). JH NMR (250 MHz, CDCfi) 5:7.70 (d, 2H, J= 8.3 Hz,
ArH), 7.33 (d, 2H, J= 8.0 Hz, ArH), 5.20 (s, 1H, CH2=), 5.00 (s, 1H, CH2=), 4.62 (t,
1H, J= 5.5 Hz, CH(OEt)2), 4.12 (br, d, 2H, J= 4.4 Hz, CH2OH), 3.89 (s, 2H, CH2CH2=),
3.68-3.62 (m, 2H, OCH2CH3)2), 3.49-3.39 (m, 2H, OCH2CH3)2), 3.24 (d, 2H, J= 5.5 Hz,
CH2CH(OCH2CH3)2>), 2.43 (s, 3H, CH3ArH), 1.15 (t, 6H, J= 7.0 Hz, OCH3CH2)2). ,3C
NMR (63 MHz, CDCfi) 5:143.6 (quat), 143.4 (quat), 136.4 (quat), 129.5 (ArH), 127.1
(ArH), 115.1 (CH2=), 101.3 (CHOEt), 63.2 (CH2), 62.8 (CH2), 51.5 (CH2), 49.4 (CH2),






g, 1.37 mmol, 1 equiv) in DCM was added sequentially celite (equal amount by mass
PCC), molecular sieves and PCC (0.366 g, 1.70 mmol, 1.24 equiv). After stirring at rt
for 3 h, the solution was filtered through a plug of silica (DCM) and the solvent was
evaporated to afford the title compound (431 mg, 89 %) as a white solid; IR (neat) / cm"
!): u max 1691 (CHO), 1427 (S=0), 1154 (C-O). *H NMR (250 MHz, CDC13) 5: 9.55 (s,
1H, CHO), 7.70 (d, 2H, J= 8.3 Hz, ArH), 7.30 (d, 2H, J= 8.0 Hz, ArH), 6.49 (s, 1H,
CH2=) 6.17 (s, 1H, CH2=), 4.53 (t, 1H, J= 5.4 Hz, CH(OEt)2), 4.11 (s, 2H, CH2N),
3.70-3.57 (m, 2H, OCH2CH3), 3.47-3.36 (m, 2H, OCH2CH3), 3.23 (d, 2H, J= 5.4 Hz,
CH2CH), 2.42 (s, 3H, CH3ArH), 1.14 (t, 6H, J= 7.0 Hz, (CH3CH2)2). 13C NMR (63
MHz, CDC13) 8: 193.4 (CHO), 145.2 (quat), 143.6 (quat), 136.5 (quat), 135.5 (CH2=),
129.7 (ArH), 127.2 (ArH), 101.8 (CHOEt), 63.0 (CH2), 51.2 (CH2), 47.2 (CH2), 21.5




Ethyl-2-((4-methyl-N-(2-oxoethyl) phenylsulfonamide) raethylacrylate, 308
Ethyl-2-((N-(2,2-diethoxyethyl)-4-methylphenylsulfonamide) methylacrylate (1.0 g,
2.50 mmol, 1 equiv) was dissolved in acetic acid (2.5 mL) and the solution was cooled
to 0-5 °C in an ice bath. As soon as the solution started to freeze, HC1 solution (1M, 700
(iL) was added at once and the solution was stirred overnight in the same bath. The
mixture was diluted with DCM and the solution was washed successively with water
(100 mL) and saturated NaHC03 (100 mL). The combined organic layers were dried
MgSCL, filtered and concentrated in vacuo. After completion the solvent was evaporated
and the crude product was purified by column chromatography (Si02, 40 % Et20,
hexanes) to afford the title compound (910 mg, 92 %) as a colorless oil; IR (neat) cm"'):
omax 2809 (CHCHO), 1718 (C=0), 1705 (OO), 1431 (S=0), 1122 (C-O). *H NMR
(250 MHz, CDC13) 5: 9.72 (s, 1H, CHO) 7.75-7.55 (d, 2H, J= 8.2 Hz, ArH), 7.27 (d,
2H, J= 8.2 Hz, ArH), 6.28 (d, 1H, J= 1.0 Hz, CH2=), 5.75 (d, 1H, J= 1.0 Hz, CH2=),
4.32 (s, 2H, CH2CH2=), 4.25(q, 2H, J= 7.3 Hz, OCH2CH3), 3.25 (s, 2H, CH2CHO),
2.40 (s, 3H, CH3A1H), 1.35(t, 3H, J= 7.2 Hz, OCH3CH2). 13C NMR (63 MHz, CDC13)
5: 198.2 (CHO), 166.2 (C=0), 144.3 (quat), 135.7 (CH2=), 135.3 (quat), 130.0 (ArH),
129.1 (ArH), 127.6 (quat), 61.6 (CH3), 57.7 (CH2CHO), 52.3 (CH2CH3), 50.1 (CH2) and
21.7 (CH3).




To N-(2,2-diethoxyethyl)-N-(2-(formylallyl)-4-methylbenzenesulfonamide (0.400 g,
1.13 mmol, 1 equiv) in MeCN (3 mL) and H2O (100 pL), LiBF4 (0.127 g, 1.35 mmol,
1.2 equiv) was added in a flask MeCN (3 mL) and H20 (100 pL) and heated to reflux at
50 °C for 3 h. After stirring for 3 h, the reaction mixture was quenched with NaHCCL
and extracted with Et20 (2 x 100 mL). The combined organic layers were dried MgS04,
filtered and concentrated in vacuo to afford the title compound (235 mg, 74 %) as an
amorphous white solid; m.p.= 67-69 °C (Et20/ hexanes); IR (neat) cm"1) • D max 1682
(C=0), 1422 (S=0), 1154 (C-O). lH NMR (360 MHz, CDCI3) 5: 9.56 (s, 1H, CHO)
9.53 (t, 1H, J= 1.2 Hz, CHO), 7.76 (d, 2H, J= 8.2 Hz, ArH), 7.34 (d, 2H, J= 8.2 Hz,
ArH), 6.65 (s, 1H, CH2=), 6.28 (s, 1H, CH2=), 4.01 (s, 2H, CH2), 3.91 (s, 2H,
CH2CHO), 2.44 (s, 3H, CH3ArH). 13C NMR (63 MHz, CDCI3) 5: 197.1 (CHO), 193.3
(CHO), 144.5 (quat), 144.3 (quat), 137.3 (CH2=), 135.3 (quat), 129.9 (ArH), 127.4
(ArH), 57.9 (CH2), 46.8 (CH2), and 21.5 (CH3). HRMS (ES+) m/z calculated for








Purification by column chromatography (Si02, 15 % Et20, hexanes) afforded the title
compound (4:3 d.r.) as a colorless oil/solid; IR (neat)/ cm"1): u max 3469 (OH), 1694
(CHO), 1085 (C-O). Inseparable mixture of diastereomers. 'H NMR (360 MHz, CDCI3)
5: 9.65 (s, 1H, CHO), 7.75-7.68 (m, 4H, ArH), 7.36-7.31 (m, 4H, ArH), 4.43 (m, 1H,
CHOH), 3.74-3.36 (m, 12H, 6 x CH2), 3.31-3.15 (m, 4H, 2 x CH2CH3), 2.44 (s, 6H,
CH3Ar), 1.13 (t, 3H, J= 7.0 Hz, CH3CH2). Minor diastereomer diagnostic peaks: 'H
NMR (360 MHz, CDC13) 5: 9.51 (s, 1H, CHO), 4.50 (m, 1H, CHOH). 1.12 (t, 3H, J=
7.0 Hz, CH3CH2) 13C NMR (91 MHz, CDC13) 5: 201.2 (CHO), 200.1 (CHO), 143.7
(ipso), 132.8 (ipso), 129.6 (ArH), 127.5 (ArH), 77.1 (CHOH), 73.7 (CHOH), 71.5
(CH2), 70.6 (CH2), 68.3 (CH2), 67.1 (CH2), 61.0 (quat), 60.4 (quat), 54.6 (CH2), 54.1
(CH2), 48.9 (CH2), 48.6 (CH2), 21.4 (CH3Ar), and 14.5 (CH3). HRMS (ES+) m/z
calculated for C15H2205SN [M+H]+ 328.1213, found 328.1213.
8,8-dimethoxy-2-methyloctan-3-one 289
A 500 mL, three-necked, round-bottomed flask is fitted with a glass tube to admit ozone,
a glass stopper and a magnetic stirring bar and is charged with isopropyl-l-cyclohexene
(5 g, 40.2 mmol, 1 equiv) and dichloromethane (250 mL) with methanol (50 mL). The
flask is cooled to -78 °C and ozone is bubbled through the solution when stirring.





then the cold bath is removed. The solution is allowed to warm to room temperature as it
stirs under an atmosphere of nitrogen triphenylphosphine (12.7 g, 48.3 mmol, 1.2 equiv)
was added. After being stirred for 12 h, the heterogeneous mixture is concentrated to
approximately 50 mL by rotary evaporation. Dichloromethane (250 mL) is added and
the mixture is washed with water (3 x 50 mL). The aqueous layer is extracted with two
more portions of dichloromethane, and the combined organic layers are washed with
water. After extracting the aqueous layer with dichloromethane, the organic layers are
dried over magnesium sulphate, filtered and concentrated by rotary evaporation.
Purification by column chromatography (Si02, 20 % Et20, hexanes) afforded the title
compound (7.48 g, 92 %) as a white solid, m.p. = 81-83 °C (Et20/ hexanes); IR (neat)/
cm1): u max 2918 (CH2), 1709 (C=0), 1080 (C-O). *H NMR(360 MHz, CDC13) 8: 4.36
(t, IH, J= 5.7 Hz, CH(OCH3)2), 3.30 (s, 6H, (OCH3)2), 2.57 (sept, 1H, J= 6.9 Hz,
CH(CH3)2), 2.45 (t, 2H, J= 7.3 Hz, CH2CHO), 1.64-1.53 (m, 4H, 2 x CH2), 1.38-1.23
(m, 2H, 1 x CH2), 1.08 (d, 6H, J= 6.9 Hz, (CH3)2CH). 13C NMR (91 MHz, CDC13) 5:
214.8 (C=0), 104.3 (CHOCH3), 52.7 (CH3OCH), 40.8 (CHCH3), 40.1 (CH2), 32.3
(CH2), 24.3 (CH2), 23.5 (CH2) and 18.2 (CH3). HRMS (ES+) m/z calculated for







8,8-Dimethoxy-2-methyloctan-3-one (4.00 g, 19.8 mmol, 1 equiv) was dissolved in
acetic acid (10 mL) and the solution was cooled to 0-5 C in an ice bath. As soon as the
solution started to freeze, HC1 solution (1 M, 1.5 mL) was added at once and the solution
was stirred overnight in the same bath. The mixture was diluted with DCM and the
solution was washed successively with water and saturated NaHC03. The combined
organic layers were dried over MgS04, filtered and concentrated in vacuo. Purification
by column chromatography (Si02> 20 % Et20, hexanes) afforded the title compound
(3.09 g, 84 %) as a colorless oil; IR (neat)/ cm"1): u max2918 (CH2), 1709 (C=0), 1687
(CHO). *H NMR (360 MHz, CDC13)8: 9.76 (t, 1H, J= 1.6 Hz, CHO), 2.57 (sept, 1H, J=
6.9 Hz, CH(CH3)2), 2.51-2.42 (m, 4H, 2 x CH2), 1.66-1.57 (m, 4H, 2 x CH2), 1.09 (d,
6H, J= 6.9 Hz, (CH3)2CH). 13C NMR (91 MHz, CDC13) 5: 214.3 (C=0), 194.5 (CHO),
40.6 (CH), 39.3 (CH2), 31.5 (CH2), 26.9 (CH2), 21.6 (CH2) and 18.0 (CH3). HRMS
(ES+) m/z calculated for C9H20O2N [M+NH4] + 174.1489, found 174.1490.
7-methyl-2-methylene-6-oxoctanal 302
To a solution of 7-methyl-6-oxoctanone (4.0 g, 25.6 mmol, 1 equiv) in DCM (200 mL)
and NEt3 (12.9 g, 18 mL, 128 mmol, 5 equiv) was added Bohme's salt (7.2 g, 76.9
mmol, 3 equiv). The reaction was left to stir for 18 h, and then quenched with NaHC03





chromatography (Si02>25 % Et20, hexanes) afforded the title compound (3.79 g, 88 %)
as a colorless oil; IR (neat)/ cm"1): u max 3082 (CH2=), 2963 (CH2), 1736 (C=0), 1693
(C=0). *H NMR (360 MHz, CDC13) 5: 9.47 (s, 1H, CHO), 6.23 (s, 1H, CH2=), 5.97 (s,
1H, CH2=), 2.75 (sept, 1H, J= 6.9 Hz, CH(CH3)2), 2.66 (t, 2H, J= 7.3Hz, CH2C=0),
2.45-2.39 (m, 2H, 2 x CH2), 1.98-1.86 (m, 2H, 2 x CH2), 1.26 (d, 6H, J= 6.9 Hz,
(CH3)2CH). 13C NMR (63 MHz, CDC13) 5: 214.0 (C=0), 194.4 (CHO), 149.6 (quat),
134.2 (CH2=), 40.7 (CH (CH3)2), 39.4 (CH2), 27.0 (CH2), 21.6 (CH2) and 18.1 (CH3).
HRMS (EI) m/z calculated for CioHi602 [M] 168.1145, found 168.1143.
7-Methyl-6-oxo-2-(phenylthiomethyI)octanal 305
To a solution of 7-methyl-2-methylene-6-oxoctanal (0.05 g, 0.297 mmol, 1 equiv) in
DCM (1 mL) with molecular sieves, thiophenol was added (0.036 g, 34 pi, 0.327 mmol,
1.1 equiv) and the resulting solution was stirred for 6 h at rt. After completion the
solvent was evaporated. The mixture was diluted with DCM and the solution was
washed successively with water and saturated NaHC03. The combined organic layers
were dried over MgS04, filtered and concentrated in vacuo. Purification by column
chromatography (Si02,25 % Et20, hexanes) afforded the title compound (60 mg, 73 %)
as a colorless oil. IR (neat) cm"1): u max3062 (CHAr), 2817 (HC-O), 1737 (C-O), 1696
(C=0). *H NMR (250 MHz, CDCI3) 5: 9.60 (d, 1H, J= 2.0 Hz, CHO), 7.37-7.23 (m,
5H, ArH), 3.20 (dd, 1H, J= 7.5, 13.4 Hz, CH2SPh), 3.05 (dd, 1H, J= 6.0, 13.3 Hz,
CH2SPh), 2.54 (sept, 1H, J= 6.9 Hz, CH(CH3)2), 2.43 (t, 2H, J= 7.0 Hz, CH2C =0),
1.63-1.57 (m, 5H, 2 x CH2> 1 x CH); 1.06 (d, 6H, J= 6.9 Hz, (CH3)2CH). 13C NMR (63
MHz, CDCI3) 8: 213.9 (CHO), 202.7 (C=0), 136.7 (ipso), 130.2 (ArH), 129.1 (ArH),
126.7 (ArH), 50.9 (CHCHO), 40.8 (CH(CH3)2), 39.7 (CH2), 32.9 (CH2), 27.9 (CH2),
169
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20.6 (CH2) and 18.2 (CH3). HRMS (ES+) m/z calculated for Ci6H2602NS [M+NH4] +
296.1679, found 296.1678. HPLC (Chiralcel AD-H), hexane/isopropanol= 98/2, 1.0
mL/min, X = 254 nm, retention time: enantiomers (20.1, 21.6 mins).
2-Methyl-l-(3-(phenylthiomethyl) cyclopent-2-enyl) prop-l-one 321
To a solution of 7-methyl-2-methylene-6-oxoctanal (0.05 g, 0.298 mmol, 1 equiv) in
MeCN (2.5 mL) and H20 (107 pi, 5.96 mmol, 20 equiv) was added thiophenol (0.036 g,
34 pi, 0.328 mmol, 1.1 equiv) and t-BuOK (0.200 g, 1.78 mmol, 6 equiv). The reaction
was left to stir for 18 h. After completion the solvent was evaporated and the crude
product was purified by column chromatography (Si02, 20 % Et20, hexanes) affording
the title compound (47 mg, 61 %). as a colorless oil. IR (neat)/ cm"1): o max 1716 (C=0),
1274 (CH); *H NMR (360 MHz, CDC13) 5: 7.44-7.40 (m, 2H, ArH), 7.33-7.27 (m, 2H,
ArH), 7.22 (m, 1H, ArH), 6.37 (t, 1H, J= 1.9 Hz, CH=), 3.29 (d, 2H, J= 1.5 Hz, CH2),
2.98 (sept, 1H, J= 6.9 Hz, CH(CH3)2), 2.74-2.64 (m, 2H, 1 x CH2), 2.50 (m, 1H, CH),
2.18 (m, 1H, CH), 2.04 (m, 1H, CH), 1.07 (d, 3H, J= 6.9 Hz, (CH3)CH), 1.00 (d, 3H, J=
6.9 Hz, (CH3)CH). 13C NMR (91 MHz, CDC13) 5: 203.8 (C=0), 144.8 (quat), 142.6
(CH=), 130.0 (quat), 129.2 (ArH), 126.8 (ArH), 85.7 (CH=0), 45.3 (CH2), 37.1 (CH2),
36.5 (CH(CH3)2), 29.3 (CH2) and 19.1 (CH3). HRMS (ES+) m/z calculated for







A 500 mL, three-necked, round-bottomed flask is fitted with a glass tube to admit ozone,
a glass stopper and a magnetic stirring bar and is charged with 1-phenylcyclohexene
(2.05 g, 12.9 mmol, 1 equiv), dichloromethane (100 mL) and methanol (25 mL). The
flask is cooled to -78 °C and ozone is bubbled through the solution when stirring.
Reaction completion is judged by tic, nitrogen is then passed through the solution and
then the cold bath is removed. The solution is allowed torn warm to room temperature as
it stirs under an atmosphere of nitrogen triphenylphosphine (3.46 g, 13.2 mmol, 1.02
equiv) was added. After being stirred for 6 h, the heterogeneous mixture is concentrated
to approximately 50 mL by rotary evaporation. Dichloromethane (150 mL) is added and
the mixture is washed with water (75 mL). The aqueous layer is extracted with two more
portions of dichloromethane, and the combined organic layers are washed with water.
After extracting the aqueous layer with dichloromethane, the organic layers are dried
over magnesium sulphate, filtered and concentrated by rotary evaporation. Purification
by column chromatography (Si02, 20 % Et20, hexanes) afforded the title compound
(2.59 g, 85 %) as a colorless oil. *H NMR (360 MHz, CDCI3) 8: 7.97-7.94 (m, 2H,
ArH), 7.58-7.43 (m, 3H, ArH), 4.38 (t, 1H, J= 5.7 Hz, CH(OCH3)2), 3.32 (s, 6H,
OCH3)2), 2.98 (t, 2H, J= 7.0 Hz, CH2C=0), 1.81-1.63 (m, 4H, 2 x CH2), 1.49-1.40 (m,
2H, 2 x CH2). 13C NMR (91 MHz, CDCI3) 8: 200.4 (C=0), 137.1 (ipso), 133.1 (ArH),
128.7 (ArH), 128.2 (ArH),104.5 (CH(OMe2), 52.9 (CH3), 38.6 (CH2), 32.5 (CH2), 24.5
(CH2) and 24.2 (CH2).





A solution of LHMDS (635 pL, 0.635 mmol, 1.5 equiv), in THF was cooled to -78 °C
before dropwise addition of phenyl acetal 279 (0.100 g, 0.423 mmol, 1 equiv) in THF (4
mL). The mixture was stirred for 1 h, then canulated into a stirred suspension of
Bohme's salt (0.119 g, 1.27 mmol, 3 equiv) in THF (5 mL) at -78 °C for 10 minutes. The
contents of the flask were then transferred to a separatory funnel containing ether and
NaHCC>3. The aqueous layer is extracted with two more portions of dichloromethane,
and the combined organic layers are washed with water. After extracting the aqueous
layer with dichloromethane (100 mL), the organic layers are dried over magnesium
sulphate, filtered and concentrated by rotary evaporation. The oil was then dissolved in
DCM (15 mL), NaHCC>3 (10 mL), mcpba (0.146 g, 0.846 mmol, 2 equiv) was added in
one portion and left to stir for 20 minutes. The contents were then transferred to a
separatory funnel, the aqueous layer is extracted with two more portions of
dichloromethane, and the combined organic layers are dried over magnesium sulphate,
filtered and concentrated by rotary evaporation. Purification by column chromatography
(Si02,20 % Et20, hexanes) afforded the title compound (89 mg, 85 %) as a colorless oil;
IR (neat) cm1): u max 3077 (CH2=), 1710 (C=0), 1085 (C-O). *H NMR (360 MHz,
CDC13) 5: 7.75-7.70 (m, 2H, ArH), 7.54-7.48 (m, 1H, ArH), 7.44-7.38 (m, 2H, ArH),
5.84 (s, 1H, CH2=), 5.59 (s, 1H, CH2=), 4.38 (t, 1H, J= 5.5 Hz, CH(OCH3)2), 3.30 (s,
6H, OCH3)2), 2.52 (t, 2H, J= 6.8 Hz, CH2CH2=), 1.70-1.51 (m, 4H, 2 x CH2). 13C NMR
(91 MHz, CDCI3) 5: 198.3 (C=0), 147.9 (quat), 137.8 (quat), 132.2 (ArH), 129.5 (ArH),
128.2 (ArH), 125.7 (CH2=), 104.3 (CHOCH3), 52.8 (OCH3), 32.2 (CH2), 32.0 (CH2) and






6,6-Dimethoxy-2-methylene-l-phenylhexan-l-one (2.0 g, 8.05 mmol, 1 equiv) was
dissolved in acetic acid (10 mL) and the solution was cooled to 0-5 °C in an ice bath. As
soon as the solution started to freeze, HC1 solution (1 M, 2.5 mL) was added at once and
the solution was stirred for 5h in the same bath. The mixture was diluted with Et20 and
the solution was washed successively with water and saturated NaHC03. The combined
organic layers were dried MgSCL, filtered and concentrated in vacuo. Purification by
column chromatography (Si02, 15 % Et20, hexanes) afforded the title compound (1.48
g, 74 %) as a colourless oil; IR (neat)/ cm"1): o max 3082 (CH2=), 3063 (CHAr), 2932
(CH2), 1692 (C=0), 1686 (CHO). *H NMR (360 MHz, CDC13) 5: 9.79 (t, 1H, J= 1.5
Hz, CHO), 7.76-7.72 (m, 2H, ArH), 7.55 (m, 1H, ArH), 7.47-7.40 (m, 2H, ArH), 5.89
(s, 1H, CH2=), 5.66 (s, 1H, CH2=), 2.55 (m, 4H, 2 x CH2), 1.92 (quin, 2H, J= 7.6 Hz,
CH2). 13C NMR (91 MHz, CDC13) 6: 202.1 (CHO), 198.0 (C=0), 147.2 (quat), 137.6
(quat), 132.3 (ArH), 129.5 (ArH), 128.2 (ArH), 126.5 (CH2=), 43.3 (CH2), 31.5 (CH2)






To a solution of 5-benzoylhex-5-enol (0.08 g, 0.396 mmol, 1 equiv) in DCM (1 mL)
with molecular sieves, thiophenol was added (0.048 g, 45 pi, 0.436 mmol, 1.1 equiv)
and the resulting solution was stirred for 4 h at rt. After completion the solvent was
evaporated. Purification by column chromatography (Si02, 20 % Et20, hexanes)
afforded the title compound (108 mg, 88 %) as a colorless oil; IR (neat)/ cm"1): o max
1721 (C=0), 1678 (CO). *H NMR (360 MHz, CDC13) 5: 9.69 (t, 1H, J = 1.5 Hz,
CHO), 7.83-7.79 (m, 2H, ArH), 7.57 (m, 1H, ArH), 7.45-7.40 (m, 2H, ArH), 7.35-7.20
( m, 5H, ArH), 3.73-3.63 (m, 1H, CHCO), 3.34 (ABX, 1H, Jab= 13.2 Hz, Jax= 5.9
Hz, JBX= 7.2 Hz, CH2SPh), 3.06 (ABX, 1H, Jab= 13.2 Hz, Jax= 6.5 Hz, JBX= 6.7Hz,
CH2SPh) 2.39 (dt, 2H, J= 1.5, 7.2 Hz, CH2CH). 1.93-1.56 (m, 2 x CH2). 13C NMR (91
MHz, CDC13) 5: 202.0 (C=0), 201.7 (CO), 136.8 (ipso), 135.6 (ipso), 133.4 (ArH),
130.3 (ArH), 129.0 (ArH), 128.7 (ArH), 128.3 (ArH), 126.7 (ArH), 45.4 (CHCOPh),
43.7 (CH2), 36.1 (CH2), 31.4 (CH2) and 19.6 (CH2). HRMS (ES+) m/z calculated for






A solution of LHMDS (11.2 mL, 11.2 mmol, 1.5 equiv), in THF was cooled to -78 °C
before dropwise addition of isopropylacetal 289 (1.5 g, 7.43 mmol, 1 equiv) in THF (40
mL). The mixture was stirred for 1 h, then canulated into a stirred suspension of
Bohme's salt (2.08 g, 22.3 mmol, 3 equiv) in THF (50 mL) at -78 °C for 10 minutes. The
contents of the flask were then transferred to a separatory funnel containing ether and
NaHC03. The aqueous layer is extracted with two more portions of dichloromethane,
and the combined organic layers are washed with water. After extracting the aqueous
layer with dichloromethane (2 x 100 mL), the organic layers are dried over magnesium
sulphate, filtered and concentrated by rotary evaporation. The oil was then dissolved in
DCM (15 mL), NaHC03 (10 mL), mcpba (2.56 g, 14.9 mmol, 2 equiv) was added in one
portion and left to stir for 20 minutes. The contents were then transferred to a separatory
funnel, the aqueous layer is extracted with two more portions of dichloromethane, and
the combined organic layers are dried over MgS04, filtered and concentrated by rotary
evaporation. Purification by column chromatography (SiC>2, 10% Et20, hexanes)
afforded the title compound (1.26 g, 79 %) as a colorless oil; IR (neat)/ cm '): u max 3084
(CH2=), 2958 (CH2) 1735 (C=0), 1097 (C-O). JH NMR (360 MHz, CDC13)5: 5.96 (s,
1H, CH2=), 5.72 (s, 1H, CH2=), 4.35 (t, 1H, J= 5.7 Hz, CH(OCH3)2), 3.30 (s, 6H,
(OCH3)2), 3.29 (sept, 1H, J= 6.6 Hz, CH(CH3)2), 2.26 (t, 2H, J= 7.7 Hz, CH2CH2=),
1.64-1.55 (m, 2H, 1 x CH2), 1.49-1.39 (m, 2H, 1 x CH2) 1.07 (d, 6H, J= 6.9 Hz,
(CH3)2CH).13C NMR (63 MHz, CDC13) 5: 206.2 (C=0), 147.6 (quat), 123.2 (CH2=),
104.4 (CHOCH3), 52.8 (OCH3), 34.5 (CH(CH3)2, 32.8 (CH2), 31.0 (CH2), 23.4 (CH2)








8,8-dimethoxy-2-methyl-4-methleneoctan-3-one (0.9 g, 4.2 mmol, 1 equiv) was
dissolved in acetic acid (5 mL) and the solution was cooled to 0-5 °C in an ice bath. As
soon as the solution started to freeze, HC1 solution (1 M, 1 mL) was added at once and
the solution was stirred for 5 h in the same bath. The mixture was diluted with Et20 and
the solution was washed successively with water and saturated NaHCCL. The combined
organic layers were dried MgSCL, filtered and concentrated in vacuo. Purification by
column chromatography (Si02> 20 % Et20 hexanes) afforded the title compound (473
mg, 67 %) as a colorless oil; IR (neat)/ cm"1): o max 3086 (CH2=), 2968 (CH2) 1737
(C=0), 1693 (C=0). JH NMR (250 MHz, CDCI3) 8: 9.75 (1H, t, J= 1.6 Hz, CHO), 6.00
(s, 1H, CH2=), 5.77 (s, 1H, CH2=), 3.29 (sept, 1H, J= 6.6 Hz, CH(CH3)2),), 2.44 (dt, 2H,
J= 1.6, 7.3 Hz, CH2CH2=), 2.30 (dt, 2H, J= 1.0, 7.9 Hz CH2CHO), 1.77-1.68 (m, 2H, 1
x CH2), 1.09 (d, 6H, J= 6.9 Hz, (CH3)2CH). ,3C NMR (63 MHz, CDCI3) 5: 205.9
(C=0), 202.2 (CHO), 146.9 (quat), 123.9 (CH2=), 43.4 (CH2), 34.5 (CH(CH3)2), 30.7
(CH2), 21.0 (CH2) and 19.3 (CH3). HRMS (EI) m/z calculated for Ci0Hi6O2 [M]
168.1145, found 168.1143.
8,8- dimethoxy-4-methyleneoctan-3-ol 296
To a solution of ethylmagnesium bromide (1M THF, 8.7 mmol, 8.7 mL,1.5 equiv) at -78






mmol, 1 equiv) in THF (25 mL).The reaction was left to stir at -78 °C for 30 mins then
warmed to 0 °C and left to stir for 5 h. After being stirred for 5 h, NH4C1 is added. The
aqueous layer is extracted with Et20 (3 x 100 mL), and the combined organic layers are
dried over magnesium sulphate, filtered and concentrated by rotary evaporation.
Purification by column chromatography (Si02, 60 % Et20, hexanes) afforded the title
compound (833 mg, 71 %) as a colorless oil; IR (neat)/ cm"1): o max 3438 (OH), 3080
(CH2=), 2937 (CH2), 1127 (COCH3). *H NMR (250 MHz, CDC13) 8: 5.02 (s, 1H,
CH2=), 4.86 (s, 1H, CH2=), 4.36 (t, 1H, J= 5.7 Hz, CH(OCH3)2), 3.99 (t, 1H, J= 6.2 Hz,
CHOH), 3.31 (s, 6H, (OCH3)2), 2.07-2.01 (m, 2H, 1 x CH2CH3), 1.70-1.45 (m, 6H, 3 x
CH2), 0.88 (t, 3H, J= 7.4 Hz, CH3CH2). 13C NMR (63 MHz, CDC13) 5: 151.2 (quat),
109.8 (CH2=), 104.4 (CHOCH3), 76.7 (CHOH), 52.7 (OCH3), 32.3 (CH2), 31.0 (CH2),
28.2 (CH2), 22.9 (CH2) and 9.9 (CH3CH2). HRMS (ES+) m/z calculated for CnH2603N
[M+NH4] + 220.1907, found 220.1905.
8,8- dimethoxy-4-methyleneoctan-3-one 297
To a solution of 8,8-dimethoxy-4-methyleneoctan-3-ol (0.400 g, 1.98 mmol, 1 equiv) in
DCM was added sequentially celite (equal mass to 8,8-dimethoxy-4-methyleneoctan-3-
ol), molecular sieves and PCC (0.853 g, 3.96 mmol, 2 equiv), the solution was filtered
through a plug of silica. Purification by column chromatography (Si02, 40 %
Et20,hexanes) afforded the title compound (305 mg, 77 %) as a colorless oil; IR (neat)/
cm"1): o max 3079 (CH2=), 2933 (CH2), 1721 (C=0), 1120 (C-OMe). *H NMR (360
MHz, CDCI3) 8: 6.02 (s, 1H, CH2=), 5.75 (t, 1H, J= 1.3 Hz, CH2=), 4.37 (1H, t, J= 5.5
Hz, CH(OCH3)2), 3.32 (s, 6H, (OCH3)2), 2.69 (q, 2H, J= 7.3 Hz, CH2CH3), 2.36-2.26






NMR (91 MHz, CDCI3) 5: 202.3 (C=0), 147.6 (quat), 124.1 (CH2=), 104.3 (CHOCH3),
51.5 (OCH3), 33.5 (CH2), 30.8 (CH2), 30.2 (CH2), 23.6 (CH2) and 8.4 (CH3CH2).
HRMS (ES+) m/z calculated for CUH2403N [M+NH4] + 218.1756, found 218.1755.
5-methylene-6-oxooctanal 298
8,8-dimethoxy-4-methyleneoctan-3-one (0.200 g, 1 mmol, 1 equiv) was dissolved in
acetic acid (2 mL) and the solution was cooled to 0-5 °C in an ice bath. As soon as the
solution started to freeze, HC1 solution (1 M, 1 mL) was added at once and the solution
was stirred for 2h in the same bath. The mixture was diluted with Et20 and the solution
was washed successively with water and saturated NaHC03. The combined organic
layers were dried MgS04, filtered and concentrated in vacuo. Purification by column
chromatography (Si02j 20 % Et20 hexanes) afforded the title compound (131 mg, 85 %)
as a colorless oil; IR (neat)/ cm"1): u max 3081 (CH2=), 2957 (CH2) 1728 (C=0), 1695
(C=0). *H NMR (250 MHz, CDC13) 5: 9.75 (t, 1H, J= 1.6 Hz, CHO), 6.25 (s, 1H,
CH2=), 5.97 (s, 1H,CH2=), 2.92 (q, 2H, J= 7.3 Hz, CH2CH3), 2.66 (dt, 2H, J= 1.6, 7.3
Hz, CH2CHO), 2.31-2.23 (m, 2H, 1 x CH2), 1.79-1.64 (m, 2H, 1 x CH2), 1.08 (t, 3H, J=
7.3 Hz, CH3CH2). 13C NMR (63 MHz, CDC13) 5: 206.9 (C=0), 202.2 (CHO), 147.7








A 500 mL, three-necked, round-bottomed flask is fitted with a glass tube to admit ozone,
a glass stopper and a magnetic stirring bar and is charged with 1-methylcyclohexene (8.1
g, 84.2 mmol, 1 equiv), and dichloromethane (500 mL). The flask is cooled to -78 °C
and ozone is bubbled through the solution when stirring. Reaction completion is judged
by tic, nitrogen is then passed through the solution and then the cold bath is removed.
The solution is allowed torn warm to room temperature as it stirs under an atmosphere of
nitrogen triphenylphosphine (26.5 g, 101 mmol, 1.2 equiv was added. After being stirred
for 12 h, the heterogeneous mixture is concentrated to approximately 50 mL by rotary
evaporation. Dichloromethane is added and the mixture is washed with water. The
aqueous layer is extracted with two more portions of dichloromethane, and the combined
organic layers are washed with water. After extracting the aqueous layer with
dichloromethane, the organic layers are dried over magnesium sulphate, filtered and
concentrated by rotary evaporation. Purification by column chromatography (Si02,20 %
Et20, hexanes) afforded the title compound (7.99 g, 74 %) as a colorless oil .'H NMR
(250 MHz, CDC13) 5: 9.73 (1H, t, J= 1.5 Hz, CHO), 2.43-2.37 (m, 4H, 2 x CH2), 2.07
(s, 3H, CH3), 1.57-1.49 (m, 4H, 2 x CH2).








To a solution of 6-oxoheptanal (0.700 g, 5.47 mmol, 1 equiv) in DCM (30 mL) and NEt3
(2.76 g, 27.35 mmol, 5 equiv) was added Bohme's salt (1.54 g, 16.41 mmol, 3 equiv).
The reaction was left to stir for 18 h, and then quenched with NaHC03 and extracted
three times with DCM. After completion the solvent was evaporated. Purification by
column chromatography (Si02, 25 % Et20, hexanes) afforded the title compound (498
mg, 65 %) as a colorless oil; *H NMR (250 MHz, CDC13) 5: 9.59 (s, 1H, CHO), 6.43 (d,
1H, J= 0.6 Hz, CH2=), 6.17 (d, 1H, J= 0.6 Hz, CH2=), 2.59 (t, 2H, J= 7.3 Hz, CH2C=0),
2.38 (t, 2H, J= 7.5 Hz, CH2CH2=), 2.28 (s, 3H, CH3), 1.91-1.66 (m, 2H, 1 x CH2). 13C
NMR (63 MHz, CDC13) 5: 208.3 (OO), 194.5 (CHO), 149.6 (quat), 134.4 (CH2=), 42.9
(CH2), 29.9 (CH3), 27.1 (CH2) and 21.8 (CH2).
'H NMR and 13C NMR data was in agreement with the literature 14
6-oxo-2-(phenylthiomethyl) heptanal 304
A solution of 2-methylene-6-oxoheptanal (0.080 g, 0.606 mmol, 1 equiv) in toluene (1
mL) was added to a stirred solution of (-) quinine (0.019 g, 0.0571 mmol, 0.1 equiv) in
dry toluene (0.5 mL). The mixture was srirred for 15 min. Then a solution of thiophenol
(0.074 g, 68 pL, 0.667 mmol, 1.1 equiv) was added in dry toluene (0.5 mL) was added




is washed with water (50 mL). The aqueous layer is extracted with two more portions of
Et20, and the combined organic layers are dried over magnesium sulphate, filtered and
concentrated by rotary evaporation. Purification by column chromatography (Si02,10 %
Et20,hexanes) afforded the title compound (128 mg, 84 %) as a colorless oil; IR (neat)/
cm"1): u max 3055 (CHAr), 2918 (CH2), 1716 (C=0), 1651 (CO). *H NMR (360 MHz,
CDC13) 8: 9.67 (d, 1H, J= 1.9 Hz, CHO), 7.40-7.19 (m, 5H, ArH), 3.25 (ABX, 1H, JAB=
13.4 Hz, Jax= 6.0 Hz, JBX= 7.4 Hz, CH2SPh), 3.03 (ABX, 1H, Jab = 13.4 Hz, Jax= 6.2
Hz, JBX= 7.2 Hz, CH2SPh), 2.55 (m, 1H, 1 x CH2), 2.42 (t, 2H, J= 6.5 Hz, CH2CO),
2.12 (s, 3H, CH3), 1.79-1.48 (m, 4H, 2 x CH2). ,3C NMR (63 MHz, CDC13) 8: 208.0
(CO), 202.7 (CO), 135.3 (ipso), 130.3 (ArH), 129.1 (ArH), 126.8 (ArH), 50.9
(CHCHO), 43.2 (CH2), 33.0 (CH2), 31.0 (CH3), 27.7 (CH2) and 20.6 (CH2). HRMS (EI)
m/z calculated for Ci4Hi802S [M] 250.1022, found 250.1017.
2-hydroxy-l-(phenylthiomethyl) cyclopentanecarbaldehyde 272
To a solution of 2-methylenehexanal (0.300 g, 2.4 mmol, 1 equiv) in the presence of 4 A
molecular sieves (0.05 g) in toluene (1 mL) was added thiophenol (0.290 g, 270 pi, 2.64
mmol, 1.1 equiv) and the resulting solution was stirred for 2 h at rt. Et20 is added and
the mixture is washed with water. The aqueous layer is extracted with two more portions
of Et20 (2 x 100 mL), and the combined organic layers are dried over magnesium
sulphate, filtered and concentrated by rotary evaporation. Purification by column
chromatography (Si02, 10 % Et20, hexanes) afforded the title compound (289 mg, 51 %,
3:2 d.r.) as a colorless oil; IR (neat)/cm'): o max 3419 (OH), 1651 (C-O), 1088 (C-O).





10H, ArH), 4.46 (m, 1H, CHOH), 4.34 (m, 1H, CHOH), 3.43 (d, 1H, J= 12.5 Hz,
CHiSPh), 3.30 (d, 1H, J= 12.5 Hz, CH2SPh), 3.27 (d, 2H, J= 1.5 Hz, CH2SPh), 2.30-
1.62 (m, 12H, 6 x CH2). 13C NMR (91 MHz, CDC13) 5: 204.7 (CHO), 202.9 (CHO),
136.6 (ipso), 136.5 (ipso), 130.1 (ArH), 129.9 (ArH), 129.1 (ArH), 128.9 (ArH), 126.8
(ArH), 126.7 (ArH), 80.0 (CHOH), 74.4 (CHOH), 62.5 (quat), 60.5 (quat), 39.0 (CH2),
36.0 (CH2), 34.0 (CH2), 31.1 (CH2), 30.3 (CH2), 29.7 (CH2), 21.2 (CH2) and 20.8 (CH2).
HRMS (EI) m/z calculated for Ci3Hi502S [M] 236.0866, found 236.0865
4-hydroxy-3-(phenylthiomethyl)-l-tosylpyrrolidine-3-carbaldehyde 277
To a solution of N-(2-formylallyl)-4-methyl-N-(2-oxoethyl) benzenesulfonamide (0.05
g, 0.178 mmol, 1 equiv) in DCM (2.5 mL) was added thiophenol (0.022 g, 21 pi, 0.195
mmol, 1.1 equiv). The reaction was left to stir for 2 h. After completion the solvent was
evaporated diethylether is added and the mixture is washed with water. The aqueous
layer is extracted with two more portions of Et20, and the combined organic layers are
dried over magnesium sulphate, filtered and concentrated by rotary evaporation.
Purification by column chromatography (Si02, 40 % Et20, hexanes) afforded the title
compound (48 mg, 69 %, 5:3 d.r) as a colorless oil; IR (neat)/ cm') • f max 3484 (OH),
2925 (CH2), 1726 (C=0), 1090 (C-O). Major diastereomer. *H NMR (360 MHz, CDC13)
5: 9.41 (s, 1H, CHO), 7.68 (d, 2H, J= 8.3 Hz, ArH), 7.36-7.24 (m, 7H, ArH), 4.43 (m,
1H, CHOH), 3.71 (d, 1H, J= 10.6 Hz, CHCHO), 3.49 (ABX, 1H, Jab = 11.1 Hz, Jax=
4.9 Hz, JBX= 6.2 Hz, CHCHOH), 3.35 (d, 1H, J= 13.1 Hz, CH2SPh), 3.3-3.24 (m, 2H,
CH2), 3.19 (d, 1H, J= 13.1 Hz, CH2SPh), 2.43 (s, 3H, CH3Ar). 13C NMR (63






129.8 (ArH), 129.3 (ArH), 127.6 (ArH), 127.5 (ArH), 71.6 (CHOH), 62.2 (quat), 54.9
(CH2), 50.7 (CH2), 29.7 (CH2) and 21.6 (CH3). Minor diastereomer 'H NMR (360 MHz,
CDCI3) 5: 9.55 (s, 1H, CHO), 7.70 (d, J= 8.3 Hz, 2H, ArH), 7.36-7.24 (m, 7H, ArH),
4.42 (m, 1H, CHOH), 3.69 (d, 1H, J= 10.7 Hz, CHCHO), 3.60 (ABX, 1H, Jab = 10.8
Hz, Jax= 5.1 Hz, JBX= 5.8 Hz, CHCHOH), 3.36 (d, 1H, J= 10.7 Hz, CHCHO), 3.22 (d,
1H, J= 13.4 Hz, CHiSPh), 3.17 (d, J= 10.9 Hz, CHCHO), 3.06 (d, 1H, J= 13.4 Hz,
CH2SPI1), 2.43 (s, 3H, CH3Ar). 13CNMR (91 MHz, CDC13) 8: 200.6 (CHO), 143.8
(ipso), 134.8 (ipso), 133.2 (ipso), 130.6 (ArH), 129.9 (ArH), 129.4 (ArH), 127.7 (ArH),
127.5 (ArH), 75.5 (CHOH), 60.5 (quat), 54.0 (CH2), 50.4 (CH2), 29.6 (CH2) and 21.6
(CH3). HRMS (ES+) m/z calculated for C19H25O4N2S2 [M+NH4] + 409.1250, found
409.1250.
2-hydroxy-l-(phenylthioraethyl)cyclopentyl(phenyl)methanone 269
A solution of 5-benzoylhex-5-enol (0.080 g, 0.396 mmol, 1 equiv) in toluene (1 mL)
was added to a stirred solution of (-) cinchonidine (0.012 g, 0.0396 mmol, 0.1 equiv) in
dry toluene (0.5 mL). The mixture was srirred for 15 min at rt and the cooled to -20 °C.
Then a solution of thiophenol (0.048 g, 44 pL, 0.436 mmol, 1.1 equiv) was added in dry
toluene (0.5 mL) was added dropwise to the cooled solution at -20 °C. After being
stirred for 4 h, Et20 is added and the mixture is washed with water. The aqueous layer is
extracted with two more portions of Et20 (2 x 50 mL), and the combined organic layers
are dried over magnesium sulphate, filtered and concentrated by rotary evaporation.
Purification by column chromatography (Si02, 10 % Et20, hexanes) afforded the title





diastereomer trans m.p.= 89-91 °C (diethylether/ hexanes); IR (neat) cm"1): o max 3465
(OH), 2955 (CH2), 1670 (C=0), 1088 (C-O). Diastereomers were separated by column
chromatography; cis diastereomer. !H NMR (360 MHz, CDCI3) 8: 7.88-7.83 (m, 2H,
ArH), 7.49 (m, 1H, ArH), 7.42-7.36 (m, 2H, ArH), 7.20-7.09 (m, 5H, ArH), 4.62 (t,
1H, J= 6.6 Hz, CHOH), 3.67 (d, 1H, J= 12.4 Hz, CH2SPh), 3.43 (d, 1H, J= 12.4 Hz,
CH2SPh), 2.39-1.50 (m, 6H, 3 x CH2). 13 C NMR (91 MHz, CDCI3) 5: 205.6 (C=0),
136.8 (ipso), 136.4 (ipso), 132.1 (ArH), 130.1 (ArH), 128.8 (ArH), 128.7 (ArH), 128.2
(ArH), 126.5 (ArH), 78.0 (CHOH), 61.6 (quat), 38.8 (CH2), 34.0 (CH2), 32.2 (CH2) and
20.7 (CH2). trans diastereomer. 'H NMR (360 MHz, CDCI3) 5: 7.82-7.79 (m, 2H,
ArH), 7.52-7.46 (m, 1H, ArH), 7.43-7.36 (m, 2H, ArH), 7.20-7.09 (m, 5H, ArH), 4.56
(m, 1H, CHOH), 3.37 (d, 1H, J= 12.6 Hz, CH2SPh), 3.24 (d, 1H, J= 12.6 Hz, CH2SPh),
3.13 (br s, 1H), 2.49 (m, 1H, 1 x CH), 2.22-1.93 (m, 3H, 1 x CH2) 1 x CH), 1.84-1.75
(m, 2H, 1 x CH2). 13C NMR (63 MHz, CDCI3) 5: 206.0 (C=0), 137.6 (ipso), 135.9
(ipso), 131.8 (ArH), 130.1 (ArH), 128.7 (ArH), 128.4 (ArH), 128.1 (ArH), 126.4 (ArH),
79.5 (CHOH), 63.7 (quat), 41.3 (CH2), 32.2 (CH2), 32.0 (CH2) and 21.5 (CH2). HRMS
(ES+) m/z calculated for Ci9H2,02S [M+H] + 313.1257, found 313.1258. HPLC
(Chiralcel AD-H, hexane/ethanol= 90/10, 1.0 mL/min, h= 254 nm, retention time) cis-
diastereomer (11.4, 17.2 mins), frvms-diastereomer (14.6, 16.3 mins).




A solution of 7-methyl-5-methylene-6-oxooctanol (0.100 g, 0.594 mmol, 1 equiv) in
toluene (1 mL) was added to a stirred solution of (-) quinine (0.019 g, 0.0594 mmol, 0.1
equiv) in dry toluene (0.5 mL). The mixture was srirred for 15 min at rt and the cooled
to -20 °C. Then a solution of thiophenol (0.072 g, 66 pL, 0.654 mmol, 1.1 equiv) in dry
toluene (0.5 mL) was added dropwise to the cooled solution at -20 °C. After being
stirred for 6 h, Et20 is added and the mixture is washed with water. The aqueous layer is
extracted with two more portions ofEt20 (2 x 100 mL), and the combined organic layers
are dried over magnesium sulphate, filtered and concentrated by rotary evaporation.
Purification by column chromatography (Si02; 10 % Et20, hexanes) afforded the title
compound (142 mg, 86 %, 7:1 d.r.,70 % e.e.)111) v as a colorless oil; IR (neat)/ cm1):
o max 3462 (OH), 1696 (C=0), 1090 (C-O). Inseparable mixture of diastereomers. *H
NMR (360 MHz, CDCfi) 5: 7.32-7.15 (m, 5H, ArH), 4.37 (m, 1H, CHOH), 3.20 (d,
1H, J= 12.2 Hz, CH2SPh), 3.05 (d, 1H, J= 12.5 Hz, CH2SPh), 3.06-2.95 (sept, 1H,
CH(CH3)2), 2.14-1.44 (m, 6H, 3 x CH2), 1.07 (d, 6H, J= 6.6 Hz, (CH3)2CH). trans
diastereomer diagnostic peaks: *H NMR (360 MHz, CDCfi) 8: 4.25 (m, 1H, CHOH),
3.43 (d, 1H, J= 11.9 Hz, CH2SPh), 3.22 (d, 1H, J= 11.9 Hz, CH2SPh). I3C NMR (91
MHz, CDCfi) 8: 219.7 (OO), 218.1 (C=0), 136.7 (ipso), 136.7 (ipso), 129.5 (ArH),
129.3 (ArH), 129.0 (ArH), 129.0 (ArH), 126.4 (ArH), 126.3 (ArH), 78.7 (CHOH), 75.9
(CHOH), 64.6 (quat), 63.1 (quat), 39.7 (CH2), 37.4 (CH(CH3)2), 36.8 (CH2), 36.1
(CH(CH3)2), 32.3 (CH2), 32.1 (CH2), 31.4 (CH2), 30.4 (CH2), 21.1 (CH2), 20.5 (CH2),
20.4 (CH3) and 19.8 (CH3). HRMS (ES+) m/z calculated for C,6H2302S [M+H]+





mL/min, X — 254 nm, retention time) trans-minor diastereomer (6.2, 7.2 mins), cA-major
diastereomer (7.8, 16.8 mins).
v See Appendix for enantiomeric excess for compound 291.
l-(2-hydroxy-l-(phenylthiomethyl) cyclopentyl) propan-l-one 299
A solution of 5-methylene-6-oxooctanal (0.080 g, 0.519 mmol, 1 equiv) in toluene (1
mL) was added to a stirred solution of (-) quinine (0.017 g, 0.0519 mmol, 1 equiv) in dry
toluene (0.5 mL). The mixture was stirred for 15 min at rt and the cooled to -40 °C. Then
a solution of thiophenol (0.063 g, 58 pL, 0.570 mmol, 1.1 equiv) dry toluene (0.5 mL)
was added dropwise to the cooled solution at -40 °C. After being stirred for 8 h, Et20 is
added and the mixture is washed with water. The aqueous layer is extracted with two
more portions of Et20 (2 x 100 mL), and the combined organic layers are dried over
magnesium sulphate, filtered and concentrated by rotary evaporation. Purification by
column chromatography (Si02, 15 % Et20, hexanes) afforded the title compound as an
inseparable mixture of diastereomers. (108 mg, 79 %, 3:2 d.r.) v as a colorless oil; IR
(neat)/ cm1): o max 3466 (OH), 2928 (CH2), 1671 (C=0), 1088 (C-O). *H NMR (360
MHz, CDC13) 5: 7.36-7.15 (m, 10H, ArH), 4.26 (m, 1H, CHOH), 3.21 (d, 1H, J= 12.3
Hz, CH2SPh), 3.04 (d, 1H, J= 12.3 Hz, CH2SPh), 2.59-2.49 (dq, 4H, J= 3.4, 7.1 Hz,
CH2CH3), 2.25-1.62 (m, 12H, 6 x CH2), 0.99 (dt, 3H, J= 2.9, 7.1 Hz, (CH3CH2). Minor
diastereomer diagnostic peaks: 1H NMR (360 MHz, CDCI3) 5: 4.37 (m, 1H, CHOH),
3.47 (d, 1H J= 12.3 Hz, CH2SPh), 3.25 (d, 1H, J= 12.4 Hz, CH2SPh). 13C NMR (91
MHz, CDCI3) 5: 215.0 (C=0), 214.1 (C=0), 136.4 (ipso), 136.3 (ipso), 129.9 (ArH),





(CHOH), 63.8 (quat), 62.4 (quat), 40.3 (CH2), 37.0 (CH2), 34.7 (CH2), 32.4 (CH2), 32.2
(CH2), 30.8 (CH2), 30.3 (CH2), 29.7 (CH2), 20.9 (CH2), 20.3 (CH2), 7.8 (CH3) and 7.5
(CH3). HRMS (EI) m/z calculated for Ci5H20O2S [M] 264.1186, found 264.1178. HPLC
(Chiralcel AD-H, hexane/isopropanol= 95/5, 1.0 mL/min, 1= 254 nm, retention time)
cis-trans diastereomers (12.0, 12.7, 13.8, 28.9 mins).
v See Appendix for enantiomeric excess for compound 299.
Ethyl-4-hydroxy-3-(phenylthiomethyl)-l-tosylpyrrolidine-3-carboxylate 310
A solution of Ethyl-2-((4-methyl-N-(2-oxoethyl) phenylsulfonamide) methylacrylate
(0.050 g, 0.154 mmol, 1 equiv) in toluene (1 mL) was added to a stirred solution of (-)
quinine (0.005 g, 0.0154 mmol, 0.1 equiv) in dry toluene (0.5 mL). The mixture was
srirred for 15 min at rt. Then a solution of thiophenol (0.019 g, 17 pL, 0.169 mmol, 1.1
equiv) was added in dry toluene (0.5 mL) was added dropwise to the solution at. After
being stirred for 8 h, Et20 is added and the mixture is washed with water. The aqueous
layer is extracted with two more portions of Et20 (2 x 100 mL), and the combined
organic layers are dried over magnesium sulphate, filtered and concentrated by rotary
evaporation. Purification by column chromatography (Si02j 20 % EtOAc, hexanes)
afforded the title compound (46 mg, 68 %, 5:4 d.r, 25 % e.e.) as a colorless oil. IR
(neat)/ cm"1): o max 3449 (OH), 2925 (CH2), 1731 (C=0), 1161 (C-O). Diastereomers
were separated by column chromatography. Major diastereomer. *H NMR (250
MHz,CDC13) 8: 7.67 (2H, d, J= 8.2 Hz, ArH), 7.32-7.22 (m,7H, ArH), 4.52 (m, 1H,
CHOH), 3.82 (q, 2H, J= 7.1 Hz, CH2CH3), 3.76 (d, 1H, J= 7.5 Hz, CHCOH), 3.58






CH2SPh), 3.25 (1H, d, J= 3.0 Hz, CHC=0), 3.19 (1H, d, J= 3.0 Hz, CHC=0), 3.04 (1H,
d, J= 13.0 Hz, CH2SPh), 2.39 (3H, s, CH3Ar), 1.09 (3H, t, J = 7.2 Hz, CH3CH2). 13 C
NMR (63 MHz, CDC13) 8: 171.7 (COO), 143.6 (ipso), 135.1 (ipso), 133.6 (ipso), 131.0
(ArH), 129.6 (ArH), 129.0 (ArH), 127.5 (ArH), 127.1 (ArH), 72.7 (CHOH), 61.6
(CH2CH3), 58.2 (quat), 54.1 (CH2), 52.9 (CH2), 35.4 (CH2), 21.5 (CH3Ar) and 13.8
(CH3CH2). Minor diastereomer. 'H NMR (250 MHz, CDC13) 5: 7.72-7.67 (d, 2H, J= 8.3
Hz, ArH), 7.31-7.18 (m, 7H, ArH), 4.29 (m, 1H, CHOH), 3.88 (q, 2H, J= 7.2 Hz,
CH2CH3), 3.59 (s, 2H, CH2C=0), 3.26 (d, 1H, J= 2.3 Hz, CHCOH), 3.21 (d, 1H, J= 2.3
Hz, CHCOH), 3.11 (d, 1H, J= 13.3 Hz, CH2SPh), 2.91 (d, 1H, J= 13.3 Hz, CH2SPh),
2.38 (s, 3H, CH3ArH), 1.1 (t, 3H, J= 7.2 Hz, CH3CH2). 13C NMR (63 MHz, CDCI3) 8:
171.0 (COO), 143.7 (ipso), 135.0 (ipso), 133.5 (ipso), 130.6 (ArH), 129.7 (ArH), 129.0
(ArH), 127.5 (ArH), 127.0 (ArH), 74.6 (CHOH), 61.7 (CH3CH2), 58.6 (quat), 53.4
(CH2), 51.3 (CH2), 38.5 (CH2), 21.5 (CH3Ar) and 13.8 (CH3CH2). HRMS (ES+) m/z
calculated for C2iH2605NS2 [M+H] + 436.1247, found 436.1249. HPLC (Chiralcel AD-
H, hexane/isopropanol = 90/10, 1.0 mL/min, 1= 254 nm, retention time) minor
diastereomer (36.3, 80.1 mins), major diastereomer (44.2, 47.4 mins).
2-hydroxy-l-((4-methoxyphenylthio) methyl) cyclopentyl (phenyl) methanone 314
A solution of 5-benzoylhex-5-enol (0.072 g, 0.356 mmol, 1 equiv) in toluene (1 mL)
was added to a stirred solution of (-) quinine (0.012 g, 0.0356 mmol, 0.1 equiv) in dry
toluene (0.5 mL). The mixture was srirred for 15 min. Then a solution of 4-
methoxybenzenethiol (0.055 g, 48 pL, 0.392 mmol, 1.1 equiv) in dry toluene (0.5 mL)
was added dropwise to the solution at -40 °C. After being stirred for 12 h, Et20 is added





portions of Et20 (2 x 100 mL), and the combined organic layers are dried over
magnesium sulphate, filtered and concentrated by rotary evaporation. Purification by
column chromatography (Si02j 20 % Et20, hexanes) afforded the title compound (85
mg, 70 %, 3:1 d.r.) as a colorless oil; IR (neat)/ cm"1): u max 3487 (OH), 2959 (CH2),
1671 (C=0), 1088 (C-O). Diastereomers were separated by column chromatography;
minor diastereomer *H NMR (360 MHz, CDCI3) 8: 7.87-7.77 (m, 2H, ArH), 7.54-7.35
(m, 3H, ArH), 7.15-7.07 (m, 2H, ArH), 6.73-6.66 (m, 2H, ArH), 4.54 (m, 1H, CHOH),
3.74 (s, 3H,OCH3Ar), 3.29 (d, 1H, J= 12.8 Hz, CH2SPh), 3.17 (d, 1H, J= 12.9 Hz,
CH2SPh), 2.54-1.66 (m, 6H, 3 x CH2). 13C NMR (91 MHz,CDCl3) 5: 205.3 (C=0),
159.1 (OMe ipso), 136.8 (ipso), 134.1 (ArH), 133.7 (ArH), 132.0 (ipso), 128.7 (ArH),
128.2 (ArH), 114.5 (ArH), 77.9 (CHOH), 61.9 (quat), 55.3 (OCH3), 41.0 (CH2), 34.2
(CH2), 32.3(CH2), 20.8 (CH2). Major diastereomer. \H NMR (360 MHz, CDCI3) 8:
7.87-7.83 (m, 2H, ArH), 7.58-7.36 (m, 3H, ArH), 7.15-7.10 (m, 2H, ArH), 6.72-6.67
(m, 2H, ArH), 4.62 (m, 1H, CHOH), 3.75 (s, 3H, OCH3Ar), 3.59 (d, 1H, J= 12.7 Hz,
CH2SPh), 3.37 (d, 1H, J= 12.7 Hz, CH2SPh), 2.41-1.56 (m, 6H, 3 x CH2). 13 C NMR
(91 MHz, CDCI3) 8: 206.1 (C=0), 159.1 (OMe ipso), 137.8 (ipso), 133.8 (ArH), 131.9
(ipso), 128.7 (ArH), 128.4 (ArH), 128.2 (ArH), 114.5 (ArH), 79.6 (CHOH), 64.1 (quat),
55.3 (OCH3), 43.6 (CH2), 32.5 (CH2), 32.2 (CH2) and 21.7 (CH2). HRMS (ES+) m/z
calculated for C20H22O3S 342.1283, found 342.1284. HPLC (Chiralcel AD-H,
hexane/isopropanol= 99/1, 1.0 mL/min, X= 254 nm, retention time) mixture of




A solution of 5-benzoylhex-5-enol (0.070 g, 0.346 mmol, 1 equiv) in toluene (1 mL)
was added to a stirred solution of (-) quinine (0.012 g, 0.0346 mmol, 0.1 equiv) in dry
toluene (0.5 mL). The mixture was srirred for 15 min. Then a solution of 4-
methoxytoluenethiol (0.059 g, 53 pL, 0.381 mmol, 1.1 equiv) in dry toluene (0.5 mL)
was added dropwise to the solution at -40 °C. After being stirred for 48 h, Et20 is added
and the mixture is washed with water. The aqueous layer is extracted with two more
portions of Et20, and the combined organic layers are dried over magnesium sulphate,
filtered and concentrated by rotary evaporation. Purification by column chromatography
(Si02j 20% Et20, hexanes) afforded the title compound (83 mg, 67 %, 3:2 d.r) as a
colorless oil; IR (neat)/ cm1): u max 3458 (OH), 2916 (CH2), 1671 (C=0), 1095 (C-O);
Inseparable mixture of diastereomers. *H NMR (360 MHz, CDCI3) 5: 7.86-7.77 (m, 4H,
ArH), 7.58-7.51 (m, 2H, ArH), 7.47-7.37 (m, 4H, ArH), 7.07-7.00 (m, 4H, ArH), 6.78-
6.73 (m, 4H, ArH), 4.45 (m, 1H, CHOH), 3.78 (s, 6H, OCH3Ar), 3.44 (s, 2H, CH2Ar),
2.81 (d, 1H, J= 12.9 Hz, CH2SPh), 2.70 (d, 1H, J= 12.9 Hz, CH2SPh), 2.20-1.51 (m,
12H, 6 x CH2). Minor diastereomer diagnostic peaks: *H NMR (360 MHz, CDCI3) 5:
4.56 (m, 1H, CHOH), 3.09 (d, 1H, J= 12.6 Hz CH2SPh), 2.90 (d, 1H, J= 12.6 Hz,
CH2SPh). 13 C NMR (91 MHz, CDC13) 8: 206.5 (C=0), 205.8 (C=0), 158.7 (OMe
ipso), 158.6 (OMe ipso), 137.8 (ipso), 136.9 (ipso), 132.0 (ArH), 131.9 (ArH), 129.8.
(ArH), 129.8. (ArH), 129.6 (ipso), 129.5 (ipso), 128.6 (ArH), 128.3 (ArH), 128.2 (ArH),
128.2 (ArH), 113.8 (ArH), 113.8 (ArH), 79.7 (CHOH), 76.8 (CHOH), 63.8 (quat), 61.5
(quat), 55.2 (CH3), 37.4 (CH2), 37.1 (CH2), 36.9 (CH2), 35.0 (CH2), 34.1 (CH2), 32.4





for C21H24O3S [M] 356.1445, found 356.1440. HPLC (Chiralcel AD-H,
hexane/isopropanol= 95/5, 1.0 mL/min, X= 254 nm, retention time) mixture of
diastereomers (42.0, 46.2, 51.5 mins).
l-((4-chlorobenzythio)methyI-2-hydroxycyclopentyl)phenylmethanone 312
A solution of 5-benzoylhex-5-enol (0.060 g, 0.297 mmol, 1 equiv) in toluene (1 mL)
was added to a stirred solution of (-) quinine (0.010 g, 0.0297 mmol, 0.1 equiv) in dry
toluene (0.5 mL). The mixture was srirred for 15 min. Then a solution of 4-
chlorobenzenemethanethiol (0.052 g, 44 pL, 0.327 mmol, 1.1 equiv) was added in dry
toluene (0.5 mL) was added dropwise to the solution at -40 °C. After being stirred for 42
h, Et20 is added and the mixture is washed with water. The aqueous layer is extracted
with two more portions of Et20 (2 x 100 mL), and the combined organic layers are dried
over magnesium sulphate, filtered and concentrated by rotary evaporation. Purification
by column chromatography (Si02,30 % Et20, hexanes) afforded the title compound (89
mg, 78 %, 4:3 d.r) as a colorless oil; IR (neat)/cm_I): o max3464 (OH), 2916 (CH2), 1671
(C=0), 1091 (C-O). Inseparable mixture of diastereomers. *H NMR (360 MHz, CDCI3)
8: 7.86-7.75 (m, 4H, ArH), 7.61-7.35 (m, 6H, ArH), 7.19-7.12 (m, 4H, ArH), 7.05-6.99
(m, 4H, ArH), 4.56 (t, 1H, J= 6.2 Hz, CHOH), 3.44 (s, 4H, 1 x CH2Ar), 2.79 (d, 1H, J=
12.7 Hz, CH2SPh), 2.68 (d, 1H, J= 12.7 Hz, CH2SPh), 2.46-2.34 (m, 4H, 2 x CH2),
2.28-2.18 (m, 4H, 2 x CH2), 2.11-1.52 (m, 4H, 2 x CH2). Minor diastereomer diagnostic
peaks: *H NMR (360 MHz, CDCI3) 5: 4.44 (m, 1H, CHOH), 3.10 (d, 1H, J= 12.5 Hz,
CH2SPh), 2.87 (d, 1H, J= 12.5 Hz, CH2SPh). 13 C NMR (91 MHz, CDC13) 5: 206.3
(C=0), 205.5 (C=0), 137.6 (ipso), 136.8 (ipso), 136.7 (ipso), 136.3 (ipso), 136.1 (ipso),





(ArH), 128.6 (ArH), 128.5 (ArH), 128.4 (ArH), 128.3 (ArH), 79.8 (CHOH), 76.8
(CHOH), 63.6 (quat), 61.4 (quat), 37.5 (CH2), 36.9 (CH2), 36.7 (CH2), 35.2 (CH2), 34.2
(CH2), 33.4 (CH2), 32.5 (CH2), 32.0 (CH2), 21.5 (CH2) and 20.7 (CH2). HRMS (EI) m/z
calculated for C20H21O2ClS [M] 360.0949, found 360.0945. HPLC (Chiralcel AD-H,
hexane/isopropanol= 90/10, 1.0 mL/min, X= 254nm, retention time) mixture of
diastereomers (24.5, 30.1, 37.3, 39.8 mins).
l-((4-methylbenzythio)methyI-2-hydroxycyclopentyl)phenylmethanone 313
A solution of 5-benzoylhex-5-enol (0.065 g, 0.321 mmol, 1 equiv) in toluene (1 mL)
was added to a stirred solution of (-) quinine (0.011 g, 0.0321 mmol, 0.1 equiv) in dry
toluene (0.5 mL). The mixture was stirred for 15 min. Then a solution of 4-
toluenemethanethiol (0.049 g, 53 pL, 0.353 mmol, 1.1 equiv) in dry toluene (0.5 mL)
was added dropwise to the solution at -40 °C. After being stirred for 42 h, Et20 is added
and the mixture is washed with water. The aqueous layer is extracted with two more
portions of Et20 (2 x 50 mL), and the combined organic layers are dried over
magnesium sulphate, filtered and concentrated by rotary evaporation. Purification by
column chromatography (Si02,30% Et20, hexanes) afforded the title compound (80 mg,
73 %, 3:2 d.r., 32 % e.e.) as a colorless oil; IR (neat)/ cm"1): u max 3406 (OH), 1668
(C=0), 1094 (C-O). Diastereomers were separated by column chromatography; minor
diastereomer *H NMR (360 MHz, CDCI3) 5: 7.85-7.76 (m, 2H, ArH), 7.54-7.36 (m,
3H, ArH), 7.04-6.98 (m, 4H, ArH), 4.45 (m, 1H, CHOH), 3.45 (s, 2H, CH2Ar), 2.81





2.12-1.48 (m, 6H, 3 x CH2). 13C NMR (91 MHz, CDC13) 5: 206.6 (C=0), 137.9 (ipso),
137.0 (ipso), 134.5 (ipso), 131.9 (ArH), 129.1 (ArH), 128.7 (ArH), 128.4 (ArH), 128.2
(ArH), 79.7 (CHOH), 63.8 (quat), 37.5 (CH2), 37.2 (CH2), 32.5 (CH2), 32.0 (CH2), 21.5
(CH3), 21.1 (CH2). Major diastereomer *H NMR (360 MHz, CDC13) 5: 7.84-7.80 (m,
2H, ArH), 7.55-7.36 (m, 3H, ArH),7.04 (s, 4H, ArH), 4.55 (m, 1H, CHOH), 3.45 (s,
2H, CH2Ar), 2.91 (d, 1H, J= 12.5 Hz, CH2SPh), 2.91 (d, 1H, J= 12.5 Hz, CH2SPh), 2.31
(s, 3H, CH3Ar), 2.51-1.49 (m, 6H, 3 x CH2). 13C NMR (63 MHz, CDC13) 5: 205.8
(C=0), 137.0 (ipso), 136.6 (ipso), 134.6 (ipso), 132.0 (ArH), 129.1 (ArH), 128.6 (ArH),
128.4 (ArH), 128.2 (ArH), 76.9 (CHOH), 61.5 (quat), 37.1 (CH2), 35.1 (CH2), 34.1
(CH2), 32.1 (CH2), 21.1 (CH3) and 20.7 (CH2). HRMS (EI) m/z calculated for
C21H2402S [M] 340.14908, found 340.14915. HPLC (Chiralcel AD-H,
hexane/isopropanol= 95/5, 1.0 mL/min, A,= 254 nm), retention time: minor diastereomer
(12.5, 16.3 mins), major diastereomer (13.8, 17.9 mins).
193
Experimental
Synthesis of cinchona alkaloid catalysts
(l/?)-(8-ethylquinuclidin-2-yl) (6-methoxyquinolin-4-yl) methanamine 101
101
Hydroquinine (3.5 g, 10.7 mmol, 1 equiv) and triphenylphosphine (3.38 g, 12.9 mmol,
1.2 equiv) were dissolved in 50 mL of dry THF and the solution was cooled to 0 °C.
Diisopropyl azodicarboxylate (2.61 g, 12.9 mmol, 1.2 equiv) was added all at once.
Then a solution of diphenyl phosphoryl azide (3.56 g, 12.9 mmol, 1.2 equiv) in 20 mL of
dry THF was added dropwise at 0 °C. The mixture was allowed to warm to rt. After
being stirred for 12 h, the solution was heated to 50 °C for 2 h. Then triphenylphosphine
(3.65 g, 13.91 mmol, 1.3 equiv) was added and heating was maintained until gas
evolution had ceased (2 h). The solution was cooled to room temperature and 1 mL of
water was added and the solution was stirred for 3 h. Solvents were removed in vacuo
and the residue was dissolved in CH2CI2 and 10% HC1 (1:1, 100 mL). The aqueous
phase was washed with CH2C12 (4 x 50 mL). Then the aqueous phase was made alakline
with excess cc. aqueous ammonia and was washed with CH2CI2 (4 x 50 mL). The
combined organic phases were dried over MgS04 and concentrated in vacuo.
Purification by column chromatography (SiC>2, EtOAc/ MeOH/ cc. aq. NH40H= 50/ 50/
1) afforded the title compound (3.02 g, 87 %) as a yellowish viscous oil. 'H NMR (360
MHz, CDCI3) 5: 8.73 (d, 1H, J= 4.7Hz, ArH), 8.11 (d, 1H, J= 9.1Hz, ArH), 7.70 (br, s,
1H, ArH), 7.65 (d, 1H, J = 4.4Hz, ArH), 7.49 (d, 1H, J= 2.7, 9.2Hz, ArH), 4.77 (d, 1H,
J= 10.2Hz, CHNH2), 4.00 (s, 3H, OCH3), 3.33 (dddd, 1H, J= 2.2, 7.8, 10.5, 15.5Hz,
CH), 3.29 (dd, 1H, J= 9.8, 13.6Hz, CH), 3.19 (q, 1H, J= 10.7Hz, CH), 2.85 (ddd, 1H, J=
4.9, 13.7, 15.5 Hz, CH), 2.61 (ddd, 1H, J= 2.3, 4.7, 13.5Hz, CH), 1.71-1.33 (m, 8H),
194
Experimental
0.89 (t, 3H, J= 7.3Hz, CH3CH2).13 C NMR (91MHz, CDC13)8: 157.9 (OMe ipso), 147.4
(ipso), 146.5 (ArH), 143.2 (ipso), 129.6 (ArH), 128.2 (ipso), 121.5 (ArH), 119.2 (ArH),
101.0 (ArH), 61.3 (CHN), 56.8 (CH2), 54.3 (OCH3), 50.4 (CHNH2), 39.9 (CH2), 36.7
(CH), 27.4 (CH2CH3), 26.7 (CH2), 24.9 (CH2), 24.7 (CH) and 10.4 (CH3CH2).
'H NMR and 13C NMR data was in agreement with the literature. 18
l-(3, 5-bis (trifluoromethyl) phenyl)-3-3(fl)-(8-ethylquinuclidin-2-yl)(6-
methoxyquinolin-4-yl)methyl)thiourea 284
To a solution of 9-amino(9-deoxy)ep/'-hydroquinine 101 (0.5 g, 1.54 mmol, 1 equiv) in
dry THF (5 mL) was slowly added a solution of 3,5-bis(trifluoromethyl)phenyl
isothiocyanate (0.422 g, 1.54 mmol, 1 equiv) in 5 mL of dry THF at ambient
temperature. The mixture was stirred overnight and the solvent was removed in vacuo.
Purification by column chromatography (Si02, EtOAc/ MeOH/ cc. aq. NH40H= 300/ 5/
1) afforded the title compound (716 mg, 78 %) as an off white amorphous solid; 'H
NMR (250 MHz, CDOD) 8: 8.58 (d, 1H, J= 4.7Hz, ArH), 8.00 (br, s, 2H, ArH), 7.96
(d, 1H, J= 2.6Hz, ArH), 7.94 (d, 1H, J= 9.3Hz, ArH), 7.49 (br, s, 1H, ArH), 7.47 (d,
1H, J= 4.8Hz, ArH), 7.36 (dd, 1H, J= 2.7, 9.3Hz, ArH), 6.31 (d, 1H, J= 11.0Hz,
CHNH2), 3.91 (s, 3H, OCH3), 3.45 (dddd, 1H, J= 2.3, 7.8, 10.5, 15.6Hz, CHax), 3.26
(q, 1H, J= 10.7Hz, CHeq), 3.17 (dd, 1H, J= 9.9, 13.6 Hz, CHN), 2.71 (ddd, 1H, J= 4.9,
13.8, 15.6Hz, CHeq), 2.43 (ddd, 1H, J= 2.3, 4.7, 13.6Hz, CHN), 1.59 (br, m, 2H, CH2),
1.41 (br m, 1H, CHCH2), 1.28 (br m, 1H, CH), 1.27 (ddd, 1H, J= 2.7, 10.4, 13.3Hz,
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CHeq), 1.21 (m, 2H, CH2CH3), 0.75 (t, 3H, J= 7.3Hz, CH3CH2), 0.61 (dd, 1H, J= 10.4,
13.3Hz, CHax). 13C NMR (91 MHz, CDOD) 5:180.7 (OS), 157.8 (OMe ipso), 146.4
(ArH), 145.5 (ipso), 143.3 (ipso), 141.2 (ipso), 130.6 (q, JCF= 33.0 Hz, ipso), 129.4
(ArH), 128.3 (ipso), 121.8 (q, JCF= 272.2 Hz, CF3), 121.3 (ArH), 121.1 (ArH), 119.3
(ArH), 115.0 (ArH), 102.3 (ArH), 59.6 (CHN), 56.5 (CH2), 54.7 (OCH3), 54.1 (CH2),
41.2 (CH2), 36.3 (CHCH2), 27.1 (CH2), 26.4 (CH2CH3), 24.7 (CH2), 24.5 (CH2) and 10.4
(CH3CH2).
'H NMR and 13C NMR data was in agreement with the literature. 19
2-((S)-benzyloxy (6-methoxyquinolin-4-yl) methyl)-8-vinylquinuclidine 283
To a solution of (+) quinidine (1.0 g, 3.08 mmol, 1 equiv) in DMF (10 mL) was added
NaH (0.300 g, 60% suspension in mineral oil, 2.5 equiv). The resulting mixture was
stirred at room temperature for 1 h, benzylchloride (0.429 g, 3.39 mmol, 1.1 equiv) was
added dropwise via syringe over 10 minutes. The resulting mixture was stirred
overnight. When the reaction was complete, brine was added carefully and the resulting
mixture was extracted with EtOAc. The organic phase was washed with brine and the
combined layers are dried over magnesium sulphate, filtered and concentrated by rotary
evaporation. Purification by column chromatography (Si02_ 95 % EtOAc/ MeOH)
afforded the title compound (1.05 g, 82 %) as yellowish oil; JH NMR (360 MHz,
CDC13) 5: 8.68 (d, 1H, J= 4.5 Hz, ArH), 7.97 (d, 1H, J= 9.3 Hz, ArH), 7.40 (d, 1H, J=
4.5 Hz, ArH), 7.32-7.20 (m,7H, ArH), 5.90 (m, 1H, CH=CH2), 5.24 (br, 1H, 1 x CH),




4.33 (d, 1H, J= 11.4 Hz, CH2OBn), 3.84 (s, 3H, OCH3), 3.22 (m, 1H,CH), 2.99 (m, 1H,
CH), 2.90-2.63 (m, 3H, 3 x CH), 2.20-1.95 (m, 2H, 2 x CH), 1.68 (br, m, 1H, CH),
1.49-1.36 (m, 2H, 2 x CH), 1.26-1.14 (m, 1H, 1 x CH). 13C NMR (91 MHz, CDC13) 5:
157.9 (OMe ipso), 147.7 (ArH), 144.8 (ipso), 144.7 (ipso), 140.6 (CHCH2=), 137.9
(ipso), 131.9 (ArH), 128.5 (ipso), 128.0 (ArH), 127.9 (ArH), 127.6 (ipso), 121.9 (ArH),
119.1 (ArH), 114.6 (CH2=), 101.3 (ArH), 80.6 (CHC-O), 71.4 (CH2OBn), 60.2 (CHN),
55.8 (OCH3), 50.2(CH2), 49.5 (CH2), 40.1 (CH), 28.2 (CH), 26.5 (CH2) and 22.2 (CH2).
'H NMR and 13C NMR data was in agreement with the literature. 20
4((5)-benzyloxy(8-vinylquinuclidin-2-yl) methyl) quinolin-6-ol, 90b
A suspension of 2-((6)-benzyloxy (6-methoxyquinolin-4-yl) methyl)-8-vinylquinuclidine
283 (0.400 g, 0.965 mmol, 1 equiv) and NaSEt (0.324 g, 3.86 mmol, 4 equiv) in dry
DMF was stirred at 110 °C until tic analysis showed that the starting material had been
consumed. The reaction mixture was cooled down to room temperature, mixed with sat
NH4C1 and H20. The resulting mixture was extracted with EtOAc. The organic phase
was washed with brine and the combined layers are dried over magnesium sulphate,
filtered and concentrated by rotary evaporation. Purification by column chromatography
(Si02,98% EtOAc/ MeOH) then 90 % EtOAc/ MeOH) afforded the title compound (294
mg, 76 %) as a yellowish powder. *H NMR (250 MHz, CDC13) 8: 10.83 (br, 1H,
ArOH), 8.58 (d, 1H, J= 4.5 Hz, ArH), 7.93 (d, 1H, J= 9.3 Hz, ArH), 7.77 (s, 1H, ArH),




(m, 1H, CH=CH2), 5.45 (br, 1H, 1 x CH), 4.87 (d, 1H, J= 10.0 Hz), 4.85 (s, 1H, 1 x
CH), 4.25 (d, 1H, J= 11.4 Hz, CH2OBn), 4.18 (d, 1H, J= 11.4 Hz, CH2OBn), 3.47 (br,
1H, 1 x CH), 2.97-2.94 (m, 2H, 2 x CH), 2.79-2.70 (m, 2H, 2 x CH), 2.17-2.15 (m, 2H,
2 x CH) 1.65 (br, 1H, 1 x CH), 1.43-1.30 (m, 2H, 2 x CH), 1.02 (br, 1H, 1 x CH).,3C
NMR (91 MHz, CDCI3) 5: 157.2 (ArOH), 147.1 (ArH), 144.3 (ipso), 144.2 (ipso), 140.1
(CHCH2=), 137.3 (ipso), 131.4 (ArH), 128.0 (ipso), 127.6 (ArH), 127.3 (ArH), 127.2
(ipso), 121.3 (ArH), 118.8 (ArH), 114.1 (CH2=), 100.8 (ArH), 80.1 (CHCO), 71.0
(CH2OBn), 58.7 (CHN), 48.8 (CH2), 49.1 (CH2), 39.7 (CH), 27.8 (CH), 26.0 (CH2) and
21.7 (CH2).
1H NMR and 13C NMR data was in agreement with the literature. 20
l-(3, 5-bis (trifluoromethyl) phenyl-3-((15, 25)-2-aminocyclohexyl) thiourea 323 21
3,5-bistrifluoromethylphenylisothiocyanate (0.600 g, 2.21 mmol, 405 pi, 1 equiv) was
added over a period of 1 h to a stirred solution of (15, 25)-(+)-l,2 diaminocyclohexane
(0.252 g, 2.21 mmol, 1 equiv) in dry dichloromethane (11 mL). The reaction mixture
was stirred for a further 3 h at rt. The solvent was concentrated by rotary evaporation.
Purification by column chromatography (Si02; 75 % EtOAc/EtOH) to afford the title
compound (485 mg, 57 %) as a crystalline yellow solid; m.p. = 97-99 °C (EtOAc/
EtOH). IR (neat)/ cm"1): u max 3252 (NH), 2936 (CH2), 1587 (NH2), 1176 (CF3), 1132
(CF3). *H NMR (360 MHz, MeOH) 5: 8.23 (s, 2H, ArH), 7.67 (s, 1H, ArH), 4.26 (m,
1H, CH), 2.64 (m, 1H, CH), 2.19-2.05 (m, 2H, 1 x CH2), 1.82-1.79 (m, 2H, 1 x CH2),
1.42-1.32 (m, 4H, 2 x CH2). 13 C NMR (91 MHz, MeOH) 5: 183.4 (C=S), 143.8 (ipso),
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132.7 (q, CF3, J= 190.4 Hz), 127.4 (ArH), 124.4 (ArH), 118.7 (ArH), 61.9 (CH), 56.4
(CHNC=S), 35.7 (CH2), 33.0 (CH2), 26.4 (CH2) and 26.3 (CH2).[a] 25D=-76.2 (c= 1.0 in
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Appendix 1: !H and 13C NMR Data
Spectroscopic Data
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'J-! NMR and 13C NMR data for 2-hydroxy-l-
(phenylthiomethyl)cyclopentyl(phenyl)methanone 269-trans
Experimental














' ' 1 ' 1
1.0
C7, 1X1 D ID (D CO
ir>-=i- Of— O) CD CD S
CO CO in CN O) O) CO CN
ca co cyjcrioo'ocicoco
CO CO (N CN (N CN M (N SIS
I
Li
I 1 1 T I T T 1 ' ' ' ' 1 ' T 1 1 I 1 ' ' 1 T




















Appendix 2: Chiral HPLC Data
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2.2. Chiral HPLC Data for 269 using (-) Quinine
o
269-trans





2.3. Chiral HPLC Data for 269 using (+) Quinidine
o o







2.4. Chiral HPLC Data for 291 using (-) Quinine







2.5. Chiral HPLC Data for 291 using (+) Quinidine
o o
291 -cis







2.6 Chiral HPLC Data for 291 using (+) Cinchonine
o o
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-2.934 -4.961 -5.767 'fidfiQUJ
n
1
I AKX*K*>AA A IAa v O O1 OK^O" A A'A'A A 1 O1 O 1 01 A A A
—i—1—1—1 i—1—1—1—i—1—1—1—i—'—r—'—i-1—'—1—i—1—1—1—i—■—'—i—1—'—'—i—1—1—1—i—'—1—1—i—1—1—1—i—1—1—'—i—1—1—1—I—1—1—"—
2 00 < 00 6.00 8.00 10.00 12.00 MAO 16.00 18.00 20.0 0 2 2.00 2 1 00 26.0 0 2 8 00 30.00







2.7. Chiral HPLC Data for 291 using (-) Cinchonidine
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2.8. Chiral HPLC Data for 299 using (-) Quinine
o o
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2.9. HPLC Data for 239b






2.10. Chiral HPLC Data for 239b
o
Peak # Retention time(mins) Area
1 12.079 47.25
2 13.038 51.35
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